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“Si buscas resultados distintos,  
no hagas siempre lo mismo” 
Albert Einstein 
“I have not failed.  
I’ve just found 10000 ways that won’t work” 
Thomas Alva Edison 
“Vive como si fueras a morir mañana.  
Aprende como si fueras a vivir siempre” 
Mahatma Gandhi 
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ABBREVIATIONS 
The most used abbreviations throughout the text are outlined below: 
1
H-NMR: Proton nuclear magnetic resonance spectroscopy 
Apo A1: Apolipoprotein A1 
Apo B: Apolipoprotein B 
ARE: Antioxidant-response element  
ATF6: Activating transcription factor 6 
BiP/Grp78: Binding immunoglobulin/Glucose-regulated protein 78 kDa 
BP: Blood pressure 
CAT: Catalase  
CoQ: Coenzyme Q10
CRT: Calreticulin 
eIF2: Eukaryotic initiation factor 2  
ER: Endoplasmic reticulum 
ERAD: ER-associated degradation  
GSH: Glutathione 
GPx: Glutathione peroxidase  
HDL: High-density lipoproteins 
IKK-: Beta subunit of IB kinase 
IL-1: Interleukin 1-
IRE1: Inositol-requiring kinase 1 
IRH: Ischemic reactive hyperemia 
IB-: alpha subunit of NF-B inhibitor 
JNK-1: c-Jun N-terminal kinase-1 
Keap-1: Kelch-like erythroid cell-derived protein with CNC homology 
(ECH)-associating protein 1 
LDL: Low-density lipoprotein 
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LPL: Low density lipoproteins 
LPO: Lipid peroxidation 
Med diet: Mediterranean diet 
Med+CoQ diet: Mediterranean diet supplemented with coenzyme Q10
MetS: Metabolic syndrome 
MMP-9: Matrix metalloproteinase-9 
MUFA: Monounsaturated fatty acids 
NADPH: Nicotinamide adenine dinucleotide phosphate 
NF-B: Nuclear factor kappa B 
NO: Nitric oxide 
Nrf2: Nuclear factor erythroid 2 – related factor 2 
oxLDL: Oxidized low-density lipoprotein 
OxS: Oxidative stress 
p22
phox
: p22phox nicotinamide adenine dinucleotide phosphate oxidase subunit 
p47
phox
: p47phox nicotinamide adenine dinucleotide phosphate oxidase subunit 
PBMC: Peripheral blood mononuclear cells 
PC: Protein carbonyl 
PCA: Principal component analysis 
PERK: Double-stranded RNA-activated protein kinase-like ER kinase  
PLS-DA: Partial least squares discriminant analysis
PUFA: Polyunsaturated fatty acids 
RNS: Reactive nitrogen species 
ROS: Reactive oxygen species 
RTL: Relative telomere length 
SFA diet: Saturated fatty acid-rich diet 
SOD: Superoxide dismutase 
sXBP-1: X-box binding protein 1 
TC: Total cholesterol 
TG: Triglycerides 
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TRL: Triglycerides-rich lipoproteins 
TrxR: Thioredoxin reductase 
UPR: Unfolded protein response 
VLDL: Very low density lipoproteins 
VIP: Variable importance in the projection 
VOO: Virgin olive oil 
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I. ABSTRACT 
Introduction: Accelerated aging population is a global phenomenon that is 
expanding over the last decades. The aging process is known to be 
accompanied by an increase in oxidative stress (OxS) and endoplasmic 
reticulum (ER) stress, which have been associated with the activation of 
inflammatory pathways. Nutrition and other lifestyle habits have a major 
impact on the risk of developing chronic diseases that appear more frequently 
in the elderly. Diet, particularly fat quality, may affect the reactive oxygen 
species (ROS) production and, in consequence, both OxS and ER stress. Due 
to the fact that postprandial state is the main physiological condition of the 
occidental society, it is crucial to study the postprandial effect induced by the 
long-term consumption of different dietary patterns. In this connection, the 
consumption of a diet with antioxidant properties such as the Mediterranean 
diet (Med diet) and supplementation with a natural antioxidant compound such 
as Coenzyme Q10 (CoQ) have been proved to decrease the postprandial OxS 
by reducing processes of cellular oxidation.
Hypothesis: The consumption of diets with different fat quality modulates the 
processes related to OxS, ER stress and the inflammatory response in terms of 
gene expression in an elderly population, during both fasting and postprandial 
state. Moreover, the supplementation with a natural antioxidant such as CoQ 
further improves this modulation. 
Main objective: To evaluate whether the long-term consumption of three 
dietary patterns with different fat quality (Med diet with or without 
supplementation in CoQ and saturated fatty acid-rich diet) modulates OxS in 
fasting and postprandial state by modifying the gene expression of Nrf2, 
p22phox and p47phox NADPH oxidase subunits, SOD1, SOD2, Gpx1, TrxR and 
Abstract 
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the protein levels of cytoplasmic and nuclear Nrf2 and Keap-1 in peripheral 
blood mononuclear cells (PBMC) from elderly people.
Secondary objectives: 1) To investigate the effect of the long-term 
consumption in fasting and postprandial state of the three dietary patterns on 
the expression of genes related to ER stress (sXBP-1, CRT, BiP/Grp78) in 
PBMC from elderly people. 2) To study the effect of the long-term 
consumption in fasting and postprandial state of the three dietary patterns on 
the expression of genes related to inflammatory response (p65 subunit of NF-
B, IB-α, IKK-, MMP-9, IL1- and JNK-1) in PBMC from elderly people. 
3) To investigate whether diets with different fat quality and supplementation 
with CoQ affect the metabolomic profile in urine samples from elderly people.
4) To study whether there is a direct relationship between endothelial function, 
through OxS mechanisms, and relative telomere length (RTL) in a cross-
sectional study involving an elderly population and a subgroup of metabolic 
syndrome (MetS) participants. 
  
Subjects, design and methodology: 20 elderly participants ( 65 years) were 
randomly assigned to receive, in a crossover design, three isocaloric diets with 
different fat quality for 4-week period each. The three diets were as follows: 
A. Mediterranean diet supplemented with 200mg of CoQ (Med+CoQ diet), B. 
Mediterranean diet supplemented with placebo (Med diet) and C. Western diet 
rich in saturated fat (SFA diet). At the end of the dietary intervention period, 
participants were given a fatty breakfast with the same fat composition as they 
have consumed in each intervention dietary period. Subsequent blood samples 
were drawn at 0 hours (before the test meal), at 2 and 4 hours. We determined 
the CoQ plasma levels, Nrf2 and Keap-1 protein levels, and the expression of 
genes related to OxS (Nrf2, p22phox, p47phox, SOD1, SOD2, Gpx1, TrxR), ER 
stress (sXBP-1, CRT, BiP/Grp78) and inflammatory response (p65, IB-α, 
                                                                                                                          Abstract 
13
IKK-, MMP-9, IL1-, JNK-1) in PBMC. In urine samples, we analyzed the 
metabolomic profile at baseline (pre-intervention) and after a 12 h fast (time 0, 
post-intervention) by proton nuclear magnetic resonance spectroscopy (1H-
NMR). 
Aditionally, a cross-sectional study was conducted with the involvement of the 
20 elderly participants and 66 MetS participants from the LIPGENE cohort, 
who were divided into four groups by quartiles of relative telomere length 
(RTL). We measured ischemic reactive hyperemia (IRH), total nitrite (NO) 
and protein carbonyl (PC) levels, superoxide dismutase (SOD) and gluthatione 
peroxidase (GPx) plasma activities. 
Results: The long-term consumption of Med diet, with or without CoQ 
supplementation, reduced the fasting gene expression of p22phox, SOD2 and 
Gpx1. Moreover, the supplementation of CoQ had an additive effect on the 
Med diet resulting in a greater fasting increase in cytoplasmic Nrf2 and Keap-
1 compared to the SFA diet. Regarding to the postprandial state, the Med diet 
with or without CoQ supplementation, reduced the gene expression of Nrf2, 
SOD (SOD1 and SOD2), TrxR and NADPH-oxidase subunits (p22phox and 
p47phox). Additionally, the Med+CoQ diet decreased postprandial Nrf2 and 
Gpx1 gene expression and also increased the postprandial cytoplasmic Nrf2 
and Keap-1 protein levels, in comparison with the SFA diet. We found that the 
long-term intake of the Med diet and the Med+CoQ diet, reduced the 
postprandial gene expression of sXBP-1 and BiP/Grp78, and the fasting gene 
expression of CRT when comparing to the SFA diet. Furthermore, we found 
lower gene expression of MMP-9, IL-1 and JNK-1 at fasting and 
postprandial state after Med diet intake, with or without CoQ supplementation. 
Notably, CoQ supplementation produced and additive effect on the Med diet 
by decreasing the postprandial gene expression of p65 (RelA) and IKK-
compared to SFA diet in PBMC from elderly people. As a result of the 
Abstract 
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metabolomic analysis, we found differences in the urinary profile of elderly 
women when comparing the Med+CoQ diet and the SFA diet, with greater 
excretion of hippurate levels after Med+CoQ diet and higher excretion of 
phenylacetylglycine levels after SFA diet consumption. Interestingly, 
hippurate excretion was positively correlated with CoQ and -carotene plasma 
levels and inversely related to Nrf2, thioredoxin, SOD1 and gp91phox subunit 
of NADPH oxidase gene expression, following Med+CoQ diet consumption. 
By contrast, phenylacetylglycine excretion was inversely related to CoQ 
plasma levels and positively correlated with isoprostanes urinary levels 
following SFA diet intake.  
Regarding to the cross-sectional study involving the elderly population and the 
MetS participants, we found that IRH and NO plasma levels were higher in 
participants with longer RTL (quartile 3 and 4), while PC plasma levels, GPx 
and SOD plasma activities were lower in quartile 4 subjects (longest RTL). 
Additionally, participants with longer RTL had greater homeostatic model 
assessment- (HOMA-) level and lower triglycerides plasma levels. 
Main conclusion: The long-term consumption of Med diet contributes to the 
redox homeostasis of elderly people at fasting and postprandial state. 
Supplementation with exogenous CoQ enhances this contribution by 
modifying antioxidant protein levels and reducing the expression of genes 
related to OxS processes. 
Secondary conclusions: 1)The long-term consumption of Med diet, with or 
without CoQ supplementation, modulates ER stress by reducing the 
postprandial expression of genes associated with the unfolded protein 
response. 2) The intake of Med diet, with an additive effect provided by CoQ 
supplementation, modifies the inflammatory response by decreasing the 
fasting and postprandial expression of pro-inflammatory genes in an elderly 
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population. 3) The consumption of Med+CoQ diet modifies the metabolomic 
urinary profile of elderly women through greater excretion of metabolites 
associated with antioxidant properties, while metabolites excreted after the 
intake of a SFA diet are related to increased biomarkers of oxidative damage. 
4) There is a direct relationship between endothelial function, OxS and RTL in 
elderly people and MetS subjects, where high levels of oxidative damage may 
induce endothelial dysfunction and may increase telomere attrition. 
Resumen 
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I. RESUMEN 
Introducción: El envejecimiento acelerado de la población es un fenómeno 
mundial que se está produciendo progresivamente a lo largo de las últimas 
décadas. Este proceso se asocia con un incremento del estrés oxidativo (EO) y 
de estrés del retículo endoplásmico (RE), los cuales a su vez están 
relacionados con la activación de la respuesta inflamatoria. La nutrición y 
otros hábitos de vida ejercen un gran impacto sobre el riesgo de desarrollar 
enfermedades crónicas que se presentan con mayor frecuencia en personas de 
edad avanzada. Se ha demostrado que la dieta, particularmente la calidad de la 
grasa de la misma, afecta a la producción de especies reactivas de oxígeno y, 
en consecuencia, a los procesos de EO y de estrés del RE. Debido al hecho de 
que el estado postprandial constituye la situación fisiológica habitual en la que 
se encuentra el ser humano a lo largo del día en las sociedades occidentales, es 
necesario estudiar el efecto postprandial inducido por el consumo de diferentes 
modelos dietéticos. En este sentido, el consumo de una dieta Mediterránea 
(dieta Med) con propiedades antioxidantes y la suplementación con un 
compuesto natural antioxidante como la Coenzima Q10 (CoQ) contribuyen a 
reducir los procesos de oxidación celular, disminuyendo a su vez el EO 
postprandial. 
Hipótesis: El consumo de dietas con distinta calidad grasa puede modular la 
expresión génica de parámetros asociados con mecanismos de EO, estrés del 
RE y de respuesta inflamatoria en ayunas y durante el período postprandial en 
una población de edad avanzada. Además, la suplementación con un 
antioxidante natural como la CoQ podría aportar un beneficio adicional en 
estos parámetros. 
                                                                                                                         Resumen 
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Objetivo principal: Evaluar si el consumo de tres modelos dietéticos con 
distinto tipo de grasa (dieta Med con o sin suplementación en CoQ y una dieta 
rica en ácidos grasos saturados) modula el EO a largo plazo en ayunas y 
durante el estado postprandial modificando la expresión génica de Nrf2, 
subunidades p22phox and p47phox de la NADPH oxidasa, SOD1, SOD2, Gpx1, 
TrxR; así como los niveles citoplasmáticos y nucleares de Nrf2 y Keap-1 en 
células mononucleares de sangre periférica (PBMC) de personas de edad 
avanzada. 
Objetivos secundarios: 1) Investigar el efecto a largo plazo en ayunas y en 
estado postprandial del consumo de tres modelos dietéticos con distinto tipo de 
grasa sobre la expresión de genes relacionados con el estrés del RE (sXBP-1, 
CRT, BiP/Grp78) en PBMC de personas de edad avanzada. 2) Estudiar el 
efecto a largo plazo en ayunas y en estado postprandial del consumo de tres 
modelos dietéticos con distinto tipo de grasa sobre la expresión de genes 
relacionados con la respuesta inflamatoria (subunidad p65 de NF-B, IB-α, 
IKK-, MMP-9, IL1- y JNK-1) en PBMC de personas de edad avanzada. 3)
Investigar si el consumo de modelos dietéticos con distinto tipo de grasa y 
suplementación en CoQ afecta al perfil metabolómico en muestras de orina de 
una población de edad avanzada. 4) Estudiar si existe asociación directa entre 
la función endotelial, mediante mechanismos de EO, y la longitud relativa del 
telómero (RTL) en una población de edad avanzada y un subgrupo de 
participantes con síndrome metabólico (SMet). 
Sujetos, diseño y metodología: 20 voluntarios con edad superior a 65 años 
fueron sometidos de forma randomizada y cruzada, a tres períodos de 
intervención dietética de cuatro semanas de duración cada uno. Las tres dietas 
fueron las siguientes: A. Dieta Mediterránea suplementada con 200mg de 
CoQ10 (dieta Med+CoQ), B. Dieta Mediterránea suplementada con placebo 
Resumen 
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(dieta Med), C. Dieta rica en grasa saturada (dieta SFA). Tras cada periodo de 
intervención, los voluntarios consumieron una sobrecarga grasa de similar 
composición que la dieta a la que habían sido asignados, y se les realizó 
extracciones sanguíneas a las 0 horas (antes de tomar la sobrecarga), a las 2 y a 
las 4 horas. Se determinaron las concentraciones plasmáticas de CoQ, los 
niveles proteicos de Nrf2 y Keap-1, así como los niveles de expresión de genes 
relacionados con el EO (Nrf2, p22phox, p47phox, SOD1, SOD2, Gpx1, TrxR), 
estrés del RE (sXBP-1, CRT, BiP/Grp78) y la respuesta inflamatoria (p65, 
IB-α, IKK-, MMP-9, IL1-, JNK-1) en PBMC. En muestras de orina, se 
analizó el perfil metabolómico en el tiempo basal (pre-intervención) y en 
ayuno de 12 horas (tiempo 0h, post-intervención) mediante espectroscopía de 
resonancia magnética nuclear (1H-NMR). 
Además, se llevó a cabo un estudio comparativo transversal en la población de 
20 personas de edad avanzada y en 66 participantes con SMet de la cohorte 
LIPGENE, los cuales fueron agrupados en cuartiles según su longitud relativa 
telomérica. Se determinó la hiperemia reactiva post-isquémica (IRH), los 
niveles de nitritos totales (NO), los niveles de proteínas carboniladas (PC) y 
las actividades plasmáticas de las enzimas SOD y GPx. 
Resultados: El consumo a largo plazo de una dieta Med, con o sin 
suplementación con CoQ, disminuyó la expresión génica de p22phox, SOD2 y 
Gpx1 en el estado de ayuno. Además, la suplementación con CoQ ejerció un 
efecto aditivo sobre la dieta Med, resultando en un incremento de la fracción 
citoplasmática de Nrf2 y Keap-1 en comparación con la dieta SFA. Con 
respecto al estado postprandial, la dieta Med con o sin suplemento de CoQ, 
disminuyó la expresión génica de Nrf2, SOD (SOD1 y SOD2), TrxR y de las 
unidades de la NADPH-oxidasa (p22phox y p47phox). El consumo de la dieta 
Med+CoQ indujo un descenso postprandial en los niveles de expresión génica 
de Nrf2 y Gpx1, así como un incremento de los niveles proteicos de Keap-1 y 
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Nrf2 citoplasmático en comparación con la dieta SFA. Adicionalmente, 
observamos que la ingesta a largo plazo de la dieta Med y de la dieta 
Med+CoQ, disminuyó los niveles de expresión génica postprandial de sXBP-1 
y BiP/Grp78, así como los niveles de CRT en ayunas en comparación con la 
dieta SFA. La expresión génica de MMP-9, IL-1 y JNK-1 disminuyó en 
ayunas y en estado postprandial tras la ingesta de la dieta Med, con o sin 
suplementación en CoQ. Notablemente, la CoQ produjo un efecto aditivo 
sobre la dieta Med reduciendo la expresión génica de p65 (RelA) e IKK- en 
comparación con la dieta SFA en PBMC de personas de edad avanzada. El 
análisis metabolómico mostró diferencias en el perfil de mujeres de edad 
avanzada al comparar los efectos producidos por el consumo de la dieta 
Med+CoQ y la dieta SFA. Se observaron mayores niveles en la excreción del 
metabolito hipurato tras la dieta Med+CoQ y mayores niveles en la excreción 
de fenilacetilglicina tras el consumo de la dieta SFA. Los niveles de hipurato 
excretados se correlacionaron de manera positiva con los niveles plasmáticos 
de CoQ y -caroteno y de manera inversa con la expresión génica de Nrf2, 
tioredoxina, SOD1 y la subunidad gp91phox de la NADPH oxidasa, tras la 
ingesta de la dieta Med+CoQ. Por el contrario, la excreción de 
fenilacetilglicina se correlacionó de manera inversa con los niveles 
plasmáticos de CoQ y de manera directa con los niveles de isoprostanos en 
orina, tras el consumo de la dieta SFA. 
Con respecto al estudio comparativo transversal, encontramos que el IRH y los 
niveles en plasma de NO eran más elevados en los participantes con mayor 
RTL (cuartil 3 y 4), mientras que los niveles plasmáticos de PC, y las 
actividades plasmáticas de GPx y SOD son menores en dichos sujetos. 
Además, los participantes con RTL más elevado presentaron mayor índice 
HOMA- y menores niveles de triglicéridos en plasma. 
Resumen 
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Conclusión principal: El consumo a largo plazo de una dieta Med contribuye 
a la homeostasis redox de personas de edad avanzada en ayuno y en el estado 
postprandial. La suplementación con CoQ mejora esta contribución mediante 
la modificación de los niveles de proteínas antioxidantes y la disminución en 
la expresión de genes relacionados con procesos de EO. 
Conclusiones secundarias: 1) El consumo a largo plazo de una dieta Med, 
con o sin suplementación con CoQ, modula el estrés del RE mediante la 
reducción en la expresión postprandial de genes asociados con el mecanismo 
de respuesta a proteínas mal plegadas. 2) La ingesta de la dieta Med, con un 
efecto aditivo proporcionado por el suplemento en CoQ, modifica la respuesta 
inflamatoria mediante la reducción en ayuno y en estado postprandial de genes 
pro-inflamatorios en personas de edad avanzada. 3) El consumo de la dieta 
Med+CoQ modifica el perfil metabolómico en orina de mujeres de edad 
avanzada mediante el aumento en la excreción de metabolitos asociados con 
propiedades antioxidantes, mientras que los excretados tras la dieta SFA se 
asocian con un aumento en los biomarcadores de daño oxidativo. 4) Existe una 
relación directa entre la función endotelial, el EO y el RTL en personas de 
edad avanzada y con SMet, donde altos niveles de daño oxidativo podría 
inducir un aumento en la disfunción endotelial y podría acelerar el 
acortamiento de los telómeros.
II. INTRODUCTION
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II. INTRODUCTION
1.  AGING AND OXIDATIVE STRESS 
1.1. Aging 
Aging is generally defined as the progressive loss of function of an organism 
accompanied by decreasing fertility and increasing mortality (1). The effects 
of this unavoidable and complex process are manifested at genetic, molecular, 
cellular, organ and system levels, resulting in a decreased resistance to stress in 
its different forms, as well as an increased susceptibility to diverse diseases 
(2). For many years, the questioning of why aging occurs has been an 
intriguing mystery and numerous theories have been postulated in order to 
provide a meaningful explanation.  
One of the most widespread theories is the “free-radical” or oxidative stress 
(OxS) theory, initially postulated by Harman in 1956. Basically, it proposed 
that the constant generation of free radicals – or reactive oxygen species 
(ROS) – as by-products of metabolic reactions, induce damage to cellular 
components such as lipids, proteins and nucleic acids (3). The accumulation of 
such damage over time is suggested to contribute to the age-related 
deterioration of the organism (Figure 1). In this way, factors that increase 
ROS production are expected to accelerate aging, whereas factors that defend 
against ROS, should delay it (4). 
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Figure 1. The role of oxidants in aging and age-related diseases. Both non-modifiable risk 
factors (age, genotype) and modifiable risk factors (diet, environment) have the propensity to 
interact with, affect and be affected by inflammatory processes and OxS. The interaction of all 
of these parameters results in oxidative modifications of cellular macromolecules. These 
oxidative modifications alone or in association with other biologic factors may lead to 
changes in both gene expression and DNA repair capacity, or mitochondrial and membrane 
dysfunction. Adapted from Mechanisms of Ageing and Development 134 (2013) 139–157.
According to the World Health Organization, the proportion of the world's 
population over 60 years will double from about 11% to 22% between 2000 
and 2050 (Figure 2) (5). The number of people aged over 60 years is expected 
to increase from 605 million to 2 billion over the same period. Indeed, in 
almost every country (especially in low- and middle- income countries) people 
over 60 years is growing faster than any other age group, as a result of both 
longer life expectancy and declining fertility rates.  
This population aging can be interpreted as a successful fact for public health 
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policies and for socioeconomic development. On the other hand, it also 
presents a social and economic challenge, since the need for long-term care is 
exponentially rising. In fact, the number of elderly people who are no longer 
able to look after themselves due to physical or mental health problems is 
forecast to quadruple by 2050 (6).  
Figure 2. World population aged 0-4, 0-14 and 60 or over, 1950-2050. 
Source: UNDESA, Population Division, World Population Prospects: The 2010 Revision 
(New York, 2011). 
Because of this accelerated aging issue, numerous research studies have 
focused on extending “healthspan” more than “lifespan”. The term healthspan 
emphasizes the goal of a healthy and longer life. It could be defined as the 
length of time an individual is able to maintain good health, which is 
recognized by the ability for a system to retain or return to homeostasis in 
response to challenges (7). However, the term lifespan does not explicitly 
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include the quality of life, it only refers to the period of time for which an 
organism lives or is expected to live. That is the reason why the question of 
how to extend lifespan and, at the same time, to maintain the quality of life 
(healthspan) has been attracting significant attention over the past decade (8). 
One parameter highly related to aging is the telomere length and due to the 
universal fact that telomeres shorten with age, the study of its regulation and 
attrition in connection with the development of aging-related diseases is 
crucial (9). Telomeres are DNA-protein complexes that cap and preserve the 
integrity of the chromosomal ends. They consist of several thousands of 
repetitive sequences of TTAGGG that are naturally shortened with each cell 
division due to the end replication problem (10, 11). Progressive attrition of 
telomeres leads to a critical length that triggers the cell arrest phenomenon 
known as senescence (12), which has been widely associated with numerous 
health disorders. Notably, it has been reported that telomere attrition and 
oxidative DNA damage in endothelial progenitor cells is higher in coronary 
artery disease patients with metabolic syndrome (MetS) than in those without 
MetS (13). In addition, endothelial damage and atherosclerosis have been 
shown to be associated with telomere shortening in white blood cells more 
tightly than chronological aging (10). 
Since the mechanisms of the onset of metabolic diseases and aging-related 
diseases are very similar, they share the declining of biological functions, 
understanding the basis and pathways involved in the aging process could be 
helpful for a better comprehension of the overall disease process (14). 
1.2. Oxidative Stress 
OxS basically defines a condition in which the cellular balance between pro-
oxidant and antioxidant species is disturbed in such a way that cellular bio-
molecules undergo severe oxidative damage, compromising cell viability (15).  
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There is extensive evidence that ROS are generated continuously within 
eukaryotic cells as by-products of metabolic reactions under physiological 
state (4). This production is strictly controlled in order to maintain the 
reduction/oxidation (redox) homeostasis required for the proper functioning of 
the organism. Two connected situations may compromise this redox balance 
leading to the development of OxS: when the generation of ROS exceeds the 
ability of the system to neutralize and eliminate them or when there is a lack of 
antioxidant capacity caused by a disturbance in its production or distribution. 
As a result, this scenario leads to modification of lipids, proteins and/or DNA 
(16). Such modifications are called oxidative damage and for this reason OxS 
has been implicated in a growing list of human diseases as well as in the aging 
process. 
1.2.1. Reactive oxygen species production 
It is a well-known fact that the majority of living organisms depend on oxygen 
for survival. However, organisms have had to protect themselves from oxygen 
toxicity due to its chemical propensity to produce free radicals such as 
superoxide (O2
-) or hydroxyl radical (OH). Those radicals can be involved in 
subsequent chemical reactions producing additional molecules that can also 
elicit cellular damage, although they are not necessarily free radicals (17, 18). 
Thus, ROS and reactive nitrogen species (RNS) are collective terms for radical 
and non-radical agents derived from oxygen and nitrogen metabolism 
respectively, which have an extremely short half-life (19). 
In terms of reactivity with biological molecules, OH is the most reactive with 
a lifetime of 10-9s and practically no selectivity in order to react with most 
compounds (20). By contrast, O2- is less reactive and more selective. In 
biological systems it is able to form hydrogen peroxide (H2O2) through a self-
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dismutation reaction in a few seconds. O2
- also takes part in a diffusion-
controlled reaction with nitric oxide (NO) to produce a really potent and 
reactive RNS: peroxynitrite (ONOO-) (21), which oxidizes unsaturated fatty 
acids in biological membranes and also reacts easily with DNA, oxidizing 
purine and pyrimidine bases (20, 22). Most of the cytotoxicity attributed to 
NO is rather due to ONOO-, since nitric oxide is an essential free radical gas 
that acts as an intracellular messenger molecule in smooth muscle relaxation 
process and plays a fundamental role on endothelial function (23). In fact, it 
has been established that an increase in OxS levels, coupled with an 
impairment in nitric oxide (NO) availability, may cause alteration of 
endothelial cells causing endothelial dysfunction (24). These findings are 
usually reflected in decreased ischemic reactive hyperemia (IRH), which is a 
method for measuring changes in acute endothelial reactivity (25).  
It has been described that the majority of the ROS generated endogenously 
proceed from the mitochondria, where most of the oxygen consumed by 
aerobic organisms is reduced to water. However, a small proportion of the 
oxygen is converted to O2
- in two concrete sites of the electron transport 
chain: Complex I (NADH deshydrogenase) and Complex III (ubiquinone-
cytochrome c reductase) (26). During the respiratory process the free radical 
semiquinone (Q-), which acts as a mediatory in the regeneration of coenzyme 
Q, transfers an electron to molecular oxygen non-enzimatically, generating 
O2
-. In this way, the flux of O2
- is related to the concentration of potential 
electron donors, the local concentration of O2 and the second-order rate 
constants for the reactions between them (27). 
1.2.2. NADPH oxidase 
The cytosolic enzymatic systems that may contribute to OxS include the 
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nicotinamide adenine dinucleotide phosphate (NADPH) oxidases family. 
These enzymes were firstly described in phagocytes, participating in the 
defense against pathogens through generation of antimicrobial oxidants such 
as O2
- or O2
--derived oxidants (28) and they are likely to be the predominant 
source of ROS in the human vasculature. Activation of the NADPH oxidase 
enzyme complex requires the assembly of the cytosolic regulatory subunits 
(p47phox, p67phox, p40phox and rac) with the membrane-bound cytochrome b558 
(subunits gp91phox p22phox) (29). 
1.2.3. Pathologies associated with oxidative stress
The existence of diverse mechanisms of ROS production and their complexity 
highlights the fact that these species have a crucial role in human physiological 
and pathophysiological processes. Indeed, a large body of evidence supports 
the importance of ROS at low and regulated levels (30). As we discussed 
above, a normal immune function requires specific oxidative states, in fact, a 
lack of the ROS-generating NADPH oxidase NOX2 leads to 
immunodeficiency associated with recurrent infections in chronic 
granulomatous disease patients (31). Besides, ROS have a role in various 
signaling cascades regarding to growth factor stimulation and control of 
inflammatory responses (32) and they also participate in the regulation of 
apoptosis, differentiation, proliferation and migration (30). 
On the other hand, excessive ROS production contributes widely to the onset 
and development of diverse range of pathologies, being many of them a 
leading cause of death (Figure 3). 
The damage caused by ROS to the DNA is probably their main implication to 
cancer with changes in the genetic material such as base modification, 
rearrangement of DNA sequences, miscoding of DNA lesion, gene duplication 
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and oncogenes activation (33). 
Similarly, the oxidative damage has been studied extensively in cardiovascular 
disease. According to the theory of OxS, atherosclerosis is the result of 
oxidative modifications of low density lipoproteins (LDL) in the arterial wall 
by ROS (34). Furthermore, pathological processes such as 
ischemia/reperfusion injury and hypertension have been related to changes in 
the expression of NOX enzymes, and consequently ROS production, in 
vascular cells (35, 36). Other pathologies largely associated with aging and 
OxS are Parkinson’s and  Alzheimer’s diseases, where the amyloid soluble 
forms can lead to microglia activation and long-term ROS generation, 
contributing to neuronal damage and finally dementia (37). Regarding to 
MetS, it refers to the clustering of three or more characteristics such as 
hyperglycemia, hypertriglyceridemia, low level of high-density lipoprotein 
cholesterol (HDL-C), hypertension and abdominal obesity (40) according to 
the criteria defined by the Third Report of the National Cholesterol Education 
Program Adult Treatment Panel III (39). One of the mechanisms underlying 
this pathology is OxS (38) and it has been recently published that the degree of 
OxS in MetS pacients is directly influenced by the number of the components 
of the syndrome (41).  
Interestingly, those pathological processes have in common that when OxS 
cellular levels increases, the survival of the cell depends on its ability to adapt 
itself to the situation or withstand the oxidative damage as well as its capacity 
to repair and replace the damaged molecules. If the cell cannot afford the OxS, 
it undergoes apoptosis or programmed cell death. 
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Figure 3. ROS overproduction and its relation with disease. 
1.3. Antioxidant defense systems 
In order to decrease the intrinsically and extrinsically generated oxidative 
insults that may threaten the cellular redox status, cells possess highly 
regulated antioxidant defense systems that contribute to maintain an optimal 
functioning of the organism. Those mechanisms are divided into enzymatic 
and non-enzymatic systems. The primary antioxidant defense is formed by 
several enzymatic complex proteins that often incorporate minerals such as 
selenium or zinc in their structures. Inside this group, the main antioxidant 
enzymes include glutathione peroxidase (GPx), catalase (CAT) and superoxide 
dismutase (SOD), which serve as the most potent defense against free radicals 
and ensuing inflammatory reactions of the organism. On the other hand, the 
non-enzymatic antioxidant group includes vitamin C (ascorbic acid), vitamin E 
(-tocopherol), β-carotene, glutathione (GSH), thioredoxin (Trx), polyphenols 
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and numerous phytochemical agents. Cells must preserve the levels of all these 
antioxidant species, also defined as antioxidant potential, through endogenous 
synthesis or diet consumption (42, 43). 
1.3.1. Nrf2 regulation 
The efficiency of the whole set of antioxidant mechanisms lies on its capacity 
to adjust to increasing levels of stress through the up-regulated expression of 
its subcomponents. This adaptive response is driven by a group of 
transcription factors where the nuclear factor erythroid 2 – related factor 2 
(Nrf2) acts as orchestra conductor by regulating the inducible cell defense (44) 
through the Keap-1/Nrf2/ARE pathway (Figure 4). 
Nrf2 normally resides in the cytoplasm of unstressed cells, where interacts 
with Kelch-like erythroid cell-derived protein with CNC homology (ECH)-
associating protein 1 (Keap-1). In the absence of cellular stress, Keap-1 limits 
the activity of Nrf2 by promoting its degradation through the ubiquitin-
proteasome pathway (45), as a result, Nrf2 undergoes a constant cycle of 
production and decomposition that determines its relatively short half-life (10-
30 min) (46). In response to an oxidative insult, Nrf2 evades Keap-1 mediated 
repression and accumulates within the nucleus, where it dimerizes with 
proteins of the Maf family (47) and binds with specific affinity to the 
antioxidant-response element (ARE) located within the promoter regions of 
genes encoding many antioxidant proteins and phase-II detoxifying enzymes 
implicated in cell defense (48). In fact, AREs have been identified in 
numerous Nrf2 target genes such as those involved in regulating glutathione 
metabolism, antioxidant enzymes specialized in detoxification of ROS, 
xenobiotic transporters and many other stress response proteins (49, 50). Thus, 
Nrf2 widely increases the range of cell defense processes by inducing the 
expression of a large battery of genes, which in turn enhances the overall 
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capacity of an organism to detoxify and remove potentially harmful entities.  
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Figure 4. Schematic model of Nrf2 regulation by Keap1. Keap-1 is a key regulator of the 
Nrf2-signaling pathway and serves as a molecular switch to turn on and off the Nrf2-mediated 
antioxidant response. (i) Under basal conditions, Keap-1 constantly targets Nrf2 for 
ubiquitination and degradation. (ii) OxS and ROS increased production inhibit activity of
Keap-1, resulting in increased levels of Nrf2 and activation of its downstream target genes. 
Adapted from Pharmacological Research 58 (2008) 262–270. 
1.3.2. Antioxidant enzymes: SOD, GPx and TrxR 
In this connection, one of the main enzymes of the first line of the antioxidant 
defense is SOD, which consists of three isoforms in mammals: the 
cytoplasmic isoform that employs copper (Cu) and zinc (Zn), Cu/ZnSOD 
(SOD1); the mitochondrial isoform that employs manganese (Mn), MnSOD 
(SOD2); and the extracellular isoform that requires Cu and Zn, Cu/ZnSOD 
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(SOD3). In each subcellular fraction, SODs catalyze the dismutation reaction 
of O2
- to O2  and H2O2 and it involves successive reductions and oxidations of 
a transition metal as cofactors for their activation (51). The distinct subcellular 
location highlights the importance for compartmentalization in redox 
signaling. 
2O2
- + 2H+ → H2O2 + O2
In contrast to O2
-, which normally remains close to the place where it was 
produced, H2O2 is able to diffuse through cellular membranes (52) and to 
generate the critically reactive radical OH in the presence of reduced 
transition metals such as iron, as a result of the Fenton reaction (53). Since 
H2O2 is a powerful oxidant, several mechanisms are present in the cell in order 
to neutralize it. The universal enzyme CAT is a tetramer that catalyzes the 
decomposition of H2O2 to water and oxygen (54), according to the reaction 
below: 
2H2O2 → 2H2O + O2
Furthermore, H2O2 and organic hydroperoxides can be reduced to water or to 
the corresponding alcohols through a chemical reaction catalyzed by GPx, 
where reduced GSH acts as an electron donor (55): 
H2O2 + 2GSH → GS-SG + 2H2O 
or 
ROOH + 2GSH → ROH + GS-SG + H2O 
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GPx is the general name for a family of isozymes that have a selenium-
dependent glutathione peroxidase activity in mammals. The presence of 
selenocysteine in the catalytic centre has been suggested to guarantee a fast 
reaction with the hydroperoxide and a fast reducibility by GSH. There are four 
major GPx isozymes and they seem to have an antioxidant function at different 
locations in cellular compartments: GPx1 ubiquitously in the cytosol and 
mitochondria (considered as the prototype of glutathione peroxidase), GPx2 in 
the intestinal epithelium, GPx3 in plasma and GPx4 in cellular membranes 
(55, 56). 
As mentioned above, the transcription factor Nrf2 downregulates genes related 
to cell defense against OxS including those that encode for the enzymes SODs, 
GPxs and thioredoxin reductase (TrxR) (57). TrxR belongs to a family of 
flavoenzymes that catalyze the transfer of two electrons from NADPH to the 
substrate. These oxido-reductases are required for the reduction of the active 
site disulfide in Trx, thereby maintaining the pool of reduced and reactive Trx 
(58, 59). It has been also described that peroxides, including lipid 
hydroperoxides and hydrogen peroxide, can directly be reduced by TrxR. By 
this mechanism, TrxR could function as an alternative enzymatic pathway for 
detoxification of lipid hydroperoxides, otherwise mainly managed by GPx (60, 
61).
The effectiveness of this complex antioxidant response not only lies in its 
enzymatic machinery, it is worth noting the role of non-enzymatic compounds 
that largely contributes to maintaining the redox homeostasis. A clear example 
of that is the liposoluble vitamin E (α-tocopherol), whose important function 
is related to its capacity to retain the integrity of long-chain polyunsaturated 
fatty acids in the cellular membranes (fluidity, phase separation and lipid 
domains) and thus preserve their bioactivity. As these bioactive lipids are 
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important signaling molecules, changes in their amount or in their function 
due to oxidation affect crucial signaling pathways in cells (62). Another 
essential non-enzymatic compound is Vitamin C or ascorbic acid, which acts 
as an electron donor and a potent water-soluble antioxidant in humans. It is 
involved in the neutralization of free radicals and regeneration of vitamin E. In 
fact, both vitamins have been suggested to participate in the prevention of 
cardiovascular diseases (63, 64).
1.4. Endoplasmic reticulum stress 
The endoplasmic reticulum (ER) is a complex and well-organized system that 
catalyzes protein folding and detects the presence of misfolded or unfolded 
proteins (65). The continuous accumulation of misfolded proteins can affect 
the normal cellular functioning and trigger a condition called ER stress, which 
is known to contribute to the pathophysiology and development of numerous 
diseases such as neurodegenerative disorders, cardiovascular disease, diabetes 
mellitus and other aging-related diseases. Accumulated evidence has suggested 
a crosstalk between the generation of ROS and the cellular response to ER 
stress, although the exact mechanisms have not been fully clarified yet.  
All proteins that undergo the secretory pathway in eukaryotic cells first enter 
the ER, where they have to pass a quality control after being folded and 
assembled into subunit complexes (66). In this way, misfolded proteins are 
either retained in the ER lumen by chaperones that assist them for a proper 
folding or they are directly decomposed by the ER-associated degradation 
(ERAD) machinery or by autophagy (67). Some of these chaperones are 
calnexin and calreticulin (CRT), which are lectin proteins responsible for 
glycoprotein quality control and also contribute to the maintenance of Ca2+
homeostasis (68, 69). 
                                                                                                                    Introduction
37
In response to the ER stress caused by the aggregation of misfolded proteins, 
cells activate the “unfolded protein response” (UPR) to nullify the stress 
deleterious effects in the ER lumen (70). By and large, the UPR system acts 
through four main mechanisms: a) attenuation of protein synthesis in order to 
avoid more extra protein aggregation, b) enhancement of the folding capacity 
by inducing the transcriptional expression of ER chaperone genes, c) 
increment of ERAD capacity by inducing the expression of ERAD genes, and 
eventually through d) induction of apoptosis to delete damaged stressed cells 
(71) (Figure 5). 
Figure 5. Schematic model of the unfolded protein response (UPR). Misfolded or unfolded 
proteins induce the release of BiP from the 3 transducers of ER stress: PERK, IRE-1 and 
ATF6. Activated PERK phosphorylates eIF2a to attenuate protein translation and 
phosphorylates Nrf2 to up-regulate the anti-oxidant response. Cleaved activated ATF6 leads 
to induction of molecular chaperones BiP, PDI, etc. IRE-1 activation leads to XBP-1 splicing, 
transcriptional activation of chaperones and stimulation of protein degradation. ER 
Introduction 
38
chaperones, such as BiP, are protective and control protein folding and components of the 
UPR.. Adapted from N. Naidoo / Ageing Research Reviews 8 (2009) 150–159.
1.4.1. UPR pathway 
The molecular components of the UPR signaling pathway have been 
successfully determined over the last decades. Three proximal ER-located 
transmembrane signal transducers act together in harmony with the purpose of 
regulating the UPR through their respective signal cascades. These transducers 
are two protein kinases IRE1 (inositol-requiring kinase 1) and PERK (double-
stranded RNA-activated protein kinase-like ER kinase), and the transcription 
factor ATF6 (activating transcription factor 6) (71, 72). In this framework, the 
protein chaperone BiP (binding immunoglobulin protein) - also known as 78 
kDa glucose-regulated protein (GPR78) - is the master regulator of the whole 
pathway. Under non-stressed conditions, BiP binds to the luminal domains of 
the three transmembrane sensors to prevent their activation. However, under 
stress conditions (accumulation of misfolded and unfolded proteins in the ER 
lumen) BiP is released from IRE1, PERK and ATF6 and preferentially binds to 
the damaged proteins (73). Despite the fact that the exact mechanism by which 
the transducers sense ER stress is still under research, several models have 
been propose for the UPR activation, suggesting that each branch of the 
system is separately regulated (74). 
IRE1 is a type I transmembrane protein kinase that separates from BiP and 
oligomerizes during ER stress. Following oligomerization, its kinase activity 
becomes activated, initiating a signaling cascade that may activate the 
inflammatory protein c-Jun amino terminal kinase (JNK) (75). Its 
endoribonuclease domain becomes active as well, favouring a selective 
splicing through the cleavage of the mRNA that codes for the factor called X-
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box binding protein-1 (XBP-1) (76). This process leads to the translation of 
the spliced form of XBP-1 (XBP-1s), which is a highly active transcription 
factor that upregulates the expression of genes encoding chaperones, the 
expression of components involved in ERAD and also plays a key role in ER 
expansion (77, 78). 
ATF6 is categorized as a type II transmembrane protein that contains a DNA-
binding domain and a transcriptional activation domain. In response to ER 
stress, the dissociation from BiP leads to its transport to the Golgi complex 
where it is sequentially cleaved by two proteases (79). The resulting fragment 
is a transcription factor that translocates to the nucleus and activates UPR 
target genes related to chaperone expression and mechanisms of apoptosis. 
PERK is a type I transmembrane protein kinase whose activation during RE 
stress reduces protein synthesis globally, thereby preventing continued influx 
of newly synthesized polypeptides into the stressed lumen (80). This 
translational attenuation is achieved through activation of the main 
downstream effector of PERK, the eukaryotic initiation factor 2 (eIF2). In 
addition to the global inhibition of protein synthesis, PERK-mediated 
phosphorylation of eIF2 activates the transcription factor 4 (ATF4), which 
contributes to ER function, growth arrest mechanisms and apoptosis (81). 
PERK is also able to initiate the anti-OxS response due to the fact that upon 
ER stress, the transcription factor Nrf2 may be a substrate for its kinase 
activity. In such a way, PERK may phosphorylate Nrf2 resulting in 
dissociation of the Nrf2/Keap1 complex (82). 
Finally, if the UPR-mediated efforts to correct the protein folding damage fail, 
the cell undergoes apoptosis. At that point, ER generate apoptotic signals 
through several mechanisms that include PERK/ eIF2-dependent induction of 
the pro-apoptotic transcription factor (CHOP), IRE1-mediated activation of 
JNK and activation of pro-caspase 12 (65). 
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With age, the adaptive response of the UPR declines in terms of a progressive 
failure of chaperoning systems. In fact, in many age-related diseases, proteins 
or fragments of proteins convert from their soluble state to insoluble fibrils 
that accumulate in a variety of organs causing serious damage, as is the case of 
Alzheimer’s, Parkinson’s and type II diabetes (83). 
1.5. Inflammatory response 
The aging process has been tightly integrated with inflammation over the last 
years. In this connection, many research studies have shown that a low-grade 
chronic inflammatory status is characteristic of the aging process as a 
consequence of the global reduction in the ability of the elderly to cope with 
chemical, physical and nutritional stress factors and the concomitant 
progressive increase in pro-inflammatory markers. Different age-related 
pathologies, such as cardiovascular disease, type II diabetes, MetS, 
osteoporosis and cognitive decline, share a common inflammatory 
pathogenesis. Moreover, a large body of evidence suggests that environmental 
and lifestyle factors may also contribute to modulation of both inflammatory 
processes and age-related dysfunction (84, 85). 
Inflammation is the primary immune system reaction by the organism to 
remove pathogens or other injurious stimuli that may threaten the cellular 
normal state. The interaction of the cellular immune system with endogenous 
or exogenous antigens results in the generation of ROS and RNS, leading to 
signaling cascades that produce pro-inflammatory cytokines and inducing OxS 
phenomena (86).  
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1.5.1. NF-B activation  
The master regulators of immune and inflammatory processes in response to 
both injury and infection are the NF-B (nuclear factor kappa B) family 
transcription factors. This family can function as homo- or heterodimers 
according to the combination of the different subunits: RelA (p65), RelB, c-
Rel, p50 (p105 precursor) and p52 (p100 precursor) (87), where the most 
common association is a heterodimer of the p50 and p65 proteins. All of them 
share a highly conserved DNA-binding and dimerization domain known as 
Rel homology region. On the contrary, the subunits p65, RelB and c-Rel are 
the only ones that contain a transactivation domain that allows them to activate 
target gene expression (87, 88). The activity of these dimers is directly 
controlled by a set of proteins termed as IB (inhibitor of NF-B) through its 
non-covalent association with NF-B, shifting the steady-state subcellular 
location of the transcription factor to the cytoplasm (89). Members of the IB 
family are the classical IB proteins (IB-, IB-, IB-), the precursor 
proteins p100 and p105 and the nuclear IB (IB- and Bcl-3). The best 
characterized interaction is the one between IB- and the heterodimer 
p50/p65, due to the fact that IB- is related to the transient activation of NF-
B and interestingly, it is regulated at the same time by NF-B (87). 
NF-B pathway can be activated by at least three routes named the classical 
(canonical), alternative (non-canonical) and atypical pathway (90), where the 
first two pathways require the activation of the IB kinase (IKK) complex 
consisting of IKK-, IKK- and IKK- (also known as NEMO) subunits.  
The classical pathway relies on the phosphorylation of IB- by IKK- and 
IKK- subunits that leads to ubiquitination and consequent degradation of 
IB- through the proteosomal pathway (91). Free NF-B then rapidly 
translocates to the nucleus, where it binds to concrete DNA sequences, known 
as B DNA/sites, located in the promoter regions of numerous genes and 
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elevates or represses their expression (89). This pathway is activated by 
diverse stimuli that include pro-inflammatory cytokines such as tumor necrosis 
factor  (TNF), interleukins (IL-1, IL-6), bacterial lipopolysaccharide 
(LPS), Toll-like receptor (TLR) and ROS (91) (Figure 6). 
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Figure 6. Schematic model of the classical NF-B activation.  Upon stimulation of cells, 
activation of protein kinases induces phosphorylation of IKK-. IB- is rapidly 
phosphorylated by IKK- and degraded via the ubiquitin-proteasome pathway. The resulting 
free NF-B dimer (p50-p65) translocates to the nucleus for the transcriptional regulation of 
multiple target genes. 
In the alternative pathway, the IKK- is the main effector and this sort of 
activation is completely independent of IKK- and IKK-. Its activation may 
be triggered by a subset of the TNF superfamily receptors such as lymphotoxin 
 receptor, B-cell activating factor receptor (BAFF) or CD40 and requires the 
NF-B-inducing kinase (NIK) (92). This process results in the processing of 
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p100 and nuclear localization of the dimer RelB/p52. The alternative pathway 
is generally slower than the classical one but it has been demonstrated that is 
important for B cell homeostasis and adaptive immunity (93). 
Finally, the atypical NF-B activation is IKK-independent and can be caused 
by hypoxia/reoxygenation, UV irradiation and in some cell types, by H2O2
(94).  
1.5.2. Cytokines: IL-β
Cytokines are a diverse group of soluble proteins, peptides and glycoproteins 
that act as hormonal regulators in response to inflammatory or antigenic 
stimuli. They can exert their activity through autocrine, paracrine or endocrine 
pathways and their excessive production may lead to diverse pathological 
situations such as inflammatory, immune and infectious diseases (95). 
In this framework, interleukin-1 (IL-1) is a potent pro-inflammatory 
cytokine that is crucial for host-defense responses to infection and cell injury, 
and it also plays key roles in acute or chronic inflammatory and autoimmune 
disorders. The IL-1 family of cytokines comprises 11 proteins encoded by 11 
distinct genes in humans members, being IL-1 the best characterized and 
most studied (96). A large body of evidences has shown that this important 
molecule is produced and secreted by a variety of cell types, especially cells of 
the innate immune system such as monocytes and macrophages. It is produced 
as an inactive 31 kDa precursor, known as pro-IL-1, in response to the 
interaction of the pathogen associated molecular patterns (PAMPs) with their 
corresponding receptors in macrophages. Then, pro-IL-1 is processed and 
cleaved by the pro-inflammatory caspase-1, resulting in an active IL-1
molecule (97). Both isoforms, IL-1 and IL-1, have potent pro-inflammatory 
activities restricted at three levels: 1) synthesis and release, 2) membrane 
receptors and 3) intracellular signal transduction. Moreover, their pathways 
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include diverse positive- and negative- feedback mechanisms that amplify or 
terminate the inflammatory response. In the end, as a consequence of its 
activation, diverse cascades of phosphorylation and ubiquitination are 
triggered, resulting in the initiation of the NF-B and JNK pathways (98). 
1.5.3. JNK signaling 
JNK is a multifunctional kinase involved in numerous physiological and 
pathological processes. Its pathway plays a major role in apoptosis and can be 
triggered in response to growth factors and cytokines such as TNF and IL-1
(99).   
In mammals, the JNKs are encoded by three genes (JNK1, JNK2 and JNK3) 
and each of them belongs to a different chromosome. Interestingly, each 
mammalian JNK gene has alternative splicing products, resulting in 10 
different identified proteins. JNK1 and JNK2 are ubiquitously expressed, 
whilst JNK3 is only expressed in the central nervous system, cardiac smooth 
muscle and testis (100). 
Depending on the context of its expression, JNK is essential for critical 
cellular processes such as cell death, survival, proliferation and differentiation. 
Moreover, it is necessary for the induction of a great diversity of genes that 
encode cytokines, vascular endothelial growth, transmembrane receptors, 
matrix metalloproteinase 9 (MMP9), cell cycle regulator cyclins and 
intercellular adhesion molecules, among others (101-103).  
In addition to its key role in inflammatory pathways, JNK is also connected to 
OxS and ER stress mechanisms, where it is activated through the IRE1 route 
and it is involved in apoptotic processes (104). Regarding to OxS, there are 
many ways in which ROS may modify JNK activity, through both chemical 
(105) and enzymatic (106) reactions. Generally, increased levels of ROS very 
often correlate with increased JNK phosphorilation and subsequent activation. 
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One mechanism by which JNK is activated by ROS results from the fact that 
JNK can be held in an inactive form by GSTPi (glutathione-S-transferase 
enzyme class Pi). Under OxS situation, JNK dissociates from GSTPi and 
translocates to the nucleus or mitochondria in order to activate substrates 
(106). In addition, another mechanism that reflects this connection is 
conducted by hydroxynonenal, a molecule that is generated as an end product 
of lipid peroxidation and possesses the ability to form aggregates with JNK, 
causing its activation (105).  
1.5.4. Matrix metalloproteinases: MMP-9 
Matrix metalloproteinases (MMPs) are a family of Ca2+ and Zn2+ dependent 
endopeptidases that are able to degrade most of the extracellular matrix 
components (ECM). They regulate numerous physiological processes such as 
cell migration, proliferation and apoptosis, playing an important role in tissue 
remodeling in inflammatory diseases and cancer metastasis. MMPs alter cell 
function through the cleavage and release of microenvironment molecules 
from the ECM and through modulation of gene expression (107, 108). 
MMP-9 (gelatinase B) belongs to the MMP family and is synthesized as a 
zymogen with a molecular mass of 92-kDa, which is converted to an active 
enzyme of 82-kDa. Some of its substrates include collagen IV or V, 
fibronectin, ICAM-1, plasminogen and interleukin-2 (109). It has been 
described the relationship of MMP-9 with inflammatory processes in various 
diseases, which has led to a profound investigation in the mechanisms 
responsible for its regulation. MMP-9 gene expression is controlled by 
transcriptional factors including JNK/AP-1 and NF-B (110) and also can be 
induced by pro-inflammatory cytokines such as TNF, IL-1 or IL-6 (111). In 
this way, MMP-9 participates in several stages of atherosclerosis, where foam 
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cells increase its expression in response to oxidized lipoproteins and cytokines, 
facilitating the migration of muscle cells (112). 
1.6. Diet, postprandial state and oxidative stress 
Taking into account the great influence of processes such as OxS, ER stress 
and inflammation over the aging process, as well as the capacity of the 
organism in terms of dealing with them, it has been suggested that factors that 
increase the resistance to stress could be highly beneficial for the organism and 
could improve the lifespan. According to this, several relations between the 
stress response and genetic factors have been established in different models 
such as Drosophila, Caenorhabditis elegans (C. elegans) and mice. In fact, a 
mutation in the gene clk-1 of C. elegans has been described to increase 
longevity and to improve the antioxidant capacity of the nematode. This gen 
encodes for a mitochondrial protein that is homologous to a protein involved 
in the synthesis of Coenzyme Q, an electron transporter required for the 
cellular respiratory chain, in yeast. Those clk-1 mutants could lengthen 
lifespan by decreasing the metabolic rate, which in consequence would 
decrease the damage caused by ROS (113). 
Hence, the interest of the scientific community in the development of anti-
aging therapies has been growing up in the last years. In this framework, 
caloric restriction has been suggested to be the most reliable intervention to 
prevent age-related disorders and extend lifespan. This technique consists of 
the reduction of calories by 10-30% compared to ad libitum diet and despite 
the fact that the underlying mechanisms by which its benefits occur have not 
been clearly defined yet, some indications point towards an alteration of the 
metabolic rate and the accumulation of ROS (114). Experiments conducted in 
non-human primates have shown that caloric restriction may extend the 
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median lifespan and reduce the onset of age-related diseases (115). Further 
research in mimetics of caloric restriction such as resveratrol (116) is needed 
in order to broaden studies to humans since, owing to ethical and experimental 
limitations the investigation of human caloric restriction have not been 
actively conducted.  
1.6.1. Diet and oxidative stress 
Dietary components with antioxidant activity have received great attention due 
to their demonstrated role in modulating the OxS associated with aging and 
age-related conditions. Several research studies have indicated potential 
beneficial effects produced by dietary antioxidants related to the decrease of 
degenerative disease such as vascular dysfunction, cardiovascular disease and 
cancer (117). The importance of some of these antioxidants lies in the fact that 
they cannot be synthesized by the organism, as is the case of vitamin C. 
Humans and primates depend on the diet as a source of vitamin C, which has 
the ability to protect against lipid peroxidation (LPO) by acting as a scavenger 
of ROS and by reducing lipid hydroperoxyl radicals in the “vitamin E 
recycling process” (118). LPO is a biomarker of OxS that is often increased in 
cardiovascular disease, neurodegenerative diseases and diabetes (119, 120). 
These observations have raised the question whether there is a direct 
relationship between diet and OxS, and because of this, numerous studies 
including antioxidant dietary interventions have been conducted. Indeed, 
vitamin C supplementation was found to decrease the urinary concentrations 
of LPO by 20-30% in a placebo-controlled study (121) and vitamin E 
supplementation was shown to decrease heart attack risk in subjects with 
inadequate antioxidant protection (122). However, a variety of trials have 
resulted in conflicting outcomes regarding to antioxidant therapies. A possible 
explanation for this could be that the chronic intake of a healthy food pattern 
Introduction 
48
such as the Mediterranean diet (Med diet), which includes a combination of 
antioxidant compounds, is more effective that the supplementation with just 
one antioxidant element during an acute intake (123). 
In fact, extensive prospective studies suggest that a high degree of adherence 
to Med diet is associated with reduced mortality and also prevents the onset 
and progression of coronary heart disease (124) and other aging-related 
diseases (125). Common components of this diet include monounsaturated 
fatty acids (MUFA), -tocopherol, phenolic compounds, phytoesterols and 
other antioxidants, thus the leading hypothesis of this association is a decrease 
of OxS because of the antioxidant capacity of this diet (126). 
Recent studies have shown that the fat quality modification of meals may 
affect significantly the OxS levels. According to Perez-Martinez et al., the 
comparison of four diets with different fat quality and quantity in the 
postprandial state resulted in an improvement of the OxS biomarkers after 
consumption of a MUFA-rich diet. In this interventional study, the 
GSH/GSSG ratio was improved following the MUFA intake. In addition, this 
dietary pattern also induced lower plasma levels of LPO and protein carbonyl 
(PC), and also lower SOD activity compared with subjects adhering to the 
other three diets. Conversely, the consumption of a saturated fatty acid (SFA)-
rich diet increased H2O2 plasma levels (127). 
It is worth noting the main role that the oxidation of LDL plays in the scenario 
of cardiovascular disease. This mechanism generates oxidized LDL (oxLDL) 
particles which are further harmful than natives LDL in the vascular wall 
during the atherosclerosis process. In a recent review by Lapointe et al., 
twelve of the fourteen studies selected for obtaining an overview of the dietary 
patterns that participate in the oxLDL generation, showed that MUFA diet 
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consumption induced lower LDL oxidizability than diets rich in 
polyunsaturated fatty acid (PUFA diet) (123). 
Interestingly, marine-derived (n-3) PUFA has been reported to contribute to 
cardiovascular health through its anti-inflammatory properties and also 
through the decrease of very low density lipoproteins (VLDL) cholesterol and 
triglycerides (TG) plasma levels (128).  
1.6.2. Oxidative stress and postprandial state 
The postprandial state is a dynamic, non steady-state condition, with rapid 
remodeling of lipoproteins compared to the relatively stable fasting condition 
(129).  
Much of our knowledge of the relationship between lipids, lipoprotein 
metabolism and the development of atherosclerosis and cardiovascular disease 
is based on measurements taken in the fasting state. Despite such 
measurements remain the foundation of clinical assessment and are an 
important basis for medical treatments, it is remarkable that we spend most of 
the time in a non-fasting, postprandial state with continuous lipemia 
fluctuations throughout the day. In Western society, the most typical eating 
pattern consists of three or more meals a day, with each containing 20-70 g of 
fat (130). Unlike circulating carbohydrates that normally show only transient 
elevations following a typical fat containing meal, circulating TG show a 
pronounced elevation (postprandial lipemia) within an hour after meal 
ingestion and can remain elevated for 5–8h (129). Thus apart from breakfast, 
each of these meals is most likely consumed before plasma TG have returned 
to the baseline condition resulting from the previous intake. Several studies 
support the concept that the levels of circulating TG-rich lipoproteins (TRL) 
after meals are significantly associated with the development of 
atherosclerosis (131). Determination of the postprandial response is complex, 
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and consequently, it is more challenging to assess the cardiovascular risk 
associated with postprandial lipemia than during fasting conditions.  
After a fatty meal has been ingested, chylomicrons from absorption, VLDL 
and their remnants contribute to fast plasmatic elevation of TG, whilst LDL 
particles become smaller and denser and HDL are quickly catabolized (132). 
The capacity of individuals to regulate the circulating TG levels and clear 
TRLs is obviously an important reflection of their metabolic efficiency, which 
can be affected by age, sex, insulin levels, abdominal adiposity, exercise or 
genetic background (133, 134). 
The concept voiced by Zilversmit marked postprandial lipemia as a putative 
atherogenic factor in 1979 (135) and since then, growing evidences have 
suggested that remnant lipoproteins contribute largely to the atherosclerotic 
process. Due to the strong relation between OxS and atherosclerosis, those 
phenomena have been widely studied during postprandio, demonstrating that 
postprandial state is associated with OxS (136). Consumption of a meal rich in 
lipids and carbohydrates involves oxidative damage, because of the fact that 
macronutrients have an effect on the redox homeostasis in the organism. They 
can be either targets of oxidative modifications after absorption or they can be 
presented in a pro-oxidant form in the diet (137). These oxidized and/or 
oxidizable lipids give rise to increased plasma concentration of lipid 
hydroperoxides, which are associated with elevated susceptibility of LDL  to 
oxidation, apparently due to a structural perturbation at the particle surface 
(138). Furthermore, many studies have focused on the direct influences of OxS 
on the endothelial function, since the endothelium is the site for the etiology of 
atherosclerotic vascular disease (139). In this way, postprandial hyperglycemia 
and hypertriacylglycerolemia induced by high carbohydrate or SFA diet intake 
leads to increased postprandial OxS and impaired endothelial function in the 
majority of cases (140). By contrast, consumption of Med diet have been 
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shown to reduce the damage and dysfunction of the endothelium (141). These 
studies highlight the fact that dietary fat may be able to modulate the OxS 
produced at the postprandial state. 
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2.  MEDITERRANEAN DIET 
2.1. Mediterranean diet as a healthy dietary pattern 
The interest in nutrition has been gaining in ground over the last several 
decades. This is evidenced by numerous guidelines that combine balanced diet 
education with others healthy practices such as quitting smoking, increasing 
physical activity and avoiding behavioural risk factors that may compromise 
the personal well-being (142).  
Due to the fact that the genetic background of individuals is pre-determined 
and genetic manipulations nowadays cannot influence the aging rate of people, 
lifestyle and environmental factors are the ones in our hands to be modified. In 
this context, nutrition appears to be one of the strongest factors in order to 
ameliorate the rate of aging as well as the incidence of age-related diseases 
(143). 
With such a background, Med diet have emerged not only as a mere collection 
of some selected foods but as an recognized Intangible Cultural Heritage by 
the UNESCO in 2010, which ascribes the eating habits typical of the 
Mediterranean basin a cultural promotion role (144). This dietary pattern 
originally represented the food habits of Italy and Greece around the 1970s, 
which were part of the Seven Countries Study. This study was the first to 
demonstrate the association between Med diet and a decrease in all-cause 
mortality (especially cardiovascular mortality), when comparing the Med 
dietary pattern with diets from United States and northern European countries 
(145). 
There is no single Med diet, indeed more than 20 countries are included in 
what is termed Mediterranean region and therefore, there are many variations 
to the Med diet due to social, political and economic differences between these 
countries. By and large, Med diet typically emphasizes plant foods (cereals, 
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fruits, vegetables, legumes, tree nuts, seeds and olives) and olive oil as the 
main source of added fat. It also recommends reasonable consumption of fish, 
sea food, eggs, poultry and dairy products such as cheese and yoghurt, low 
intake of red meat and moderate ingestion of alcohol (especially red wine) 
(146). 
Despite the Med diet is high in fat content, the adherence to this dietary pattern 
has been related to greater longevity, improved life quality and lower 
incidence of cardiovascular diseases, cancer or cognitive impairment (147). 
In this way, intervention studies that assess the value of a Med dietary pattern 
have a great impact on the scientific community but also on society habits. 
The PREDIMED (Prevención con Dieta Mediterránea) Spanish study is a 
large-scale, multicenter, randomized, primary prevention trial in a high risk 
population that have addressed the effects of the three healthy diets on 
cardiovascular outcomes: low-fat diet, Med diet rich in olive oil and Med diet 
rich in tree nuts. After 3 months of follow-up, both Med diets resulted in lower 
blood pressure, improved lipid profiles, decreased insulin resistance and 
reduced concentrations of inflammatory biomarkers compared with the control 
low-fat diet (125). Eventually, after 4.8 years of follow-up the researchers 
observed that a Med diet supplemented with extra- virgin olive oil or nuts, 
resulted in an important reduction in the risk of major cardiovascular events 
among high-risk people (148). 
Similar outcomes resulted from the Medi-RIVAGE French intervention study, 
in which a Med diet group was compared to a low-fat diet group for risk 
factors of cardiovascular disease. After 3 months of intervention, LDL 
cholesterol, TG and insulin levels were lower in the Med diet group (149). 
Regarding to cohort prospective studies, a recent meta-analysis by Sofi et al.
showed a significant protection against major chronic degenerative diseases 
and overall mortality for individuals who reported a greater adherence to a 
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Med diet. Indeed, a 2-point increase of adherence to the Med diet significantly 
reduced death from any cause in a 8%, death or incidence from cardiovascular 
diseases in a 10% and neurodegenerative diseases in a 13% (150). 
2.2. Olive oil 
Olive oil is undoubtedly the core element of the Med diet. The healthy 
qualities derived from the consumption of olive oil have been known for 
thousands of years. It is remarkable that a great interest in this fat is referred in 
the myths and legends of the ancient Greece and in the writings of important 
Arabic doctors such as Maimónides or Averroes. However, all these beliefs 
only have had scientific basis in the twentieth century (151). 
Unlike other fat-rich diets such as the Western diet, in which most of the fat 
comes from the consumption of red meat or dairy products, most of the fat 
content of the Med diet comes from a single food component, namely olive 
oil. It means that the diet is low in SFA and high in MUFA, particularly in 
oleic acid. In fact, numerous estimations suggest that olive oil provides some 
85% of the fat content. The gastronomic characteristics of this dietary 
component are due to its richness in several micro-components that provide 
odour, colour and taste to the meals. That is why the addition of olive oil to 
certain dishes easily stimulates the consumption of healthy food such as fruits, 
vegetables, legumes and cereals. All of them contain high amounts of 
carbohydrates of low glycemic index and have important potential for 
promoting good health. Thus the benefits of the Med diet are not given 
exclusively by olive oil itself, but to the combination with its other health-
promoting components (152, 153).  
Olive oil is mainly composed of two fractions, saponifiable and non-
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saponifiable. The first fraction represents the 98-99% of oil and is basically 
formed by TG esterifying oleic acid (55-83% of the total fatty acid 
composition) and moderate quantities of other fatty acids such as linoleic acid 
(3.5-21%). The non-saponifiable fraction, or micro-components, contains a 
great variety of non-fat compounds that represent the 1-2% and provide the 
biological interest that is missing in other oils extracted from certain seeds 
such as sunflower, soya and rapeseed oils. Although they have high contents of 
oleic acid, they also need to be refined for human ingestion, which means that 
during the refinery process they will lose the vast majority of their original 
micro-components (153, 154).  
These non-fat components with great biological potential include a complex 
combination of vitamin E (tocopherols), hydrocarbons (squalene, carotenes 
and chlorophyll), triterpenes, phytosterols and a number of phenolic 
compounds. Phenolic compounds represent the polar fraction and are divided 
in four groups: the simple phenols (tyrosol, hydroxytyrosol, p-coumaric, 
vanillic, caffeic and gallic); flavonoids (luteolin and apigenin); secoiridoids 
(oleuropein); and lignans (pinoresinol and 1-acetoxypinoresinol) (155, 156). 
With regard to olive oil, a number of commercial varieties are offered on the 
market, being Virgin olive oil (VOO) and Extra virgin olive oil the ones that 
are real natural juices obtain directly from olives through physical processes 
and without organic solvents. Another product is sold simply as Olive oil and 
contains a small percentage of VOO (5-10%), which is added to previously 
refined olive oil. In the end, the content of micro-components is lower than in 
VOO, although it is higher than those derived from seeds (157). 
2.3. Olive oil and oxidative stress 
As a result of the Seven Countries Study, a great deal of interest in elucidating 
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the effects of MUFA on cholesterol metabolism has been exponentially 
growing. Over the past decade a new paradigm has emerged, with the idea that 
the beneficial effects of a Med diet go much further than cholesterol and even 
traditional cardiovascular risk factors.  
Notably, there are approximately 20 human intervention studies that indicate 
that extra VOO (rich in polyphenols) is superior to the rest of oils in 
modulating selected biomarkers of cardiovascular disease. It is of note that 
while some human studies have been conducted using excessive doses of olive 
oil that do not approximate the usual consumption, several others were 
performed using more realistic quantities (158). 
One of the most complete human experiments on olive oil phenols and 
cardiovascular prevention is the Eurolive study. In this trial, 200 healthy 
subjects from 5 European countries were given three different oils in a 
crossover design, with different polyphenol content each. Oils were namely 
with low, medium and high polyphenol content. The results showed on one 
hand that all of the oils reduced serum TG and the oxidative damage to DNA; 
on the other hand, there was an increase in HDL-C levels and in the 
GSH/GSSG ratio. Interestingly, these improvements in HDL levels and 
oxidative damage to lipids were related to the phenolic content in a dose-
dependent manner (159, 160).  
These beneficial effects on the lipid profile showing a decrease in LDL-C and 
an increase in HDL/cholesterol ratio after Med diet versus SFA diet were also 
observed and demonstrated in studies such as PREDIMED (125), 
MediRIVAGE (149) and the study conducted by Ahuja et al., where both diets 
were rich in lycopene (161). 
An important consideration that links LDL particles and the antioxidant 
capacity of the VOO components, particularly polyphenols, is the 
susceptibility of these particles to suffer oxidative modifications. It has been 
proven that after VOO intake, LDL molecules increase its content in 
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antioxidants (phenols and vitamin E) and oleic acid as well as its resistance to 
oxidation, by decreasing the progression rate of the curve of LDL oxidation 
(162, 163). 
Recent studies have suggested that chronic consumption of Med diet avoids 
the postprandial deterioration of endothelial function. In this way, the 
bioavailability of NO was higher and thus the endothelium-dependent 
vasodilatory response was greater following the ingestion of a MUFA-rich diet 
compared to a SFA or a low-fat diet (164, 165). In line with the improvement 
in the endothelial function, the influence of different dietary models on 
hemostasis has been widely studied due to the fact that this process is the 
result of a complex balance between coagulation and fibrinolysis, which both 
are crucial in the development of atherosclerosis. VOO consumption promotes 
a less pro-thrombotic environment compared with SFA diets, reducing platelet 
aggregation and modulating several different thrombogenic factors such as 
thromboxane B2 production, von Willebrand factor, tissue factor, tissue factor 
pathway inhibitor, plasminogen activator inhibitor-1 (PAI-1), Factor VII and 
Factor XII (166, 167). 
Moreover, the long-term consumption of the Med diet produces a lower NF-
B activation when compared with other types of fat either in fasting or 
postprandial state, and these results have been observed both in healthy people 
(168) and in MetS patients (169). 
Regarding to elderly people, the more recent studies consistently support that 
the Med diet, based in VOO, promotes a healthier aging and increased 
longevity (170). In fact, a prospective study of 8.5-year follow-up on older 
non-demented subjects, a MUFA-rich diet intake was shown to be protective 
against age-related cognitive decline (171). 
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3.  COENZYME Q10
3.1. Introduction 
Coenzyme Q10 or 2, 3-dimethoxy-5-methy-6-decaprenyl-1, 4-benzoquinone is 
a liposoluble molecule naturally present in most aerobic organisms from 
bacteria to mammals. It was first isolated and characterized by Festenstein et 
al. in 1955 (172) and two years later, in 1957, Crane et al. established that this 
compound functions as a member of the mitochondrial respiratory chain (173). 
In higher organisms, such as humans, the redox active benzoquinone ring is 
connected to a 10 isoprenoid units in its side chain, hence the name Coenzyme 
Q10 (CoQ).
At the time of its discovery, the CoQ distribution and synthesis was attributed 
exclusively to the inner mitochondrial membrane due to the fact that its only 
known function was transferring electrons from complexes I and II to complex 
III in the mitochondrial membranes (174). However, nowadays it is known 
that CoQ is a lipid-soluble molecule located in the hydrophobic domain of the 
phospholipid bilayer of virtually all cellular membranes and also in blood, 
both in HDL and LDL particles (175). 
CoQ is the only endogenously synthesized lipid with a redox function in 
mammals that exhibits broad tissue and intracellular distribution. It is also the 
only liposoluble antioxidant to date that can be synthesized de novo by animal 
cells, which is why CoQ is not considered a vitamin although its chemical 
structure is very similar (176). 
Cells generally rely on biosynthesis for their supply of CoQ: the precursor of 
the benzoquinone ring is 4-hydroxybenzoate (derived from the amino acid 
tyrosine) and the isoprenoid side chain comes from the mevalonate pathway. 
Endogenous CoQ levels are determined by both the rate of production and the 
rate of consumption in the body. The alteration of these levels can trigger 
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numerous disease states, especially those related to cardiovascular and 
neurodegenerative disease (174). 
In order to maintain CoQ levels, animal cells have unique enzymatic 
mechanisms to regenerate CoQ from its oxidized product, which is formed 
during the course of its antioxidant activities (177).  
CoQ can be also obtained through dietary sources such as heart, chicken leg, 
spinach and herring, with an estimated daily intake from food of 3-5 mg (175). 
Its absorption follows the same process as lipids in the gastrointestinal tract, 
but unlike them CoQ is taken up from the intestine into the circulation in a low 
rate, ranging between 2-3% of the total dose (178). CoQ is practically 
insoluble in aqueous solutions because of its long isoprenoid tail chain and due 
to this lipid characteristic, exogenous CoQ is incorporated into chylomicrons 
for transport to the peripheral blood (179). Following absorption, CoQ appears 
in plasma lipoproteins and in liver, but not usually in heart, kidney, muscle or 
brain. 
Administration of an exogenous substance may have consequences for the 
endogenous synthesis, but in vivo labeling of endogenous CoQ with 3H-
mevalonate have demonstrated that there is no product inhibition upon 
exogenous administration of the lipid (180). 
3.2. Function 
The two main functions of CoQ that constitute the basis for the research that 
supports its clinical use, are its key role in mitochondria bioenergetics and its 
antioxidant role. At mitochondrial membrane level, CoQ has three well-
characterized functions: transfer electrons among complexes of the 
mitochondrial respiratory chain, making it possible to produce energy in the 
form of ATP; generation of O2
- by autoxidation of ubisemiquinone; and 
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neutralize free radicals, thereby exercising its antioxidant role. This apparently 
paradox in its properties that allows CoQ to act both as a pro-oxidant and an 
antioxidant suggests that it may also modulate the cellular redox state under 
physiological or pathological conditions, and in particular, the aging process 
(181). The redox functions of CoQ are due to its ability to exchange two 
electrons in a redox cycle between the oxidized form (ubiquinon) and the 
reduced form (ubiquinol). This reaction can occur in a single step by the 
simultaneous transfer of two electrons or by two sequential steps of one 
electron each, through a semiquinone mediatory (182). 
Furthermore, at the inner mitochondrial membrane, CoQ is recognized as a 
crucial co-factor for uncoupling proteins and a modulator of the transition pore 
(183).  
Recent data have revealed that some of its effects may be related to gene 
induction mechanisms involved in human cell signaling, metabolism and 
cellular transport (184). 
In its reduced form, CoQ inhibits protein and DNA oxidation (185), although 
its capacity in order to avoid lipid peroxidation is the antioxidant function 
most deeply studied. Ubiquinol protects cell membrane lipids from oxidation 
and also interferes in the oxidation process of lipoprotein lipids present in the 
circulation. In fact, studies performed on LDL peroxidability in relation to its 
CoQ content clearly show that ubiquinol is the most active antioxidant and this 
content can be boosted through supplementation with exogenous CoQ. In this 
way, the resistance of the LDL particles is increased against the initiation of 
lipid peroxidation (186).  
3.3. Therapeutic use of CoQ 
CoQ has been widely used as a dietary supplement for more than 30 years and 
its use has grown with a corresponding increase in daily dosage. For this 
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reason, many studies concerning CoQ safety levels have been reported 
demonstrating its low toxicity in humans. Indeed, several clinical trials have 
indicated that the safety level for CoQ is 1200 mg/day/person and 
pharmacokinetic studies in animals and humans suggest that exogenous 
supplementation does not influence its endogenous biosynthesis nor does it 
accumulate in the organism (187). 
Cardiovascular disease is basically the main field of study of the CoQ 
therapeutic use and recent findings confirm a role of this antioxidant lipid in 
improving endothelial function. Patients affected by coronary artery disease 
have decreased levels of endothelium-bound extracellular SOD (ecSOD). In a 
randomized and controlled study of patients with ischemic heart disease, CoQ 
treatment at doses of 300 mg/day resulted in an improvement in ecSOD 
activity and this effect was accompanied by an increase of the flow-mediated 
dilation of the endothelium (188). In this regard, a recent meta-analysis 
conducted by Gao et al. provided important evidence that CoQ therapy 
improves endothelial function in patients both with and without cardiovascular 
disease (189). Furthermore, CoQ has been demonstrated to have an anti-
atherogenic effect in apo-E deficient mice fed with high-fat diet. In this model, 
CoQ supplementation was capable of decreasing the concentration of lipid 
hydroperoxides in atherosclerotic lesions (190).  
In reproductive medicine, several treatments with exogenous CoQ have also 
been employed. A study with 212 infertile men showed that the administration 
of 300 mg/day of CoQ or placebo for 26 weeks significantly improved sperm 
count and motility values (191).  
A common shared characteristic among degenerative diseases is mitochondrial 
dysfunction with abnormal energy metabolism and increased levels of cellular 
OxS. Therefore, the use of antioxidants is being widely explored for its 
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potential treatment, in which CoQ may be a promising neuroprotectant at high 
dosages in order to slow progression of Alzheimer’s disease, Parkinson’s 
disease, Friedeich’s ataxia, Huntington’s disease and other neurodegenerative 
disorders (175, 192). 
Regarding to the aging process, it seems that the CoQ content decreases during 
aging especially in mitochondria of some tissues and also in certain species 
(181). Moreover, it has been suggested that the high rate of ROS production by 
the mitochondrial respiratory chain induces a progressive peroxidation of 
mitochondrial phospholipids. This fact could lead to the dissociation of 
Complexes I-III and the subsequent loss of electron transferring. Thus, 
according to this statement, an increase in CoQ levels through 
supplementation may partially counteract this detrimental effect (193).  
In our study population of elderly people, we have previously demonstrated 
that the supplementation of 200mg/day of CoQ in sinergy with Med diet 
(Med+CoQ diet) has an additive effect on the antioxidant benefits provided for 
this dietary pattern. Indeed, the consumption of Med+CoQ diet resulted in a 
greater postprandial decrease in PC plasma levels; in SOD, CAT and GPx 
plasma activities and a greater increase in capillary flow and NO plasma levels 
with respect to the intake of a Med diet or a SFA diet (194). Furthermore, we 
have also proved that Med+CoQ diet consumption reduces the activation and 
stabilization of p53 in response to the DNA damage produced by OxS during 
the postprandial period in an elderly population (195). 
Taken together, all of these intervention studies with supplementation of CoQ 
make evident its beneficial effects on numerous health disorders, particularly 
those that are related to OxS process such as aging and age-related diseases. 
III. HYPOTHESYS 
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III. HYPOTHESIS  
Aging population is a global and progressive phenomenon that is expanding 
over the last decades. Accelerated aging population is occurring mainly 
because of declining fertility rates and increasing life expectancy, especially in 
the developing world (5). Nowadays, people over 60 years old constitute 11 
per cent of the global population and, by 2050 it is expected to account for 22 
per cent of the global population (6). Accordingly, the demand for long-term 
healthcare is exponentially growing and compromising the sustainability of 
health and social services. Nutrition and other lifestyle habits have a major 
impact on the risk of developing chronic diseases that appear more frequently 
in the elderly. In order to prevent these chronic disorders, a balanced diet and 
healthy lifestyles may be the main strategy to follow. 
Previous evidences support the fact that the aging process is accompanied by 
an increase in OxS and ER stress, phenomena that have been associated with 
the activation of inflammatory pathways and the production of pro-
inflammatory cytokines, which contribute to the low-grade chronic 
inflammatory state that underlies aging and age-related diseases (196). 
Another parameter highly related to aging and to some health disorders such as 
MetS, is the telomere length, which seems to be affected by OxS processes. In 
fact, progressive telomere attrition leads to a critical length that triggers the 
cell arrest phenomenon known as senescence (12). Due to the universal fact 
that telomere shorten with age, its study is crucial for understanding 
mechanisms of age-related diseases (9). 
Diet and particularly fat quality may affect the ROS homeostasis and, in 
consequence, both OxS and ER stress levels. Despite the majority of our 
knowledge about this fact comes from fasting state studies, fasting is not the 
typical physiological state of the occidental society, where successive food 
intake makes humans spend most of the time in the postprandial state (197, 
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198). Thus, it is fundamental to study the effect induced by the long-term 
consumption of different dietary patterns as well as the metabolic changes that 
occur during the postprandial state. In this connection, the long-term 
consumption of a Mediterranean diet has been shown to decrease the 
postprandial OxS by reducing processes of cellular oxidation in elderly people
(199).
CoQ is part of the mitochondrial electron transport chain and a potent 
antioxidant. Its beneficial effect has been reported in large preclinical and 
clinical studies regarding to cardiovascular disease, endothelial dysfunction 
and other conditions linked to mitochondrial dysfunction. In this regard, 
antioxidant supplementation interventions have been carried out suggesting 
that these therapies may ameliorate the oxidant and inflammatory status (189, 
200).
Our hypothesis focuses on demonstrating that the consumption of diets with 
different fat quality modulates the processes related to oxidative stress, ER 
stress and inflammatory response in terms of gene expression in an elderly 
population, during fasting and postprandial state. Moreover, the 
supplementation with a natural antioxidant such as CoQ further improves this 
modulation. 
IV. OBJECTIVES 
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IV. OBJECTIVES 
Main objective 
To evaluate whether the long-term consumption of three dietary patterns with 
different fat quality [1. Mediterranean diet supplemented with coenzyme Q10
(Med+CoQ diet); 2. Mediterranean diet without supplementation (Med diet); 
3. Saturated fatty acid-rich diet (SFA diet)] modulates oxidative stress in 
fasting and postprandial state, by modifying the gene expression of Nrf2, 
p22phox and p47phox NADPH oxidase subunits, SOD1, SOD2, Gpx1, TrxR and 
the protein concentrations of cytoplasmic and nuclear Nrf2 and Keap-1 in 
PBMC from elderly people.  
Secondary objectives 
 1. To investigate the effect of the long-term consumption in fasting and 
postprandial state of three dietary patterns with different fat quality and 
supplementation with CoQ, on the expression of genes related to endoplasmic 
reticulum stress (sXBP-1, CRT, BiP/Grp78) in PBMC from elderly people. 
2. To study the effect of the long-term consumption in fasting and postprandial 
state of three dietary patterns with different fat quality and supplementation 
with CoQ, on the expression of genes related to the inflammatory response 
(p65 subunit of NF-B, IB-α, IKK-, MMP-9, IL1- and JNK-1) in PBMC 
from elderly people. 
3. To investigate whether diets with different fat quality and supplementation 
with CoQ affect the metabolomic profile in urine analyzed by proton nuclear 
magnetic resonance spectroscopy (1H-NMR) from elderly people. 
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4. To determine whether there is a direct relationship between endothelial 
function, through oxidative stress mechanisms, and relative telomere length 
(RTL) in a cross-sectional study involving an elderly population and a 
subgroup of metabolic syndrome patients from a LIPGENE subcohort.
  
V. MATERIALS AND 
METHODS 
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V. MATERIALS AND METHODS
A.  STUDY POPULATION I
1. Participants and recruitment 
Volunteers were recruited using various methods including the use of general 
practitioner databases, poster and newspaper advertisements. Recruitment of 
participants and dietary intervention took place between January 1st, 2006 and 
November 15st, 2007. A total of 63 persons were contacted among those 
willing to enter the study. All participants underwent a comprehensive medical 
history, physical examination and clinical chemistry analysis before enrolment 
and gave their informed consent before joining the study. Inclusion and 
exclusion criteria were fulfilled by 20 participants (age  65 years; 10 men and 
10 women). This study was conducted according to the guidelines laid down 
in the Declaration of Helsinki and all procedures involving human subjects 
were approved by The Human Investigation Review Committee at Reina Sofía 
University Hospital (Córdoba, Spain).
1.1. Sample size calculation 
The calculation was made based on the following premises: 
- Primary endpoint of the study: Gene expression of Nrf2 (mRNA 
levels) 
- Standard deviation of the primary endpoint: 30% 
- Difference in minimum expected: 20% 
- Alpha error = 0.05 (Confidence level: 95%) 
- Beta error = 0.10 (Power: 90%) 
- Hypothesis Contrast: Bilateral. 
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Based on these premises are required 18 participants per group.
1.2. Inclusion criteria 
 Age  65 years.
 Body mass index: 20–40 kg/m2.
 Apo E E3/E3 genotype. 
 Total cholesterol concentration equal to or < 8.0 mmol/L.
 Non-smokers.
 No severe chronic pathology associated. The concomitance of 
diseases such as hypertension without micro- or macroangiopathy, 
dyslipidemia, degenerative joint disease, obesity, benign prostatic 
hyperplasia or chronic venous insufficiency. 
1.3. Exclusion criteria 
 Age < 65 years.
 Diabetes or other endocrine disorders.
 Chronic inflammatory conditions.
 Kidney or liver dysfunction.
 Iron deficiency anemia (hemoglobin < 12 g/dL men, < 11 g/dL 
women).
 Prescribed hypolipidemic medication.
 Prescribed anti-inflammatory medication.
 Fatty acid supplements including fish oil.
 Consumers of high doses of antioxidant vitamins (A, C, E, -
carotene).
 Highly trained or endurance athletes or those who participate in 
more than three periods of intense exercise per week.
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 Weight change equal or > 3 kg within the last 3 months.
 Alcohol (> 20g/day) or drug abuse (based on clinical judgment).
 Smokers.
2. Study design 
2.1. Randomization and diet intervention 
Participants were randomly assigned to receive, in a crossover design, three 
isocaloric diets with different fat quality for 4-week period each (Figure 7).  
The three diets were as follows: 
 Mediterranean diet supplemented with CoQ (Med+CoQ diet): 
containing 15% of energy as protein, 47% of energy as 
carbohydrates and 38% of total energy as fat [24% MUFA 
(provided by virgin olive oil), 10% SFA, 4% PUFA]. CoQ 
supplementation was supplied with daily capsules of 200 mg.
 Mediterranean diet supplemented with placebo (Med diet): with the 
same composition of the Med+CoQ diet but supplemented with 
placebo capsules.
 Western diet rich in saturated fat (SFA diet): containing 15% of 
energy as protein, 47% of energy as carbohydrate and 38% of total 
energy as fat (12% MUFA, 22% SFA, 4% PUFA).
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Figure 7.  Flow-chart of subjects who participated in each 4-week feeding trial. 
The cholesterol intake was kept constant (< 300 mg/day) during the three 
periods.  Eighty percent of the MUFA diet was provided by VOO, which was 
used for cooking, dressing salads and as a replacement for butter. Butter was 
used as the main source of fat during the SFA dietary period. 
Both the CoQ and the placebo capsules were specially produced by the same 
company (Kaneka Corporation, Osaka, Japan) and were identical in weight 
and external aspect. Participants taking capsules were unaware whether they 
were in the Med+CoQ or Med dietary period.  
The composition of the experimental diets was calculated by using the US 
Department of Agriculture food tables (201) and Spanish food composition 
tables for local foodstuff (202). The nutrient composition for each dietary 
pattern is detailed in Table 1. 
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Table 1: Composition of diet at the end of intervention period, alongside dietary targets1 
Med+CoQ diet Med diet SFAdiet
Energy (MJ/d) (E) 8.16 ± 0.32 8.22 ± 0.35 8.21 ± 0.31
%E from fat 39.73 ± 2.65 39.11 ± 2.02 40.38 ± 2.03
%E from SFA 9.04 ± 0.71a 8.78 ± 0.61a 20.75 ± 0.87b
%E from MUFA 24.36 ± 1.47a 24.24 ± 0.92a 13.46 ± 0.71b
%E from PUFA 4.28 ± 0.29a 4.15 ± 0.23a 3.92 ± 0.25b
%E from protein 16.07 ± 0.64 16.33 ± 0.52 16.16 ± 0.53
%E from CHO 44.31 ± 2.29 44.64 ± 1.86 43.64 ± 1.73
Cholesterol (mg/d) 345.86 ± 36.92 345.71 ± 35.93 378.18 ± 59.29
EPA (g/d) 0.15 ± 0.23 0.15 ± 0.23 0.15 ± 0.23
DHA (g/d) 0.26 ± 0.48 0.26 ± 0.48 0.26 ± 0.48
Total fibre (g/d) 27.17 ± 2.38 27.93 ± 2.22 27.42 ± 2.34
Ascorbic acid (mg/d) 181.17 ± 6.12 187.54 ± 5.83 195.62 ± 6.86
α-tocoferol (mg/d) 18.95 ± 0.84a 18.91 ± 0.73a 6.97 ± 0.76b
-carotene (mg/d) 3.13 ± 0.66 3.11 ± 0.92 3.21 ± 0.23
Nicotinic acid (mg/d) 21.54 ± 3.72 21.90 ± 3.95 21.87 ± 3.90
C14 (g/d) 0.48 ± 0.26a 0.47 ± 0.27a 7.00 ± 2.41b
C16:0 (g/d) 14.10 ± 4.79a 14.10 ± 3.96a 25.83 ± 6.85b
C16:1 (g/d) 1.81 ± 0.45a 1.81 ± 0.40a 3.11 ± 0.75b
C18:0 (g/d) 4.81 ± 2.45a 4.82 ± 2.23a 10.23 ± 3.41b
C18:1 (g/d) 61.10 ± 12.39a 60.40 ± 6.60a 37.15 ± 9.02b
C18:2 n6 (g/d) 9.28 ± 2.03 9.27 ± 1.64 5.82 ± 2.43
C18:3 n3 (g/d) 0.65 ± 0.16 0.66 ± 0.11 0.86 ± 0.26
1Values are means ± SE (n = 20). Means in a row with superscripts without a common letter 
differ, p < 0.05. Med diet, Mediterranean diet; Med+CoQ diet, Mediterranean diet 
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supplemented with CoQ; SFA diet, SFA-rich diet; CHO, carbohydrate; SFA, Saturated fatty 
acid; MUFA, Monounsaturated fatty acid; PUFA, Polyunsaturated fatty acid; g, grams; mg, 
milligrams; EPA, eicosapentaenoic acid; DHA, docosahexaenoic; C14:0, myristic saturated 
fatty acid; C16:0, palmitic saturated fatty acid;  C16:1, palmitoleic monounsaturated fatty 
acid; C18:0, stearic saturated fatty acid; C18:1, oleic monounsaturated fatty acid; C18:2, 
linoleic polyunsaturated fatty acid; C18:3, linolenic polyunsaturated fatty acid. 
Before the start of the intervention period, volunteers completed a 3-day 
weighed food diary and extensive Food Frequency Questionnaires, which 
allowed the identification of foods to be modified. At the start of the 
intervention period, each participant was provided with a handbook for the diet 
to which they had been randomized. Advice was given on foods to choose and 
those to avoid if eating outside home. They were also instructed to write down 
in the diary about any menu eaten out of home and to call the monitoring study 
nurse reporting such event. At baseline, volunteers were provided with a 
supply of study foods to last for 2 weeks (extra VOO for Med and Med+CoQ 
diet and butter for SFA diet). They collected additional study foods every 
fortnight or when required. 
At these times, a 24-h recall of the previous day food intake and a short food 
use questionnaire based on the study foods were completed to monitor and 
motivate volunteers to adhere to the dietary advice. A point system was used to 
assess the number of food exchanges achieved in the 24-h recall and additional 
advice was given if either the 24-h recall or food use questionnaire showed 
inadequate intake of food exchange options. Volunteers were asked to 
complete 3-day weighed food diaries at baseline, weeks 2 and 4. Weighed food 
intake over two weekdays and one weekend day was obtained using scales 
provided by the investigators. Fat foods were administered by dietitians in the 
intervention study. The dietary analysis software Dietsource version 2.0 was 
used (Novartis S.A., Barcelona, Spain). 
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2.2. Postprandial study 
At the end of the dietary intervention period, subjects were given a fatty 
breakfast with the same fat composition as consumed in each of the dietary 
intervention period. Participants presented at the clinical centre at 8-hours 
following a 12 hours fast (time 0), abstained from alcohol intake during the 
preceding 7 days. After canulation of a blood vessel, a fasting blood sample 
was taken before the test meal, which was then ingested within 20 min under 
supervision.  
The test meal reflected the fatty acid composition of each subject after the 
chronic dietary intervention. Subsequent blood samples were drawn at 2 and 4 
hours after the fat challenge. Test meals provided an equal amount of fat (0.7 
g/kg body weight), cholesterol (5 mg/kg of body weight) and vitamin A 
(60,000 IU/m2 body surface area). It provided 65% of energy as fat, 10% as 
protein and 25% as carbohydrates. The composition of the breakfasts was as 
follow:  
 Med+CoQ diet: with 12% of the total fat as SFA, 43% as MUFA and 
10% as PUFA, supplemented with 400 mg of CoQ in capsules. 
 Med diet: with 12% of the total fat as SFA, 43% as MUFA and 10% as 
PUFA, supplemented with 400 mg of placebo in capsules. 
  SFA diet: with 38% of the total fat as SFA, 21% as MUFA and 6% as 
PUFA.  
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Figure 8.  Diagram of the study design. 
3. Biochemicals determinations 
3.1. Plasma samples 
Venous blood samples were obtained at the end of each dietary intervention 
period at fasting state (time 0h), following a 12-fast, and at 2 and 4 hours after 
the intake of the breakfast. Samples from the fasting and postprandial state 
were collected in tubes containing 1g EDTA/L, stored in containers with ice 
and kept in the dark. Particular care was taken to avoid exposure to air, light, 
and ambient temperature. Plasma was separated from whole blood by low-
speed centrifugation at 1500 x g for 15 min at 4°C within 1 h of extraction. 
3.2. Lipid analysis 
Lipid variables were analyzed with a modular autoanalyzer (DDPPII Hitachi; 
Roche, Basel, Switzerland) with the use of Boehringer-Mannheim reagents®. 
Total cholesterol (TC), TG and lipoprotein fractions were assayed in plasma 
by means of enzymatic procedures. Apolipoprotein A1 (Apo A1) and 
apolipoprotein B (Apo B) levels were determined by inmunoturbidimetry. 
HDL-C was measured by analyzing the supernatant obtained following 
precipitation of a plasma aliquot with dextran sulfate-Mg2+. LDL-C levels 
                                                                                                     Materials and methods
81
were estimated using the Friedewald formula based on TC, TG, and HDL-C 
concentrations. Plasma glucose concentrations were measured with an 
Architect-CG16000 analyzer (Abbott Diagnostics, Tokyo, Japan) by the 
hexoquinase method. Plasma insulin concentrations were measured by 
chemoluminesence with an Architect-I2000 analyzer (Abbott Diagnostics, 
Tokyo, Japan). High-sensitivity C-reactive protein concentrations were 
measured according to Rifai et al (203). 
3.3. Coenzyme Q10 
CoQ levels were carried out in plasma samples according to the method 
described by Santos-Gonzalez et al (204). Quantification was perfomed by 
reversed-phase HPLC. Separation was performed at 1 mL/min in a C18 
column (5 m particles, 5×0.45 cm) and with a mobile phase that consisted of 
a mixture of methanol and n-propanol (1:1) containing lithium perchlorate 
(2.12 g/L). Monitoring was carried out with a Coulochem II electrochemical 
detector (ESA, Chelmsford, MA) fitted with a Model 5010 analytical cell with 
the electrodes set at potentials of −500 and +300 mV. CoQ was detected from 
the signal obtained at the second electrode. Eluted compounds were quantified 
by integration of peak areas and comparison with an external CoQ standard 
(Sigma Aldrich, Madrid, Spain). 
3.4. Isolation of PBMC
Peripheral blood mononuclear cells (PBMC) are a sub-set of white blood cells, 
including lymphocytes and monocytes, which play a critical role in the 
immune system. Various studies have referred to PBMC as a model to study 
the response of energy homeostasis-related genes to acute changes in feeding 
conditions and also have shown disease-characteristic gene expression patterns 
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(205, 206). These cells can be easily and repeatedly collected in sufficient 
quantities in contrast to the more invasive sampling of adipose, muscle and 
liver tissues, amongst others (207). 
PBMC were isolated from 20 mL of venous blood in tubes containing 1 
mg/mL of EDTA. Blood samples were diluted 1:1 in PBS, and cells were 
separated in Ficoll gradient by centrifugation at 800×g for 25 min at 20°C. 
Cells were collected and washed with cold PBS twice and finally resuspended 
in buffer A. This buffer contained 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 15 mM KCl, 2 mM MgCl2 and 1 mM 
EDTA. At the time of use 1 mM PMSF and 1 mM DTT were added. Finally, 
cells obtained were stored at −80°C for further analysis. 
4. RNA isolation and real time-polymerase chain reaction (RT-PCR) 
4.1. RNA isolation
Total RNA from PBMC was isolated using the trizol method according to the 
recommendations of the manufacturer (Tri Reagent®, Sigma, St Louis, MO, 
USA) and quantified in a NanoDrop 1000A Spectrophotometer. RNA integrity 
was verified on agarose gel electrophoresis and stored at −80°C. Next, since 
qRT-PCR can detect even a single molecule of DNA, RNA samples were 
digested with DNAse I (AMPD-1 KT, Sigma) before RT-PCR. 
4.2. Gene expression analysis by RT-PCR 
4.2.1. Reverse transcription polymerase chain reaction 
The reverse transcription polymerase chain reaction was performed using the 
commercial kit iScript cDNA Synthesis Kit (Bio Rad) according to the 
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manufacturer’s instruction. Briefly, cDNA was synthesized from 1g of total 
RNA in a final volume of 20µL. Each mixture was prepared in sterile tubes of 
0.2µL, RNase, DNase and exogenous DNA free. The reverse transcription 
reaction was carried out in a thermo-cycler MJ Thermal Cycler Personal 
mini™ closure (BioRad Inc., Hercules, CA, USA) consisted of 25°C for 5 min, 
42°C for 30 min and 85°C for 5 min. The cDNA ready for qRT-PCR, was 
stored at -20 °C until its performing. 
4.2.2. RT-PCR
The reaction of real-time PCR was carried out using the platform 
OpenArray™ NT Cycler (Applied Biosystems). This system of gene 
expression analysis is used as a method for quantification TaqMan probes. 
OpenArray™ subarrays were preloaded by Biotrove with the selected primer 
pairs. The individual primer pairs (synthesized by Sigma-Aldrich, St. Louis, 
MO, USA) were preloaded into Bio Trove OpenArray™ plates. Each primer 
pair was spotted in duplicate. Primers that amplify the genes of interest were 
selected from the database TaqMan Gene Expression Assays (Applied 
Biosystems;https://products.appliedbiosystems.com/ab/en/US/adirect/ab?Cmd
=catNavigate2&catID=601267) in Assays search tab taking as search criteria: 
selection and Homo sapiens Gene Expression Assays for each of the genes of 
interest. 
Samples were loaded into OpenArray plates with the OpenArray NT 
Autoloader according to the manufacturer's protocols. Each subarray was 
loaded with 5.0 l of master mix consisted of 1× LighCycler FastStart DNA 
Master SYBR Green Kit (Roche Applied Sciences, Indianapolis, IN, USA), 1× 
SYBR Green I 80×, 0.5% glycerol, 0.2% Pluronic F-68, 1 mg/mL bovine 
serum albumin (New England Biolaboratories, Beverly, MA, USA), 1 mM 
MgCl2, 400 nM FP, 400 nM RP, 8% Formamide, 0.25× Rox, 1× TfR 
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amplicon, and cDNA samples. The PCR OpenArray thermal cycling protocol 
consisted of 95°C for 10 min, followed by cycles of 10 s at 95°C, 10 s at 53°C, 
and 10 s at 72°C. All samples were tested in duplicate. The Biotrove 
OpenArrayTM NT Cycler System Software (version 1.0.2) uses a proprietary 
calling algorithm that estimates the quality of each individual CT value by 
calculating a CT confidence value for each amplification reaction. 
In our assay, CT values with CT confidence values below 700 were regarded 
as background signals. The remaining positive amplification reactions were 
analyzed for amplicon specificity by studying the individual melting curves. 
The same program allowed the selection of the most stable housekeeping gene 
in the samples processed for the relativization of the expression of genes of 
interest. 
Following this methodology, we analyzed the relative gene expression of the 
following genes: Nrf2, p47phox and p22phox (NADPH oxidase subunits), SOD1, 
SOD2, GPx1, TrxR, p65 (RelA), IB-, IKK-, MMP-9, IL-1, JNK-1, 
sXBP-1, CRT and BiP/Grp78.  
5. Western Blot analysis 
5.1. Protein extraction 
PMBC were thawed on ice and buffer A was supplemented with 5g 
Aprotinin, 10g Leupeptin and 0.8% Nonidet NP-40. Cells were incubated on 
ice for 5 minutes, subjected to gentle agitation for 20 seconds in the vortex, 
and then centrifuged at 13000 rpm for 5 minutes at 4ºC. The supernatant 
containing cytoplasmic proteins was distributed in aliquots that were stored at 
-80ºC. The pellet was treated with 100L of lysis buffer (20mM HEPES, 
400mM NaCl, 1mM EDTA, 1mM EGTA, 1mM PMSF, 1mM DTT, 20g 
Aprotinin and 40g Leupeptin). The sample was incubated on ice for 20 
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minutes with periodic mixing with a vortex by stirring for 30 seconds every 5 
minutes of incubation. Cells were then centrifuged at 13000 rpm for 5 minutes 
at 4ºC. The obtained supernatant, containing the nuclear proteins, was 
distributed in aliquots and stored at -80ºC. The extracted proteins were 
quantified using the method of Bradford (1976) (Bio-Rad Protein Assay).
5.2. Western Blot 
Electrophoretic separation was carried out with 50g of protein for both 
cytoplasmic and nuclear fractions. After separation in SDS-PAGE gels (11% 
polyacrylamide) proteins were transferred to nitrocellulose membranes 
(BioTrace NT Membrane; PALL Gelman Laboratory). The following proteins 
were detected using their corresponding antibodies: Nrf2 (C-20, sc-722: mouse 
monoclonal, Santa Cruz Biotechnology, inc.); Keap-1 (Kelch-like ECH 
associating protein 1) (H-190, sc-33569: rabbit polyclonal, Santa Cruz 
Biotechnology, inc.); Actin (C-2, sc-8432: mouse monoclonal, Santa Cruz 
Biotechnology, inc.); TFIIB (C-18, sc-225: rabbit polyclonal Santa Cruz 
Biotechnology, inc.). After incubation with these primary antibodies, samples 
were incubated with respective secondary antibodies (goat anti-mouse or anti-
rabbit HRP-conjugate, Santa Cruz Biotechonology, inc.). The development 
process was carried out with ECL-Plus Western Blotting Detection System 
(AmershamTM) and used for autoradiography Hyperfilm MP High 
performance autoradiography film (AmershamTM). 
5.3. Quantification of protein bands 
Proteins were identified in the autoradiography by its relative position to 
molecular weight markers: 57 kDa for Nrf2, 69 kDa for Keap-1, 40 kDa for 
actin and 30 kDa for TFIIB. The relative amount of each on was quantified by 
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densitometry using the software Quantity One. 
6. Metabolomic analysis 
6.1. Biofluid collection 
First void urine samples were collected from ten elderly participants at 
baseline (pre-intervention) and after a 12 h fast (time 0, post-intervention) and 
centrifuged at 1800g for 10 min at 4ºC. Aliquots (500µL) of the urine were 
stored at -80ºC until analysis by Proton Nuclear Magnetic Resonance 
spectroscopy (1H-NMR). 
6.2. 1H-NMR spectroscopy 
Urine samples were prepared by the addition of 250µL phosphate buffer (0.2M 
KH2PO4, 0.8M K2HPO4) to 500µL urine. Following centrifugation at 7155 x g 
for 5 minutes, 50µL D2O and 10µL TSP were added to 540µL of the 
supernatant. Spectra were acquired on a 600 MHz NMR spectrometer (Varian, 
Palo Alto, CA 94304-1039, United States) using a Noesypresat pulse sequence 
at 25ºC. Spectra were acquired with 16 K data points and 128 scans over a 
spectra width of 8 kHz. Water suppression was achieved during the relaxation 
delay (2.5s) and the mixing time (100ms). All 1H-NMR urine spectra were 
referenced to TSP at 0.0 ppm, line broadened (0.3 Hz) and phase and baseline 
corrected using the processor on Chenomx NMR suite 5.1 (Chenomx Inc, 
Edmonton, Alberta, T5K 2J1). Spectra were integrated into spectral regions of 
0.01 ppm. The water region (4–6 ppm) was excluded and the data was 
normalized to the sum of the spectral integral. 
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7. Statistical analysis 
The Statistical Package for the Social Sciences (SPSS 17.0 for Windows Inc., 
Chicago, Illinois) was used for the statistical comparisons. The Kolmogorov-
Smirnov test did not show a significant departure from normality in the 
distribution of variance values. In order to evaluate data variation, Student’s t 
test and an analysis of variance for repeated measures (ANOVA) was 
performed, followed by Bonferroni’s correction for multiple comparisons. We 
studied the statistical effects of the type of fat meal ingested, independent of 
time (represented by p1), the effect of time (represented by p2), and the 
interaction of both factors, indicative of the degree of the postprandial 
response in each group of subjects with each fat meal (represented by p3). 
Differences were considered to be significant when p < 0.05. All data 
presented in text and tables are expressed as means ± standard error (± SE). 
7.1. Statistical analysis for metabolomics 
The 1H-NMR spectral data were processed using SIMCA-P+ (version 12.0.1; 
Umetrics, Umea; Sweden) mean centered and pareto scaled (1/SD). Principal 
component analysis (PCA) was applied to the urine dataset and the score plots 
were visually inspected for patterns and outliers. Differences between baseline 
and diet intervention were further analyzed by using partial least squares 
discriminant analysis (PLS-DA) which is a supervised technique that uses 
previous knowledge about the samples. The quality of the models formed by 
PCA and PLS-DA was assessed by interrogation of the R2 and Q2 parameters. 
The R2 parameter is a representation of how much of the variation within the 
data set is explained by the components of the model, and the Q2 parameter 
gives an indication of the prediction power of the model. Additionally, 
permutation testing was performed on each PLS-DA model (with 20 
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permutations) to assess the validity of the model. Permutation testing was 
performed in SIMCA-P+. 
Where robust PLS-DA models were built, the variable importance in the 
projection (VIP) and loading plots were used to identify the regions of the 
spectra that had the largest discriminatory effect in the model. Variables with a 
VIP value > 2 were considered important in discriminating between groups. 
Metabolites responsible for the peaks in these regions were assigned using in-
house databases and the Chenomx Database. Assignments were confirmed 
using 2D TOCSY experiments. 
Hippurate, phenylacetylglycine, glycerol results and gender comparison were 
analyzed using Student’s t test in order to evaluate data variation after dietary 
intervention. A study of the relationship among parameters was also carried 
out using Pearson’s linear correlation coefficient. Differences were considered 
to be significant when p<0.05.  
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B.  STUDY POPULATION II
1. Participants and study design 
This cross-sectional study was conducted within the framework of the 
LIPGENE study (‘Diet, genomics and the metabolic syndrome: an integrated 
nutrition, agro-food, social and economic analysis’), a Framework VI 
Integrated Project funded by the European Union (208).  
Subject eligibility was determined using a modified version of the NCEP 
criteria for MetS, according to published criteria (209).  
Subjects were required to meet at least two of the following five criteria: waist 
circumference > 102 cm (men) or > 88 cm (women); fasting glucose 5.5–7.0 
mmol/l; TG  1.5mmol/l; HDL-C < 1.0mmol/l (men) or < 1.3mmol/l 
(women); blood pressure (BP)  130/85mmHg or treatment of previously 
diagnosed hypertension. We used a subgroup of pre-intervention data for 68 
subjects (26 men and 42 women), which conformed to the LIPGENE inclusion 
and exclusion criteria (210). 
All participants provided written informed consent and underwent a 
comprehensive medical history, physical examination and clinical chemistry 
analysis before enrollment. Participants displayed no signs of cardiac 
dysfunction or hepatic, renal and thyroid diseases and were requested to 
maintain their regular physical activity and lifestyle. Participants were also 
asked to record in a diary any event that could affect the outcome of the study. 
All of them were free from cardiovascular complications at the time of the 
enrollment. The study was carried out in the Lipid and Atherosclerosis Unit at 
the Reina Sofia University Hospital, from February 2005 to April 2006. The 
experimental protocol was approved by the local ethics committee according 
to the Helsinki Declaration. The study was registered with the US National 
Library of Medicine Clinical Trials registry (NCT00429195). 
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1.1. Sample size calculation 
The calculation was made based on the following premises: 
- Primary endpoint of the study: IRH measurement according to RTL 
- Standard deviation of the primary endpoint: 60% 
- Difference in minimum expected: 60% 
- Alpha error = 0.05 (Confidence level: 95%) 
- Beta error = 0.10 (Power: 90%) 
- Hypothesis Contrast: Bilateral. 
Based on these premises are required 12 patients per group.
1.2. Inclusion criteria 
 Age: 35-70 years. 
 Gender: males and females (not pregnant or lactating). 
 Body mass index: 20–40 kg/m2.
 Total cholesterol concentration equal to or < 8.0 mmol/L.
 Medications/nutritional supplements allowed, on conditions that 
the subjects adhere to the same regimen during the study: anti-
hypertensive medication (including beta-blockers), oral contraceptives, 
hormone replacement therapy, multi-vitamin supplements and other 
non-fatty acid based nutritional supplements. 
 Smokers and non-smokers.
 No severe chronic pathology associated. The concomitance of 
diseases such as hypertension without micro- or macroangiopathy, 
dyslipidemia, degenerative joint disease, obesity, benign prostatic 
hyperplasia or chronic venous insuffiency. 
 Regular consumer of alcohol, which is not excessive as defined by 
elevated liver enzymes (AST and ALT). 
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 Ethnicity: intention to include white Europeans. 
1.3. Exclusion criteria 
 Age < 35 or > 70 years. 
 Diabetes or other endocrine disorders.
 Chronic inflammatory conditions.
 Kidney or liver dysfunction.
 Iron deficiency anemia (hemoglobin < 12 g/dL men, < 11 g/dL 
women).
 Prescribed hypolipidaemic medication.
 Prescribed anti-inflammatory medication.
 Fatty acid supplements including fish oils, evening primrose oil, 
etc.
 Consumers of high doses of antioxidant vitamins (A, C, E, -
carotene).
 Red rice yeast (Monascus purpureus) supplement usage. 
 High consumers of oily fish (>2 serving of oily fish per week). 
 Highly trained or endurance athletes or those who participate in 
more than three periods of intense exercise per week.
 Volunteers planning to start a special diet or lose weight (e.g. the 
Slimfast Plan, Atkins Diet, etc.). 
 Weight change equal or > 3 kg within the last 3 months.
 Alcohol (> 20g/day) or drug abuse (based on clinical judgment).
2. Anthropometric measurements 
After recording clinical histories and conducting physical examinations, we 
obtained the following anthropometric measurements for each individual: 
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weight, height, body mass index and waist circumference. Weight was 
measured while the subject was wearing light indoor clothing, without shoes 
and after voiding. Height was obtained with a stadiometer graduated in 
millimeters. The subject was barefoot with the back and head in contact with 
the stadiometer in the Frankfurt horizontal plane. Body mass index was 
calculated by dividing weight (kg) by height squared (m2). Waist 
circumference (cm) was measured to the nearest 0.5cm with a tape measure at 
the umbilical scar level. A non-stretchable tape measure was used to measure 
waist circumference. The measurement was taken directly on the skin with the 
subject in a standing position with the abdomen relaxed, the arms at the sides 
and the feet together. We used the homeostatic model assessment index for 
insulin resistance (HOMAIR: fasting insulin (mUl
-1)/fasting glucose (mmol l-
1)/22.5) and HOMAβ-cell function as the index of insulin secretory function 
derived from fasting plasma glucose and insulin concentrations, calculated as 
20 x fasting insulin (mUl-1)/fasting glucose (mmol l-1)-3.5 (211). Insulin 
sensitivity was estimated by a quantitative insulin sensitivity check index 
(QUICKI) (1/[log insulin (mU l-1) + log baseline glucose (mg dl-1)]) (212). BP 
was measured using an automatic BP device. In accordance with the European 
Society of Hypertension Guidelines (213), BP measurement was obtained with 
an appropriately sized cuff positioned at the heart level and after the patient 
had been relaxed for at least 5 min. The same arm was used for each 
measurement, and the average of two measurements was used for data 
processing. 
3. Biochemical determinations 
3.1. Plasma samples 
Blood was collected in tubes containing ethylene diaminetetraacetic acid 
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(EDTA) to yield a final concentration of 0.1% EDTA. Plasma was separated 
from red cells by centrifugation at 1500 x g for 15 min at 4°C within 1 h of 
extraction. Plasma was immediately aliquoted and stored at -80 ºC until 
analysis. 
3.2. Lipid analysis 
The lipid variables were analyzed with a modular autoanalyzer (DDPPII 
Hitachi; Roche, Basel, Switzerland) with the use of Boehringer-Mannheim 
reagents. Plasma TG were assayed by means of enzymatic procedures (214). 
HDL-C was measured by analyzing the supernatant obtained following 
precipitation of a plasmatic aliquot in dextran sulfate-Mg2+, as described by 
Warnick et al. (215). Plasma glucose concentrations were measured with an 
Architect-CG16000 analyzer (Abbott Diagnostics, Tokyo, Japan) by the 
hexokinase method. Plasma insulin concentrations were measured by 
chemoluminescence with an Architect-I2000 analyzer (Abbott Diagnostics, 
Tokyo, Japan). High-sensitivity C-reactive protein concentrations were 
measured according to Rifai et al. (203). 
4. Relative telomere length measurement 
4.1. DNA isolation 
DNA was isolated from buffy coats using the Gentra Puregene Blood kit 
(Gentra Systems Inc., Minneapolis, MN, USA), and low yielding samples (< 
10 ng) were subjected to whole genome amplification using the REPLI-g kit 
(Qiagen Ltd. West Sussex, UK). 
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4.2. qRT-PCR for telomere length 
RTL was determined using the Cawthon method where the measurements are 
performed by qRT-PCR (216). We estimated the relative ratio of telomere 
repeat copy number (T) normalized against a single copy gene copy number 
(Homo sapiens ribosomal protein L13a gene RPL13a; S) for all the samples. 
Results for each qRT-PCR were relativized to a standard curve built using a 
reference DNA sample. The standard curves for telomere and genomic qRT-
PCRs consisted of eight standards of reference DNA (1-25ng). The correlation 
between relative T/S ratios measured by qRT-PCR and relative telomere DNA 
restriction fragment length by Southern blotting has been confirmed 
previously to be highly consistent (216, 217). 
All qRT-PCRs were performed in duplicate with the use of iQ5-BIORAD 
thermal cycler and SensiFASTTM SYBR Lo-ROX kit (Bioline). The thermal 
cycler profile for both amplicons began with a 95ºC incubation for 3 min to 
activate the polymerase, followed by 40 cycles of 95ºC for 5 s, 54ºC 15 s. 
Specificity of qRT-PCR amplifications was verified by a melting curve 
program (60-95ºC with a heating rate of 0.5 ºC/s and a continuous 
fluorescence measurement). 
 The reaction mix composition was identical except for the oligonucleotide 
primers:  
20 ng template DNA 
1X SensiFASTTM SYBR Lo-ROX 
200 nM reverse primer 
200 nM forward primer 
Primers used are shown in Table 2. (218) 
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Table 2: Primers sequences used for the qRT-PCR 
Gene Sequence
Telomere
5’ – CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT– 3’ -forward
5’ – GGCTTGCCTTACCCTTACCCTTACCC TTACCCTTACCCT – 3’ -reverse
RPL13a
5’ – CCTGGAGGAGAAGAGGAAAGAGA– 3’ -forward
5’ – TTGAGGACCTCTGTGTATTTGTCAA – 3’ -reverse 
5. Study of endothelial function using laser Doppler 
A laser Doppler linear Periflux 5000 (Perimed S.A., Stockholm, Sweden) was 
used to measure IRH. The methodology has been published previously 
elsewhere (164, 165, 219), where we found an inter-study variability of 8.85% 
and an intra-study variability of 8.7%. 
Briefly, capillary flow of the second finger of the dominant arm of the 
participant was assessed for 1 min before (t0) and after (td) applying 4 min of 
ischemia to the arm by means of a sphygmomanometer. The ischemic reactive 
hyperemia was obtained IRH = (AUCtd 2 AUCt0) × 100AUCt0.  
6. Determination of oxidative stress biomarkers 
Total nitrite (nitrite and nitrate) was used as an indicator of NO production and was 
assayed using the Griess method (220), with an intra-assay coefficient of variation 
of 6.1%, and an inter-assay coefficient of variation of 7.7%. The reaction was 
monitored at 540 nm (UV-1603 spectrophotometer, Shimadzu). 
PC content was carried out in plasma samples using the method of Levine (221).
We found and intra-assay coefficient variation of 4.7%, and an inter-assay 
coefficient variation of 8.0%. Carbonyls were evaluated in a spectrophotometer 
(UV-1603 Shimadzu, Kyoto, Japan) at 360 nm. 
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7. Antioxidant enzyme activities 
Total SOD (E.C: 1.15.1.1) activity was determined by colorimetric assay in plasma 
at wavelength of 525 nm according to the method described by McCord and 
Fridovich et al. (222), with an intra-assay coefficient variation of 7.3% and an inter-
assay coefficient variation of 8.7%.  GPx (E.C.: 1.11.1.9) activity was evaluated in 
plasma by the Flohé and Gunzler method (223, 224), with an intra-assay coefficient 
of variation of 6.5% and an inter-assay coefficient of variation of 7.2%.  The GPx 
assay is based on the oxidation of NADPH to NAD+, catalyzed by a limiting 
concentration of glutathione reductase, with maximum absorbance at 340 nm. The 
absorbance was evaluated in a Shimadzu UV-1603 spectrophotometer (Kyoto, 
Japan).  
8. Statistical analysis 
The Statistical Package for the Social Sciences (SPSS 17.0 for Windows Inc., 
Chicago, IL, USA) was used for the statistical comparisons. RTL was analyzed as 
quartiles after removal of experimental outliers. Telomere length was categorized 
into quartiles (shortest to longest) and analyzed as a categorical variable. This 
resulted in the following distribution of RTL, quartile 1: RTL  1.10, quartile 2: 1.10 
< RTL  1.26, quartile 3: 1.26 < RTL  1.56, quartile 4: RTL > 1.56. 
 Univariate analysis of variance adjusted for age was performed to compare 
variables across quartiles of RTL with Bonferroni post hoc test used for multiple 
comparisons. Differences were considered to be significant when p < 0.05. All data 
presented in text and tables are expressed as the means ± standard error (SE). 
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VI. RESULTS
Expression of antioxidant, pro-inflammatory and endoplasmic reticulum 
stress-related genes and protein levels in an elderly population following 
consumption of diets with different fat quality  
In order to carry out the study, 20 participants (10 men and 10 women) from 
the Study Population I completed the long-term dietary intervention and the 
postprandial post-intervention study. 
1. Baseline characteristics 
The epidemiological, anthropometric and lipid data from the participants of 
the study at baseline are shown in Table 3. As expected, males had higher 
height (166.65 ± 1.43cm vs 154.8 ± 1.41cm, p < 0.001) and waist 
circumference (109.62 ± 11.61cm vs  92.35 ± 7.07cm, p = 0.001) than 
females.  
At the start of the study, males had higher TG (1.25 ± 0.11mmol/L vs 0.87 ± 
0.13mmol/L, p = 0.013) and Apo B plasma levels (0.90 ± 0.04 mmol/L vs 0.76 
± 0.02mmol/L, p = 0.036) than females. We did not find any other differences 
by gender.  
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Table 3: Epidemiological, anthropometric data and levels of lipids, apolipoproteins, glucose, 
insulin and CRP from participants of the study at baseline1. 

Male (n=10) Female (n=10) p
Age (years) 65.82 ± 0.91 68.44 ± 1.36 0.208
Weight (kg) 87.73 ± 4.72 78.44 ± 3.19 0.232
Height (cm) 166.65 ± 1.43a 154.8 ± 1.41 <0.001
BMI (kg/m2) 31.25 ± 1.57 32.52 ± 1.33 0.614
Waist circumference 
(cm)
109.68 ± 2.92a 92.41 ± 1.84 0.001
TC (mmol/L) 4.95 ± 0.21 4.52 ± 0.16 0.141
TG (mmol/L) 1.25 ± 0.11ª 0.87 ± 0.13 0.013
HDL-C (mmol/L) 1.26 ± 0.05 1.42 ± 0.07 0.137
LDL-C (mmol/L) 3.06 ± 0.12 2.70 ± 0.11 0.107
Apo B (g/L) 0.90 ± 0.04a 0.76 ± 0.02 0.036
Apo A (g/L) 1.43 ± 0.03 1.52 ± 0.05 0.301
Glucose (mmol/L) 5.77 ± 0.23 5.07 ± 0.14 0.064
Insulin (pmol/L) 80.72 ± 8.68 56.75 ± 4.45 0.078
CRP (mg/L) 4.36 ± 1.35 4.37 ± 1.01 0.996
1Values are means ± SE (n = 20). Means in a row with superscripts without a common letter 
differ, p < 0.05. Kg, kilograms; cm, centimetres; BMI, body mass index; m2, square metres; 
TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; LDL-C 
low density lipoprotein-cholesterol; ApoB, apolipoprotein B; Apo A, apolipoprotein A-1; 
CRP, C-reactive protein. 
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2. Lipid analysis after the long-term intervention of different dietary 
patterns  
Plasma levels of lipids, glucose, insulin and CRP at fasting state at the end of 
each period of dietary intervention are shown in Table 4. Plasma 
concentrations of TC (p < 0.001), LDL-C (p = 0.013), ApoB (p = 0.017), and 
ApoA-I (p = 0.002) were higher after participants consumed the SFA diet than 
when they consumed the other diets. 
Plasma levels of TG, HDL-C, glucose and insulin did not differ after the three 
periods of intervention. 
Table 4: Fasting plasma concentrations of lipids, apolipoproteins, glucose, insulin and CRP at 
the end of each dietary intervention period*. 
Med diet Med+CoQ diet SFA diet p
TC (mmol/L) 4.65 ± 0.13a 4.73 ± 0.14a 5.21 ± 0.17b <0.001
TG (mmol/L) 1.10 ± 0.01 1.15 ± 0.12 1.16 ± 0.09 0.675
HDL-C (mmol/L) 1.31 ± 0.06 1.34 ± 0.06 1.40 ± 0.07 0.069
LDL-C (mmol/L) 2.80 ± 0.12a 2.82 ± 0.06a 3.19 ± 0.17b 0.013
Apo B (g/L) 0.83 ± 0.04a 0.85 ± 0.04a 0.91 ± 0.05b 0.017
Apo A (g/L) 1.44 ± 0.05a 1.47 ± 0.05a 1.56 ± 0.06b 0.002
Glucose (mmol/L) 4.97 ± 0.12 5.06 ± 0.17 5.15 ± 0.22 0.440
Insulin (pmol/L) 10.33 ± 2.39 14.40 ± 5.02 8.63 ± 1.39 0.470
CRP (mg/L) 3.01 ± 0.83 3.60 ± 1.39 3.60 ± 1.06 0.240
*Values are means ± SE (n = 20). Means in a row with superscripts without a common letter 
differ, p < 0.05. Main effect of diet by repeated measures ANOVA. 
TC, total cholesterol; TG, triglycerides; HDL-C, high density lipoprotein-cholesterol; LDL-C 
low density lipoprotein-cholesterol; ApoB, apolipoprotein B; Apo A, apolipoprotein A-1; 
CRP, C-reactive protein.
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3. CoQ determination 
A higher fasting plasma CoQ concentration (p < 0.001) was found after the 
intake of the Med+CoQ diet compared with the Med and SFA diets (Figure 
9). At 2 and 4h after consumption of the Med+Q diet, we observed a greater 
postprandial increase in plasma CoQ levels compared with the Med and SFA 
diets (p = 0.018 and p = 0.032, respectively). No significant differences were 
detected in postprandial CoQ levels at 2 and 4h between the Med and SFA 
diets. 
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Figure 9: Fasting and postprandial plasma levels in total CoQ according to the type of fat 
consumed.  
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
4. Expression of genes related to oxidative stress in PBMC  
In the current study, we have analyzed the effect produced by the consumption 
of different dietary patterns on the expression of the following genes related to 
        Results        
                                                        
103
OxS processes: Nrf2, NADPH oxidase (p22phox and p47phox subunits), SOD 
(isoforms 1 and 2), Gpx1 and TrxR. 
4.1. Nrf2 
Nrf2 is a central transcription factor, essential for the coordinated induction of 
those genes encoding many stress-responsive or cytoprotective enzymes and 
related protein, such as SOD, GPx, glutathione S-transferase and thioredoxin 
(225, 226). At 4h after intake of the Med+CoQ diet we observed a greater 
postprandial decrease in Nrf2 mRNA levels compared with the other diets (p = 
0.029) (Figure 10). Furthermore, Nrf2 mRNA levels were lower after 
consumption of the Med diet compared with the SFA diet (p = 0.039). No 
significant differences were detected in Nrf2 mRNA levels in fasting and at 2h 
after intake of the three diets. 

0h 2h 4h
0.0
0.5
1.0
1.5
Med diet Med+CoQ diet SFA diet
a
b
c
p1= 0.037
p2 = 0.651
p3 = 0.340
m
R
N
A
 N
rf
2
 l
e
v
e
ls
Figure 10: Fasting and postprandial levels of Nrf2 mRNA in PBMCs according to the type of 
fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
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superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
4.2. NADPH oxidase 
NADPH oxidases are likely to be the predominant source of ROS in the 
vasculature (29, 227, 228). Activation of the NADPH oxidase enzyme complex 
requires the assembly of the cytosolic regulatory subunits (p47phox, p67phox, 
p40phox and Rac) with the membrane-bound cytochrome b558 (subunits 
gp91phox and p22phox) (29). 
We observed a decrease in fasting p22phox mRNA levels after consumption of 
the Med and Med+CoQ diets compared to the SFA diet (p = 0.032) (Figure 
11A). At 2 and 4h after the SFA diet, we found higher postprandial p22phox and 
p47phox mRNA levels compared with the Med and Med+CoQ diets (p = 0.038 
and p = 0.003, respectively) (Figure 11A,B). No significant differences were 
detected in p47phox mRNA levels in fasting state after the intake of any of the 
three diets (Figure 11B). 
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Figure 11: Fasting and postprandial levels of p22phox (A) and p47phox (B) mRNA in PBMC 
according to the type of fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
4.3. SOD 
SOD is a key antioxidant enzyme that participates in the scavenging of the 
superoxide radical (O2
-). It is one of the main enzymes of the first line of 
defense against OxS (51). We studied the expression of the two human 
isoforms of SOD: cytoplasmic SOD gene (SOD1) and mitochondrial SOD 
gene (SOD2). Fasting SOD2 mRNA levels were lower after participants 
consumed the Med and Med+CoQ diets than when they consumed the SFA 
diet (p = 0.007) (Figure 12A). At 2 and 4h after the SFA diet, we found higher 
postprandial SOD2 mRNA levels compared with the Med and Med+CoQ diets 
(p = 0.008 and p = 0.003, respectively) (Figure 12A). At 4h after intake of the 
Med and Med+CoQ diets we observed a greater postprandial decrease in SOD1 
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mRNA levels with respect to the SFA diet (p = 0.011) (Figure 12B). However, 
no significant differences were detected in SOD1 mRNA levels in fasting and 
at 2h after intake of the three diets (Figure 12B).  
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Figure 12: Fasting and postprandial levels of SOD2 (A) and SOD1 (B) mRNA in PBMC 
according to the type of fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
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4.4. Gpx1 
Gpx1 is a ubiquitous antioxidant enzyme that catalyzes the reduction of H2O2 
and scavenges organic hydroperoxides in both the cytosol and mitochondria 
(56, 229). 
Fasting Gpx1 mRNA levels were greater after SFA diet consumption (p = 
0.013) than after the Med diet intake, with or without CoQ supplementation 
(Figure 13). During postprandial state, we found lower postprandial Gpx1 
mRNA levels at 2 and 4h after Med+CoQ diet intake, compared with the SFA 
diet  (p = 0.013). 
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Figure 13: Fasting and postprandial levels of Gpx1 mRNA in PBMC according to the type of 
fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
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4.5. TrxR 
TrxR is a ubiquitous oxidoreductase enzyme with antioxidant and redox 
regulatory roles. It is also involved in prevention, intervention and restoring the 
damage caused by H2O2-based OxS (58, 230). 
At 4h after the intake of the SFA diet we found a greater postprandial increase 
in TrxR mRNA levels compared to Med and Med+CoQ diets (p = 0.023). No 
significant differences were detected in TrxR mRNA levels in fasting state or 
2h after consumption of any of the three diets (Figure 14).  
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Figure 14: Fasting and postprandial levels of TrxR mRNA in PBMC according to the type of 
fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
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5. Cellular protein levels related to oxidative stress in PBMC  
In the current study, we have studied the effect produced by the consumption 
of different dietary patterns on the levels of the following proteins related to 
OxS processes: Nrf2 (cytoplasmic and nuclear) and Keap-1. 
5.1. Cytoplasmic and nuclear Nrf2  
Nrf2 normally resides in the cytoplasm of unstressed cells interacting with 
Keap-1, who promotes its degradation (45). In response to an oxidative insult, 
Nrf2 evades Keap-1 mediated repression and accumulates within the nucleus, 
thus facilitating the expression of antioxidant genes. 
In fasting and at 4h after intake of the Med+CoQ diet we observed higher 
cytoplasmic Nrf2 protein levels compared to the other diets (p = 0.033 and p = 
0.011, respectively) (Figure 15A). In addition, at 4h Med diet induced a 
significant increase in the protein levels of cytoplasmic Nrf2 compared to the 
SFA diet (p = 0.026).  
Consequently, both in fasting and at 4h after Med+CoQ diet consumption we 
found lower nuclear Nrf2 protein levels compared to the SFA diet (p = 0.001 
and p = 0.019, respectively), with an intermediate effect for the Med diet 
(Figure 15B). 
5.2. Cytoplasmic Keap-1   
In fasting state and at 4h after intake of the Med+CoQ diet we observed higher 
Keap-1 protein levels compared to the other diets (p = 0.035 and p = 0.003, 
respectively) (Figure 15C). Additionally, at 4h Med diet induced a significant 
increase of postprandial Keap-1 protein levels compared to the SFA diet (p = 
0.017).  
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Figure 15: Fasting and postprandial levels of cytoplasmic Nrf2 (A), nuclear Nrf2 (B) and 
Keap-1 in PBMC according to the type of fat consumed. (D) Representative immunoblot of 
nuclear and cytoplasmatic Nrf2, Keap-1, actin and TFIIB. Depicted bands are different parts 
of the same blot stained for each antigen. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction.  
6. Expression of genes related to the inflammatory response in PBMC  
In the current study, we have studied the effect produced by the consumption 
of different dietary patterns on the expression of the following genes related to 
the inflammatory response: p65 (RelA), IB-, IKK-, MMP-9, IL-1 and 
JNK-1. 
6.1. Genes related to the activation of NF-B   
The NF-B transcription factor functions as homo- or heterodimers of the Rel 
family of proteins, which includes p50, p65 (RelA), c-Rel, p52 and RelB. The 
most common combination of subunits is a heterodimer of the p50 and p65 
(RelA) proteins. Activation of NF-kB dimers is the result of the 
  Results 
112
phosphorylation of IB by IKK, which enables NF-  B dimers to enter the 
nucleus and activate specific target gene expression (22). 
At 2 and 4h after intake of the Med+CoQ diet, we found lower postprandial 
p65 (RelA) mRNA levels compared with the other diets (p = 0.008 and p = 
0.012, respectively) (Figure 16A). Furthermore, p65 (RelA) mRNA levels 
were lower at 2 and 4h after consumption of the Med diet compared with the 
SFA diet (p = 0.033).  
At 2h after intake of the Med+CoQ diet we observed a greater postprandial 
decrease in IKK- mRNA levels compared with the other diets (p = 0.010) 
(Figure 16B). Moreover, IKK- mRNA levels were lower after consumption 
of the Med diet compared with the SFA diet (p = 0.034). At 4h after intake of 
the Med and Med+CoQ diets we observed a greater postprandial decrease in 
IKK- mRNA levels with respect to the SFA diet (p = 0.011). 
At 2h after ingestion of the Med and Med+CoQ diets, we observed a greater 
postprandial increase in IB- mRNA levels compared with the SFA diet (p = 
0.028). At 4h after the Med diet, we found higher postprandial IB- mRNA 
levels compared with the SFA diet (p = 0.018) (Figure 16C).  
No significant differences were detected in p65 (RelA), IKK- or IB-
mRNA levels in fasting after intake of any of the three diets (Figure 16A, B 
and C, respectively). 
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Figure 16: Fasting and postprandial levels of p65 (RelA) (A), IKK- (B) and IB- (C) 
mRNA in PBMC according to the type of fat consumed.
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
6.2. MMP-9 
MMP-9 is a metalloproteinase involved in several stages of atherosclerosis 
through remodelling of the extracellular matrix (23). We observed a decrease 
in fasting MMP-9 mRNA levels after intake of the Med diet compared to the 
SFA diet (p = 0.034) (Figure 17). At 2 and 4h after the SFA diet, we found 
higher postprandial MMP-9 mRNA levels compared with the Med and 
Med+CoQ diets (p = 0.008 and p = 0.032, respectively) (Figure 17). 
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Figure 17: Fasting and postprandial levels of MMP-9 mRNA in PBMC according to the type 
of fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
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superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
6.3. IL-1
IL-1 is an inflammatory cytokine that consists of two distinct ligands (IL-1
and IL-1) and both subunits appear to play an essential role in many 
inflammatory processes (24).  
Fasting IL-1 mRNA levels were lower after participants consumed the Med 
and Med+CoQ diets than when they consumed the SFA diet (p = 0.017) 
(Figure 18). At 2h after intake of the Med+CoQ diet we observed a greater 
postprandial decrease in IL-1 mRNA levels compared with the other diets (p
= 0.011). Furthermore, IL-1 mRNA levels were lower at 2h after consumption 
of the Med diet compared with the SFA diet (p = 0.029). At 4h after 
consumption of the Med and Med+CoQ diets we observed a greater 
postprandial decrease in IL-1 mRNA levels with respect to the SFA diet (p = 
0.015) (Figure 18). 
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Figure 18: Fasting and postprandial levels of IL-1 mRNA in PBMC according to the type of 
fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
6.4. JNK-1 
JNK is involved in inflammatory pathways, changes in ROS levels and a 
variety of stress stimuli. Ten isofroms, derived from three genes, are known: 
JNK-1 (four isoforms), JNK-2 (four isoforms) and JNK-3 (two isoforms) (25).  
Fasting JNK-1 mRNA levels were lower after participants consumed the Med 
and Med+CoQ diets than when they consumed the SFA diet (p = 0.037). At 2 
and 4h after the SFA diet, we found higher postprandial JNK-1 mRNA levels 
compared with the other diets (p = 0.009 and p = 0.011, respectively) (Figure 
19). 
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Figure 19: Fasting and postprandial levels of JNK-1 mRNA in PBMCs according to the type 
of fat consumed. 
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Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
7. Expression of genes related to ER stress in PBMC
The transcription factor sXBP-1 has been identified as a key regulator of the 
mammalian UPR or ER stress response, which is activated by environmental 
stressors such as protein overload that require increased ER capacity (26). 
CRT, BiP/Grp78, calnexin and other ER Ca2+ binding chaperons are important 
components of the protein folding process and quality control (27).
At 2 and 4 h after the Med and Med+CoQ diets, we found lower postprandial 
sXBP-1 mRNA levels compared with the SFA diet  (p = 0.033 and p = 0.008) 
(Figure 20A). No significant differences were detected in sXBP-1 mRNA 
levels in fasting state after intake of any of the three diets.  
In addition, fasting CRT mRNA levels were lower when participants had 
consumed the Med and Med+CoQ diets than when they had consumed the SFA 
diet (p = 0.031) (Figure 20B). 
At 2 h after intake of the SFA diet we found a greater postprandial increase in 
BiP/Grp78 mRNA levels compared to the other diets (p = 0.021). No 
significant differences were detected in BiP/Grp78 mRNA levels in fasting and 
at 4 h after intake of the three diets (Figure 20C). 
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Figure 20: Fasting and postprandial levels of sXBP-1 (A), CRT (B) and BiP/Grp78 mRNA in 
PBMC according to the type of fat consumed. 
Values are means ± SE (n = 20). Med diet, Mediterranean diet; Med+CoQ diet, 
Mediterranean diet supplemented with CoQ; SFA diet, SFA-rich diet. Bars with different 
superscript letters depict statistically significant differences, p < 0.05. Main effect of diet by 
repeated measures ANOVA. p1, diet effect; p2, time effect; p3, diet×time interaction. 
8. Metabolomic analysis of urine samples 
Urine samples, corresponding to baseline and to 12h fast after each dietary 
intervention (time 0h), were collected from 10 participants (5 women and 5 
men) from the study population I. PCA of 1H-NMR urine spectra resulted in a 
two component model with a R2 of 0.31. Figure 21A shows the PCA score 
plot for the dataset. Visual inspection of the model showed grouping of 
samples according to gender. Pair wise comparison of samples using PCA 
according to diet did not reveal any pattern with all the participants and PLS 
models were not built. Following this, PCA analysis for women and men were 
conducted separately. Analysis for women displayed differences between 
dietary interventions when comparing fasting state after Med+CoQ diet
against SFA diet. PLS-DA analysis of these groups revealed one component 
model with a R2X of 0.21, a R2Y of 0.66 and a Q2 of 0.17 (Figure 21B). 
Validation of the model was performed using permutation testing and resulted 
in a Q2 intercept of (0.0, -0.1). No significant differences were found 
comparing the other diets. 
Analysis of the VIP plots revealed greater levels of hippurate excretion after 
consumption of Med+CoQ diet compared to SFA diet. Lower excretion in 
phenylacetylglycine levels was observed after Med+CoQ diet compared to 
SFA diet intervention (Table 5). However, visual inspection of PCA score 
plots for men revealed no patterns based on diets. 
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Figure 21: (A) PCA score plot (R2 = 0.31, Q2 = 0.17) derived from 1H-NMR urine spectra 
collected pre- and post- dietary intervention. Open squares represent male samples and closed 
circles represent female samples. (B) PLS-DA score plot derived from 1H-NMR urine spectra 
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collected from women after Med+CoQ diet (open circles) and after SFA diet intervention 
(close squares).  R2 = 0.21, Q2 = 0.17
Table 5:  Metabolites identified as being discriminant between Med+CoQ and SFA diet.

Metabolite
Chemical 
shift 
(ppm)
VIP
values
Med+CoQ SFA p-value
Hippurate 3.975 6.380 0.022 ± 0.006 0.014 ± 0.004 0.037
Hippurate 3.965 6.176 0.021 ± 0.006 0.013 ± 0.004 0.038
Hippurate 7.835 5.241 0.016 ± 0.005 0.009 ± 0.003 0.041
Hippurate 7.545 3.542 0.006 ± 0.002 0.004 ± 0.001 0.049
Phenylacetylglycine 7.435 2.963 0.003 ± 0.002 0.005 ± 0.002 0.045
Phenylacetylglycine 7.375 2.380 0.003 ± 0.001 0.005 ± 0.001 0.045
Un-assigned peak 3.725 2.413 0.007 ± 0.001 0.008 ± 0.001 0.084
Un-assigned peak 2.175 2.204 0.002 ± 0.001 0.003 ± 0.002 0.167
Un-assigned peak 3.635 2.134 0.006 ± 0.001 0.007 ± 0.002 0.160
Average intensities of metabolite bin regions fot the Med+CoQ diet and SFA diet are shown.  
Values are means ± SD and are presented as arbitrary units. p-values are reported for 
paired t-test. 
8.1. Correlation analysis between urinary metabolites and other 
parameters 
After chronic consumption of Med+CoQ diet, we observed positive strong 
correlations between hippurate and CoQ and -carotene plasma levels (Table 
6). Aditionally, we found a high inverse correlation between urinary levels of 
hippurate and Nrf2 gene expression, antioxidant enzymes gene expression as 
Trx, SOD1 and gp91phox subunit of NADPH oxidase. Similarly, after 
consumption of SFA diet, we observed a strong negative correlation between 
urinary levels of phenylacetylglycine and CoQ plasma levels and a great 
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positive correlation between urinary levels of phenylacetylglycine and urinary 
isoprostanes (Table 6). 
Table 6: Correlations between urinary levels of hippurate, phenylacetylglycine and other 
factorsa after Med+CoQ diet intervention. 
CoQ -carotene Nrf2 Trx SOD1 gp91phox
Hippurate
Pearson
correlation
0.899* 0.928* -0.978** -0.976** -0.913* -0.898*
p-value 0.038 0.023 0.004 0.004 0.030 0.039
CoQ Isoprostanes
Phenylacetylglycine
Pearson
correlation
-0.897* 0.952*
p-value 0.039 0.013
aPearson´s correlation: *p < 0.05; **p < 0.01. CoQ, coenzyme Q10 plasma levels; -carotene, 
plasma levels; Nrf2, transcription factor Nrf2 gene expression; Trx, Thioredoxin gene 
expression; SOD1, superoxide dismutase 1 gene expression; gp91phox, subunit of  NADPH 
oxidase; Isoprostanes, urinary levels. 
8.2. Gender comparison of OxS biomarkers 
Gender-related differences after Med+CoQ diet intervention are shown in 
Figure 22. We observed that levels of the antioxidants compounds CoQ (A)
and -carotene (B) are significantly greater in women compared to men. By 
contrast, we found that OxS biomarkers such as LPO (A) or oxLDL (B) after 
Med+CoQ are higher in men than in women (Figure 23). Data from these 
parameters used for the correlations were previously analyzed and published 
(199, 231). 
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Figure 22: Gender-related differences after Med+CoQ diet intervention of CoQ  (A) and -
carotene (B). 
Differences in the parameter levels between pre- and post-intervention are shown as  (value 
of post-intervention minus value of pre-intervention). Data were analyzed using unpaired t-
test and differences were considered to be significant when *p < 0.05. 
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Figure 23: Gender-related differences in fasting plasma levels after Med+CoQ diet 
intervention of LPO (A) and oxLDL (B). 
Data were analyzed using unpaired t-test and differences were considered to be significant 
when p < 0.05. Bars with different superscript letters depict statistically significant 
differences. 
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Influence of endothelial dysfunction on telomere length in subjects with 
metabolic syndrome 
In order to carry out the study, 20 participants from the Study Population I and 
a subgroup of 68 participants from the LIPGENE (Study Population II) were 
divided into four groups by quartiles of relative telomere length. 
1. Baseline characteristics 
The anthropometric, biochemical, BP and metabolic parameters of the 
participants are shown in Table 7. Plasma TG was higher in the subjects with 
shortest RTL (quartile 1) compared to those in quartile 4 with largest RTL (p = 
0.031). 
Baseline HOMA was greater in the subjects grouped in the quartile 4 with 
largest RTL compared with the subjects in the quartiles 1, 2 and 3 (p = 0.003). 
We did not find significant differences with respect to the remaining 
parameters between the four groups of MetS subjects according to the RTL 
(Table 7). 
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Table 7: Baseline characteristics of the study population according to quartiles of RTL1,2,3
Quartile 1
(n = 22)
Quartile 2
(n = 24)
Quartile 3
(n = 20)
Quartile 4
(n = 22)
p
Age (years) 59.73 ± 1.87 59.71  1.55 58.60  1.60 56.59  1.94 0.540
Sex 
(female/male)
14/8 14/10 12/8 12/10
HOMAIR 3.37 ± 0.07 3.97 ± 0.10 3.42  0.11 4.32  0.12 0.700    
HOMA 89.94  9.31a 91.77  8.93 a 94.21  9.69 a 139.14  9.49 b 0.003
Weight (kg) 87.78 ± 2.74 86.50 ± 2.63 89.66 ± 2.85 96.06 ± 2.79 0.940
Height (m) 1.57 ± 0.03 1.62 ± 0.02 1.54 ± 0.05 1.56 ± 0.04 0.129
BMI 34.28 ± 0.88 33.68 ± 0.84 34.28 ± 0.92 35.28  0.90 0.800
Waist 
circumference 
(cm)
106.34 ± 2.18 103.54 ± 2.09 108.40  2.27 109.71  2.22 0.937
Insulin (mU/L) 12.22 ± 2.10 14.71 ± 2.05 12.69 ± 2.19 15.04 ± 2.14 0.657
Glucose
(nmol/L)
6.29 ± 0.22 6.20 ± 0.22 5.93 ± 0.23 5.03 ± 0.23 0.143
TG (nmol/L) 1.89 ± 0.14 a 1.51 ± 0.13 a. b 1.55 ± 0.15 a. b 1.27 ± 0.14 b 0.031
LDL-C (nmol/L) 17.38 ± 8.63 34.02 ± 8.27 21.30 ± 8.78 26.16 ± 8.97 0.647
HDL-C (nmol/L) 1.11 ± 0.05 1.22 ± 0.05 1.08 ± 0.06 1.09 ± 0.06 0.325
hsCRP (mg/L) 6.63 ± 1.17 5.24 ± 1.12 7.09 ± 1.19 6.52 ± 1.16 0.573
SBP (mm Hg) 142 ± 3 144 ± 3 138 ± 3 142 ± 3 0.306
DBP (mm Hg) 87 ± 3 87 ± 2 88 ± 3 89 ± 3 0.900
1Data are means ± SE. HOMAIR, homeostatic model assessment index for insulin resistance;
HOMA, homeostatic model assessment index of insulin secretory function; BMI, body mass 
index; TG, triglycerides; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density 
lipoprotein-cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; hsCRP, 
high sensitivity C-reactive protein. 
2 Means in a column with different superscript letters are significantly different, p < 0.05 
(Univariate analysis of variance adjusted for age).  
3 Quartile 1: RTL  1.10, quartile 2: 1.10 < RTL  1.26, quartile 3: 1.26 < RTL  1.56, 
quartile 4: RTL > 1.56. 
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2. Study of endothelial function 
NO plasma levels were higher in the quartile 3 (p = 0.012) and 4 (p = 0.016) 
than the quartile 1 (shortest RTL) (Figure 24A). Additionally, IRH shows the 
same trend as NO levels with greater percentage of change from baseline in the 
quartile 3 (longest RTL) (p = 0.015) and 4 (p = 0.011) than quartile 1 (Figure 
24B). 
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Figure 24: Total nitrite (NO) levels in plasma (A) and ischemic reactive hyperemia (IRH) (B) 
across quartiles of RTL. 
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Data were analyzed using univariate analysis of variance adjusted for age. All values 
represent the means ± SE. Differences were considered to be significant when p < 0.05. Bars 
with different superscript letters depict statistically significant differences.
3. Antioxidant enzymes activities and levels of OxS biomarker  
We found that GPx plasma activity of subjects grouped in the quartile 4 with 
longer RTL was lower compared to quartile 1 with shorter RTL (p = 0.003), 
with intermediate activity levels for quartile 2 and 3 (Figure 25A). Although 
differences of SOD plasma activity between quartiles were not statistically 
significant, there was a marked trend that showed an increase in the activity of 
the enzyme in the quartile 1 with respect to the other RTL groups (Figure 
25B). 
Regarding to PC plasma levels, which are an important biomarker of OxS, they 
were higher in the subjects grouped in the quartile 1 with the shortest RTL 
compared with the subjects in quartile 4 (p =0.036; Figure 26).

Q
ua
rt
ile
 1
Q
ua
rt
ile
 2
Q
ua
rt
ile
 3
Q
ua
rt
ile
 4
0
20
40
60
80
100
a
b
a,b
a,b
A
G
P
x
 a
c
ti
v
it
y 
(n
m
o
l/
m
in
/m
L
)
  Results 
128

Q
ua
rt
ile
1
Q
ua
rt
ile
 2
Q
ua
rt
ile
 3
Q
ua
rt
ile
4
0
2
4
6
8
B
S
O
D
 a
c
ti
v
it
y 
(U
/m
L
)
gFigure 25: Gluthatione peroxidase (GPx) plasma activity (A) and superoxide dismutase 
(SOD) plasma activity (B) across quartiles of RTL. 
Data were analyzed using univariate analysis of variance adjusted for age. All values 
represent the means ± SE. Differences were considered to be significant when p < 0.05. Bars 
with different superscript letters depict statistically significant differences.
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Figure 26: Protein carbonyls (PC) plasma levels across quartiles of RTL. 
Data were analyzed using univariate analysis of variance adjusted for age. All values 
represent the means ± SE. Differences were considered to be significant when p < 0.05. Bars 
with different superscript letters depict statistically significant differences.
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VII. DISCUSSION 
Expression of antioxidant, pro-inflammatory and endoplasmic reticulum 
stress-related genes and protein levels in an elderly population following 
consumption of diets with different fat quality
Aging is characterized for being an unavoidable and irreversible process in 
which multiple factors are involved, both genetic and environmental (2). 
Regarding to its ethiopathogeny, OxS is likely to be one of the main 
mechanisms of functional and structural impairment as the organism ages. On 
this premise, the “free-radical theory” was postulated in order to give an 
explanation of why this complex process occurs (3). Organisms have a potent 
antioxidant system to cope with the overall oxidation inherent to life with the 
purpose of maintaining the redox homeostasis. These antioxidant systems are 
formed by a number of enzymes as well as several endogenous and exogenous 
antioxidant compounds that react against ROS, by neutralizing them (44, 118).  
OxS has also been widely linked to the development and progression of 
multiple pathophysiological conditions, such as endothelial dysfunction, 
hypertension, cardiovascular disease and MetS. Although it is generally 
accepted that the main mechanism underlying metabolic changes in MetS 
patients relies on insulin resistance, there is a growing body of evidence that 
demonstrates a close link between MetS and OxS (38, 41). 
Once accepted that OxS have a significant role in the aging process and age-
related diseases, and also that the capacity to prevent OxS is determinant in 
longevity, it is reasonable to lead anti-aging strategies towards the 
improvement of the antioxidant defense or the decrease of OxS processes. 
The present study demonstrates that the long-term consumption of a Med diet, 
with or without CoQ supplementation, reduces the fasting gene expression of 
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p22phox (NADPH-oxidase subunit), SOD2, Gpx1, MMP-9, JNK-1, IL-1β and 
CRT compared to a SFA diet. The influence of the long-term intervention is 
also reflected in the fasting protein levels of Nrf2 and Keap-1, whose 
cytoplasmic fraction are greater after Med+CoQ diet than after SFA diet, with 
an intermediate effect of Med diet. With regard to the postprandial state, Med 
diet consumption reduces the expression of genes related to OxS (Nrf2, SOD, 
TrxR and NADPH-oxidase), inflammatory response (NF-B, IKK-, MMP-9, 
IL-1 and JNK-1) and ER stress (sXBP-1, BiP/Grp78) that is produced in 
response to a fat challenge in PBMC from an elderly population, with respect 
to a SFA diet. Furthermore, the addition of CoQ has an additive effect on the 
Med diet since the participants that consumed the Med+CoQ diet showed a 
greater postprandial decrease in the gene expression of p65 (RelA), IKK- , 
IL-1, Nrf2 and Gpx1; as well as a greater postprandial increase in 
cytoplasmic Nrf2 and Keap-1 protein levels in PBMC with respect to the other 
diets. 
In this study, the long-term intake of the Med+CoQ diet is associated with 
increased excreted levels of the metabolite hippurate, which is strongly 
correlated with antioxidant biomarkers; and decreased excreted levels of the 
metabolite phenylacetylglycine, which is highly related to oxidant biomarkers, 
when comparing to SFA diet in elderly women.  
Postprandial lipemia has been considered crucial during atherogenesis since 
Zilversmit introduced the concept in 1979 (135) and subsequently, a large 
body of evidence has demonstrated that remnant lipoproteins greatly 
contribute to the atherosclerotic process (232). Due to the strong relationship 
between OxS and atherosclerosis, those phenomena have been widely studied 
during postprandio, demonstrating that postprandial state is associated with 
OxS (136). In fact, the dietary intake of one particular type of fatty acids 
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directly affects the fatty acid profile of an organism and indirectly influences 
its susceptibility to oxidative processes (233, 234). 
As the human being spend most of the time in a postprandial state with a 
continual fluctuation in the degree of lipemia throughout the day, it is highly 
relevant to study the metabolic disorders related to OxS during postprandio 
instead of focusing in fasting state (129). However, the effect caused by food 
should not be viewed in isolation, since the study of an acute intake of fat 
cannot be divorced from the potential effects of chronic consumption. 
Our study highlights the importance of mainstreaming the postprandial period 
analysis into the long-term intake of different dietary patterns during the four 
weeks of intervention. Few studies have explored into the molecular effects 
caused by diet on antioxidant gene expression and levels of proteins related to 
OxS during postprandial state in the elderly. While it is now commonly 
accepted that oxidative damage plays an important role in the aging process 
(235), the influence of age on the antioxidant enzymes gene expression has not 
been widely studied. Previous research has shown that long-term 
supplementation of PUFA along with dietary CoQ increases lifespan in rats 
(236). Moreover, CoQ has been described to modulate protein levels, control 
inflammation and also decrease OxS and cardiovascular risk during aging in 
rats (204). With regard to healthy humans, plasma oxidative damage may be 
partially prevented by CoQ supplementation (237) and these results have been 
replicated in subjects with psoriasis (238) or coronary heart disease patients 
(188). 
In this connection, we have previously demonstrated in the same elderly 
population of this study, that the intake of Med diet improves postprandial 
OxS with a higher increase in IRH and NO plasma levels, lower LPO levels 
and lower GPx activity compared to the consumption of a SFA diet. Besides, 
we found that Med+CoQ diet consumption yielded a greater postprandial 
decrease in PC plasma levels; SOD, CAT and GPx activities and a higher 
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increase in IRH and NO with respect to a Med and SFA diet (199). Regarding 
to DNA damage, we have also proved that the intake of a Med+CoQ diet 
reduces the activation and stabilization of p53 in response to the OxS produced 
during postprandial state (195). 
A central role in the defense against OxS has been attributed to the 
transcription factor Nrf2. Under unstressed conditions, Nrf2 is located in the 
cytoplasm interacting with Keap-1, which limits its activity and rapidly 
promotes its degradation by the ubiquitin-proteasome pathway (45). 
Conversely, Nrf2 dissociates from Keap-1 when the cell is exposed to OxS. In 
this situation, stabilized Nrf2 then translocates to the nucleus where stimulates 
the expression of genes encoding a set of antioxidant enzymes such as CAT, 
SOD and GPx through binding to the AREs placed within the gene promoter 
regions (48, 50).  
According to these statements, our results show a greater increase in the 
cytoplasmic Nrf2 protein levels and a higher decrease in its nuclear fraction 
after the long-term consumption and during postprandial phase of the 
Med+CoQ diet with respect to the SFA diet, with an intermediate effect of the 
Med diet. These findings may be explained by the fact that the increase of 
Keap-1 protein levels, obtained after Med+CoQ diet consumption, promotes 
its interaction with Nrf2 in the cytoplasm, avoiding its translocation to the 
nucleus. On the other hand, the lower cytoplasmic levels of Keap-1 and the 
higher Nrf2 nuclear levels observed after SFA diet consumption may have 
favoured the binding of Nrf2 to the AREs and the subsequent transcriptional 
gene activation. This hypothesis seems to corroborate the increase in Nrf2, 
Gpx1, SOD1, SOD2 and TrxR mRNA levels obtained after SFA diet in our 
study. 
The first line of enzymatic antioxidant defense is formed by SOD, GPx and 
CAT, which protect cells against the ROS produced during normal metabolism 
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and after an oxidative insult. SOD decomposes O2
- to O2 and H2O2, 
preserving cells from O2
--mediated lipid peroxidation (51), while CAT and 
GPx neutralize the toxicity caused by H2O2 and/or ROOH (54, 56). Moreover, 
peroxides can be reduced directly by TrxR, providing an alternative 
mechanism for the detoxification of lipid hydroperoxides, otherwise mainly 
managed by GPx (58, 60). 
The decrease in SOD mRNA levels observed after the long-term consumption 
and during postprandial phase of the Med and Med+CoQ diets compared to 
SFA diet, may well be caused by lower generation of O2
-, due to the fact that 
the SOD gene expression has been proved to be up-regulated by ROS (239). In 
addition, Gpx1 mRNA showed the lowest postprandial levels after Med+CoQ 
diet with respect to the other diets. Presumably, it is likely that the 
supplementation with the antioxidant CoQ contributed to reduce H2O2
production and also to diminish Gpx1 expression, for which H2O2 serves as a 
substrate (240). These results, together with the increase in TrxR mRNA levels 
observed following SFA diet consumption, suggest that the OxS phenomena 
originated after this diet are higher than after the Med and Med+CoQ diets. 
The metabolic response to dietary interventions with different fat composition 
is not only related to the cellular redox state, but may also affect other 
metabolic pathways. The complexity of their effects can be explored by 
metabolomics, so that there has been a growing interest recently in the 
application of this technique in human nutritional research. Nutritional 
metabolomics focuses on the interaction between products of metabolism in a 
biological sample and dietary intake of nutrients and non-nutrients, helping us 
to understand the regulatory roles of nutrition (241, 242). 
After consumption, food components are absorbed and transformed in the 
gastrointestinal tract or liver, appearing in plasma or urine with or without 
further transformations. They can be detected and identified by using targeted 
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or untargeted metabolomic approaches (243). Indeed, numerous 
epidemiological studies have shown that the urinary profile is subject to 
dietary influences (244, 245), age, gender and hormonal status (246, 247). 
In our metabolomic analysis, the results show that the long-term consumption 
of the Med+CoQ diet after four weeks of intervention is associated with 
increased levels of excreted hippurate and decreased levels of 
phenylacetylglycine compared to the SFA diet in postmenopausal women. 
Hippuric acid (N-benzoylglycine) has been described to be catabolically 
synthesized by conjugation of benzoic acid with glycine from its precursor 
quinic acid, via the shikimate pathway in the gastrointestinal tract (248). This 
metabolite is considered as one of the final products of gut microbial 
metabolism in urine after intake of dietary polyphenols. In fact, several 
intervention studies have indicated that consumption of polyphenol-rich 
extracts (249) or tea (250) enhances its excretion. Regarding to its health 
aspects, this metabolite does not seem to be directly beneficial by itself, but it 
can be considered as an indicator of antioxidant molecules synthesis by gut 
microflora (248, 251), DNA repair enhancement and NF-B inhibition (252). 
In accordance with these studies, our our strong correlation results suggest that 
hippurate is positively related to antioxidant compounds such as CoQ and β-
carotene, and negatively associated with the gene expression of Nrf2 and 
several molecules related to OxS processes (Trx, SOD1, gp91phox). 
Little is known about the excretion of phenylacetylglycine in humans 
following dietary intervention. This metabolite is generated from 
phenylacetate via phase II detoxification mechanisms of from microbiota 
metabolism (253) and is often overexpressed in disease. It is one of the major 
metabolites excreted in spontaneous hypertensive rats (253), in which acts as a 
putative biomarker of phospholipidosis (254). Interestingly, urinary 
acylglycines are often used as diagnostic tool for mitochondrial fatty-acid 
oxidation disorders in humans (255) and, in particular, phenylacetylglycine 
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levels have been found to be significantly higher in heart failure patients than 
in healthy controls (256, 257). Due to the important role of OxS in 
cardiovascular disease (258) and considering these studies, greater 
phenylacetylglycine excretion might be linked to an increase in OxS-related 
mechanisms. Herein, our results show that phenylacetylglycine levels are 
inversely associated with CoQ levels and conversely, highly positive 
correlated to urinary levels of isoprostanes, which are considered as 
biomarkers for monitoring oxidative status (259). 
It is worth noting the fact that remarkable differences in metabolite excretion 
were just found when comparing Med+CoQ diet versus SFA diet, suggesting 
that the antioxidant compounds presents in the Med diet, together with CoQ 
may produce a synergic antioxidant effect (the most antioxidant diet) when is 
compared to SFA diet (the most oxidant diet).  
Interestingly, the benefit caused by Med+CoQ diet consumption in our study 
is greater in elderly women than in elderly men. In this regard, the antioxidant 
compounds CoQ and β-carotene are greater in women than in men, whilst 
LPO and oxLDL plasma levels in men are higher than in women. This 
interesting gender difference should be retested in further studies since these 
women are postmenopausal and therefore, they do not have the additional 
antioxidant benefits attributed to estrogens (260). Nevertheless, hippurate and 
phenylacetylglycine are microbial metabolites, thus differences in its levels 
could be due to gut microbial diversity between men and women. 
Not only is aging related to oxidative processes, but also to a low-grade 
chronic inflammatory status. In this connection, the term “inflamm-aging” 
refers to the common inflammatory pathogenesis that underlies different age-
related pathologies, such as atherosclerosis, cardiovascular diseases, 
osteoporosis, type 2 diabetes, MetS or cognitive decline (261, 262).  
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The master regulator of the inflammatory response is the transcription factor 
NF-B (p50/p65), which is normally present in an inactive form bound to its 
inhibitor IB in the cytoplasm. Diverse stimuli such as OxS or cytokines 
release (IL-1, TNF-) result in the phosphorylation of IB proteins by IKK, 
followed by its ubiquitination and degradation through the 26S proteasome 
pathway. Free NF-B is then able to translocate to the nucleus, where it binds 
to its consensus sequences and activates transcription (87, 90), thus regulating 
IL-1, TNF-, IL-6 and COX-2 gene expression (263). 
Among the numerous factors that can modulate inflamm-aging, nutrition is 
probably the most powerful tool that we have to enhance the health status of 
the elderly population (264). Accordingly, the consumption of a hypercaloric 
breakfast increases the nuclear NF-B activity at the same time that leads to a 
reduction in the cytoplasmic IB- expression in healthy subjects (265). 
However, the long-term consumption of a Med diet produces a lower NF-B 
activation when compared with other types of fat either in fasting or 
postprandial state, and these results have been observed both in healthy people 
(168) and in MetS patients (169). Consistently, our results show a greater 
postprandial decrease in p65 (RelA) and IKK- mRNA levels, as well as a 
higher postprandial increase in IB- after Med+CoQ diet intake compared to 
SFA diet, with an intermediate effect for the Med diet. We also observed 
boosted IL-1 mRNA levels following SFA diet consumption compared with 
the other diets.  
One pivotal factor down-regulated by NF-B is MMP-9, which is a 
metalloproteinase involved in several stages of atherosclerosis through 
remodeling of the extracellular matrix (110). Interestingly, its expression in 
atherosclerotic plaques is proportional to the free radical production and has 
been described as an important mediator of the phagocytic NADPH oxidase-
dependent ROS production in atherosclerosis (266). Taking into account the 
significant rise in NADPH oxidase activity after a fat challenge (265), the 
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observed increase in MMP-9 mRNA levels after SFA diet in our study could 
be explained by an increment in ROS production and a major activation of the 
inflammatory response when this type of fat is consumed. 
Activation of stress-kinase signaling has recently been recognized as an 
important pathophysiological mechanism in the development of diet-induced 
obesity, type 2 diabetes mellitus and other aging-related pathologies (100). In 
this regard, JNK is not only involved in inflammatory pathways, but also 
associated with OxS and ER stress mechanisms, in which its activation is 
related to the UPR initiation (104). In our study, Med and Med+CoQ diets are 
associated with a lower expression of JNK-1 and ER stress-related genes such 
as sXBP-1, CRT and BiP/Grp78, suggesting that the consumption of these 
dietary patterns trigger inflammation processes and ER stress to a lesser extent 
than SFA diet intake. 
The present study has the advantage of a randomized crossover design in 
which all the participants have experienced all the diet periods, each individual 
acting as his/her own control and strengthening the fact that the effects 
observed are due to the influence of the type of diet. Multiple studies have 
shown that a three week dietary period is enough for assessing its effects, and 
in longer periods there is not influence of previous diets (267, 268). In our 
study, and to avoid any doubt, we extended the dietary periods to four weeks 
each, thus securing that the outcomes found were not provided by previous 
diets. On the other hand, we are aware that our study has certain limitations, 
since ensuring adherence to dietary instructions is difficult in a feeding trial 
and also the small sample population. However, adherence to the 
recommended dietary patterns was satisfactory according to the Food 
Frequency Questionnaires.
In conclusion, our results suggest that consumption of a Med diet rich in olive 
oil contributes to the redox homeostasis and enhances the protection of the 
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organism against oxidative damage. Supplementation of Med diet with CoQ 
has an additive effect in lowering OxS levels, modifying antioxidant protein 
levels and also in reducing the expression of antioxidant genes in PBMC from 
elderly people at fasting and postprandial state. Moreover, these dietary 
patterns exert a modulatory effect on the inflammatory response and on the ER 
stress in this population, supporting the fact that the consumption of a Med 
diet supplemented in CoQ is beneficial for healthy aging. 
Influence of endothelial dysfunction on telomere length in subjects with 
metabolic syndrome from LIPGENE study 
MetS comprises a cluster of metabolic abnormalities characterized by 
hypertriglyceridemia, low HDL-C, hypertension, fasting glucose and 
abdominal obesity that lead to cardiovascular disease or increased risk of type 
2 diabetes (269). Despite insulin resistance is considered as the core of the 
MetS in terms of molecular mechanisms, OxS has been emerging as a crucial 
process involved in the pathogenesis and the etiology of the syndrome (38). 
Previous findings from the same LIPGENE subcohort as this study have 
shown that the number of MetS components is an important risk factor for the 
increase of the OxS degree (determined by SOD and GPx plasma activities, 
IRH and NO plasma levels, among other parameters) (41). An increment in 
OxS levels coupled with an impairment in NO availability has been described 
to disturb the endothelium, causing endothelial dysfunction (24). Indeed, 
endothelial damage and atherosclerosis have been related to telomere attrition 
(10) and this association is greater in coronary artery disease patients with 
MetS than in those without the syndrome (13). Hence, further knowledge of 
the redox state in early MetS patients may provide a starting point for 
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understanding the pathways that contribute to both the development of the 
syndrome as well as its subsequent complications. 
The present cross-sectional study highlights a gradual and direct relationship 
between high OxS levels and endothelial dysfunction with regard to RTL in 
MetS participants. Those subjects with shorter telomeres have increased 
biomarkers of OxS and higher plasma activity of antioxidant enzymes. 
Interestingly, their total NO plasma levels and IRH are lower than subjects 
with longer telomeres. 
Previous studies have suggested that DNA damage manifested as telomere 
attrition plays a pivotal role in the development of endothelial dysfunction in 
the pathogenesis of vascular disease, due to the strong relationship found 
between telomere shortening and cell senescence in HUVECS (270). In this 
regard, our results show that subjects with the shortest RTL have the lowest 
NO plasma levels and as one would expect, they present the lowest IRH 
compared to subjects with longer RTL.  
Interestingly, those participants with the shortest RTL are the ones with the 
highest PC plasma levels, which are biomarkers of severe OxS. These proteins 
are characterized by irreversible damage in its structure that affect to its 
function and their presence has been frequently associated with obesity, 
insulin resistance, diabetes mellitus and MetS (271). Accordingly, the activity 
of antioxidant enzymes such as GPx and SOD from participants with shorter 
RTL is greater than subjects with longer RTL. A plausible explanation to these 
findings could be the fact that cells attempt to strengthen their antioxidant 
arsenal in response to OxS and also to prevent oxidative damage. For this 
purpose, enzymes from the first line of antioxidant defense such as SOD, GPx 
and catalase increase their activity to balance the excess of OxS (41). Our 
present observations are consistent with a study in coronary artery disease 
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patients with MetS in which telomere attrition and OxS damage in endothelial 
progenitor cells were higher than in those without MetS. On the basis of the 
results obtained, the authors suggest that telomere shortening in response to 
OxS processes may induce an increment in endothelial damage, thus 
contributing to increase the risk of subsequent cardiovascular events (13). 
In the present study, we measured telomere length in circulating leucocytes 
instead of endothelial cells due to the fact that this method is less invasive than 
obtaining human vascular tissue from participants. Indeed, it has been 
demonstrated that circulating blood leucocyte DNA content is predictive of 
vascular telomere content as well as an accurate surrogate for vascular aging in 
several population studies (10, 272). 
There is evidence for the role of obesity, particularly intra-abdominal visceral 
fat accumulation, in promoting the development of metabolic diseases 
including MetS, glucose intolerance, dyslipidemia and atherosclerosis. In this 
regard, systemic OxS has been strongly associated with visceral fat 
accumulation in MetS patients (273, 274). Our results display higher TG 
plasma levels and lower HOMAβ in participants with increased OxS levels 
and shorter RTL. The same findings have been shown in a study with type 2 
diabetes patients, where telomere attrition was inversely correlated to TG 
levels and considerably explained by insulin resistance, which in turn lead to 
an increment in ROS levels (275). 
We are aware that this cross-sectional study has some limitations since these 
findings do not prove a cause-and-effect relationship and the use of a small 
sample population. In this regard, larger and prospective studies are needed to 
elucidate which of the parameters studied herein has the strongest effect above 
the others. 
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In summary, our results show that there is a clear link among endothelial 
function, OxS and RTL in MetS subjects. High levels of OxS may induce 
DNA damage in terms of telomere attrition and may also contribute to the 
dysregulation of vascular homeostasis. 
Thus, further support of the molecular and cellular mechanisms involved in 
endothelial dysfunction is needed to develop strategies in order to decelerate 
vascular aging or prevent cardiovascular disease. 
VIII. CONCLUSIONS 
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VIII. CONCLUSIONS 
Main Conclusion 
The long-term consumption of Mediterranean diet contributes in part to the 
redox homeostasis of elderly people at fasting and postprandial state through 
the modulation of the Nrf2-mediated response to oxidative stress. Moreover, 
the supplementation of coenzyme Q10 enhances this contribution by modifying 
the antioxidant protein levels and reducing the expression of genes related to 
oxidative stress processes in peripheral blood mononuclear cells from elderly 
people. 
                                                                          
Secondary Conclusions 
1. The long-term consumption of a Mediterranean diet, with or without 
coenzyme Q10 supplementation, modulates the endoplasmic reticulum stress 
response by decreasing the fasting and postprandial expression of genes 
associated with the unfolded protein response in peripheral blood mononuclear 
cells from elderly people. 
2. The long-term intake of a Med diet, with an additive effect provided by 
coenzyme Q10 supplementation, modifies the inflammatory response by 
decreasing the fasting and postprandial expression of pro-inflammatory genes 
in peripheral blood mononuclear cells from an elderly population. 
3. The long-term consumption of a Mediterranean diet supplemented with 
coenzyme Q10 modifies the metabolomic urinary profile of elderly women 
through greater excretion of metabolites associated with antioxidant 
properties. By contrast, metabolites excreted after the intake of a saturated 
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fatty acid-rich diet are related to increased biomarker of oxidative damage. 
4. There is a direct relationship between endothelial function, oxidative 
stress and relative telomere length in elderly people and metabolic syndrome 
subjects, where high levels of oxidative damage may induce endothelial 
dysfunction and may increase telomere attrition. 
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Abstract Postprandial oxidative stress is characterized
by an increased susceptibility of the organism towards
oxidative damage after consumption of a meal rich in
lipids and/or carbohydrates. We have investigated
whether the quality of dietary fat alters postprandial
gene expression and protein levels involved in oxidative
stress and whether the supplementation with coenzyme
Q10 (CoQ) improves this situation in an elderly
population. Twenty participants were randomized to
receive three isocaloric diets each for 4 weeks:
Mediterranean diet supplemented with CoQ (Med+
CoQ diet), Mediterranean diet (Med diet), saturated
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fatty acid-rich diet (SFA diet). After 12-h fast,
volunteers consumed a breakfast with a fat
composition similar to that consumed in each of
the diets. Nrf2, p22phox and p47phox, superoxide
dismutase 1 and 2 (SOD1 and SOD2), glutathione
peroxidase 1 (GPx1), thiorredoxin reductase (TrxR)
gene expression and Kelch-like ECH associating
protein 1 (Keap-1) and citoplasmic and nuclear Nrf2
protein levels were determined. Med and Med+CoQ
diets induced lower Nrf2, p22phox, p47phox, SOD1,
SOD2 and TrxR gene expression and higher cyto-
plasmic Nrf2 and Keap-1 protein levels compared to
the SFA diet. Moreover, Med+CoQ diet produced
lower postprandial Nrf2 gene expression and lower
nuclear Nrf2 protein levels compared to the other
diets and lower GPx1 gene expression than the SFA
diet. Our results support the antioxidant effect of a
Med diet and that exogenous CoQ supplementation
has a protective effects against free radical over-
generation through the lowering of postprandial
oxidative stress modifying the postprandial antioxi-
dant protein levels and reducing the postprandial
expression of antioxidant genes in peripheral blood
mononuclear cells.
Keywords CoQ10 .Mediterranean diet . Oxidative
stress . Gene expression
Abbreviations
Apo Apolipoprotein
CAT Catalase
CoQ Coenzyme Q10
GPx Gluthatione peroxidase
H2O2 Hydrogen peroxide
Keap-1 Kelch-like ECH associating
protein 1
Med diet Mediterranean diet
Med+CoQ diet Mediterranean supplemented
with CoQ
MUFA Monounsaturated fatty acid
PBMCs Peripheral blood mononuclear
cells
PUFA Polyunsaturated fatty acid
ROS Reactive oxygen species
SFA diet Saturated fatty acid-rich diet
SOD Superoxide dismutase
TG Triacylglycerol
TrxR Thiorredoxin reductase
Introduction
Aging may be defined as an inherently complex process
that is manifested within an organism at genetic,
molecular, cellular, organ, and system levels (Harman
2009). The aging process induces age-related changes
and leads to increased occurrence of many diseases.
Although the fundamental mechanisms are still poorly
understood, a growing body of evidence points toward
the oxidative damage caused by reactive oxygen species
(ROS) as one of the primary determinant of aging
(Droge 2002). A certain amount of oxidative damage
takes place even under normal conditions; however,
the rate of this damage increases during the patho-
logical conditions like diabetes, cardiovascular dis-
eases, cancer, and aging-related diseases (Elahi et al.
2009). Although aging is an inevitable event, linked
to the pass of time, nutritional intervention may
influence the intrinsic rate of aging as well as the
incidence of these age-associated diseases.
Extensive prospective studies suggest that a high
degree of adherence to a Mediterranean diet (Med diet)
is associated with reduced mortality, prevents the onset
and progression of coronary heart disease (Covas 2007)
and other aging-related diseases (Trichopoulou et al.
2003; Estruch et al. 2006). Common components of
this diet include monounsaturated fatty acids (MUFA),
α-tocopherol, phenolic compounds, phytoesterols, and
other antioxidants so the leading hypothesis on the
mechanism of this association is a decrease of oxidative
stress due to the antioxidant capacity of this diet (Visioli
and Galli 2001).
Fasting is not the typical physiological state of the
modern human being, which spends most the time in
the postprandial state. In line with this notion,
oxidative stress has received considerable attention
over the past several years in the fasting state;
however, there is a paucity of data on postprandial
oxidative stress. With regard to the postprandial state,
we have recently demonstrated the antioxidant effect
of Med diet rich in olive oil and that exogenous
coenzyme Q10 (CoQ: 2,3-dimethoxy-5-methy-6-
decaprenyl-1,4-benzoquinone) supplementation in
synergy with a Med diet (Med+CoQ diet) improves
the postprandial oxidative stress in elderly men and
women, with a higher increase in capillary flow, a
lower plasma biomarker of oxidative stress levels and
a greater postprandial decrease in plasma antioxidant
enzymatic activities with respect to a Western diet
AGE
rich in saturated fatty acid (SFA diet; Yubero-Serrano
et al. 2010).
Interest in CoQ comes from the fact that it is an
important mitochondrial redox component (Battino et
al. 2001) and endogenously produced lipid-soluble
antioxidant of the human organism. CoQ plays a crucial
role in the generation of cellular energy, enhances the
immune system, and acts as a free radical scavenger
with antioxidant properties (Quiles et al. 2005). Aging,
poor eating habits, and stress affects the organism’s
ability to provide adequate amounts of CoQ.
Many research suggest that using CoQ supplements
may help maintain health of elderly people or treat some
of the health problems or diseases such as adjunctive
therapy in the treatment of congestive heart failure
(Kaikkonen et al. 2002), as an anticancerogenic and
immune-stimulating agent (Folkers et al. 1993) and for
slowing down the progression of Parkinson’s disease in
the early stage (Muller et al. 2003).
As discussed above, one of the causes of aging is the
change at the molecular level, which may cause
alterations in the expression levels of genes and protein
involved in oxidative stress. Peripheral blood mononu-
clear cells (PBMCs) are a subset of white blood cells,
which include lymphocytes and monocytes, and play a
critical role in the immune system. Various studies
showed disease-characteristic gene expression patterns
in PBMCs (Mass et al. 2002; Burczynski and Dorner
2006) and they can be easily and repeatedly collected
in sufficient quantities in contrast to the more invasive
sampling of adipose, muscle and liver tissues, among
others (de Mello et al. 2008). However, little is known
of nutritional effects on PBMCs gene expression patterns.
According to these premises, the aim of this study
was to determine whether diets with different fat quality
influence on the postprandial gene expression and
protein levels involved in oxidative stress and that this
hypothetical improvement could be boosted by supple-
mentation with a natural antioxidant, like CoQ, a natural
antioxidant agent in PBMCs of healthy elderly people.
Experimental procedures
Participants and recruitment
Volunteers were recruited using various methods
including the use of general practitioner databases,
and poster and newspaper advertisements. A total of
63 persons were contacted among those willing to
enter the study. All participants underwent a compre-
hensive medical history, physical examination, and
clinical chemistry analysis before enrolment and gave
their informed consent before joining the study.
Inclusion and exclusion criteria were fulfilled by 20
patients (age ≥65 years; 10 men and 10 women).
Power analysis was set a 90% to detect variations equal
or larger than 20% in the mRNAs gene expression
(Jimenez-Gomez et al. 2009). The sample size calcu-
lation indicated that we needed at least 18 partic-
ipants. Clinical inclusion criteria were: age ≥65 years,
body mass index 20–40 kg/m2, total cholesterol
concentration equal to or <8.0 mmol/L and nonsmokers.
Clinical exclusion criteria were: age <65 years, diabetes
or other endocrine disorders, chronic inflammatory
conditions, kidney or liver dysfunction, iron deficiency
anemia (hemoglobin <12 g/dL men, <11 g/dL women),
prescribed hypolipidaemic and anti-inflammatory med-
ication, fatty acid supplements including fish oil,
consumers of high doses of antioxidant vitamins (A, C,
E, β-carotene), highly trained or endurance athletes or
those who participate in more than three periods of
intense exercise per week, weight change equal or >3 kg
within the last 3 months, smokers, alcohol, or drug abuse
(based on clinical judgment). The study protocol was
approved by the Human Investigation Review Commit-
tee of the Reina Sofia University Hospital according to
institutional and Good Clinical Practice guidelines.
Study design
Participants were randomly assigned to receive, in a
crossover design, three isocaloric diets for 4-week
periods each (Supporting Fig. S1). The three diets
were as follows: (1) Mediterranean diet supplemented
with CoQ (Med+CoQ diet; 200 mg/day in capsules),
containing 15% of energy as protein, 47% of energy
as carbohydrate and 38% of total energy as fat [24%
MUFA (provided by virgin olive oil), 10% SFA, 4%
polyunsaturated fatty acid (PUFA)]. (2) Mediterranean
diet not supplemented with CoQ (Med diet), with the
same composition of the first diet but supplemented by
placebo capsules and (3) Western diet rich in saturated
fat (SFA diet) with 15% of energy as protein, 47% of
energy as carbohydrate, and 38% of total energy as fat
(12% MUFA, 22% SFA, 4% PUFA).
The cholesterol intake was kept constant (<300 mg/
day) during the three periods. Both the CoQ and the
AGE
placebo capsules were specially produced by the same
company (Kaneka Corporation, Osaka, Japan) and
were identical in weight and external aspect. Patients
taking capsules were unaware whether they were in the
Med+CoQ or Med dietary period (Supporting
Table S1). The composition of the experimental diets
was calculated by using the US Department of
Agriculture (1987) food tables and Spanish food
composition tables for local foodstuffs (Varela 1980).
Before the start of the intervention period, volunteers
completed a 3-day weighed food diary and an extensive
Food Frequency Questionnaires, which allowed identi-
fication of foods to be modified. At the start of the
intervention period, each patient was provided with a
handbook for the diet to which they had been
randomized. Advice was given on foods to choose and
those to avoid if eating outside home. They were also
instructed to write down in the diary about any menu
eaten out of home and to call the monitoring study nurse
reporting such event. At baseline, volunteers were
provided with a supply of study foods to last for
2 weeks. They collected additional study foods every
fortnight or when required. At these times, a 24-h recall
of the previous day’s food intake and a short food use
questionnaire based on the study foods were completed
to monitor and motivate volunteers to adhere to the
dietary advice. A points system was used to assess the
number of food exchanges achieved in the 24-h recall
and additional advice was given if either the 24-h recall
or food use questionnaire showed inadequate intake of
food exchange options. Volunteers were asked to
complete 3-day weighed food diaries at baseline,
weeks 2 and 4.Weighed food intake over two weekdays
and one weekend day was obtained using scales
provided by the investigators. Fat foods were adminis-
tered by dietitians in the intervention study. The dietary
analysis software Dietsource version 2.0 was used.
(Novartis S.A., Barcelona, Spain).
At the end of the dietary intervention period, the
subjects were given a fatty breakfast with the same fat
composition as consumed in each of the diets. Patients
presented at the clinical centers at 8 h following a 12-
h fast (time 0), abstained from alcohol intake during the
preceding 7 days. After canulation of a blood vessel, a
fasting blood sample was taken before the test meal,
which was then ingested within 20 min under supervi-
sion. The test meal reflected fatty acid composition of
each subject after the chronic dietary intervention.
Subsequent blood samples were drawn at 2 and 4 h.
Test meals provided an equal amount of fat (0.7 g/kg
bodyweight), cholesterol (5 mg/kg of bodyweight), and
vitamin A (60,000 IU/m2 body surface area). The test
meal provided 65% of energy as fat, 10% as protein,
and 25% as carbohydrates. The composition of the
breakfasts was as follows: Med with CoQ (400 mg in
capsules) breakfast (12% SFA, 43% MUFA, and 10%
PUFA), Med with placebo capsules breakfast (12%
SFA, 43% MUFA, and 10% PUFA), and SFA-rich
breakfast (38% SFA, 21% MUFA, and 6% PUFA).
Biochemical determinations
Plasma samples
Venous blood samples were obtained at the end of the
each dietary intervention period on fasting state after a
12-h fast, before breakfast ingestion and at 2 and 4 h
after ingestion of breakfast. Samples from the fasting
and postprandial states were collected in tubes contain-
ing 1 g ethylenediaminetetraacetic acid (EDTA)/L and
were stored in containers with ice and kept in the dark.
Particular care was taken to avoid exposure to air, light,
and ambient temperature. Plasma was separated from
whole blood by low-speed centrifugation at 1,500×g for
15 min at 4°C within 1 h of extraction.
Isolation of PBMCs
PBMCs were isolated from 20 mL of venous blood in
tubes containing 1 mg/mL of EDTA. The blood samples
were diluted 1:1 in PBS, and cells were separated in
Ficoll gradient by centrifugation at 800×g for 25 min at
20°C. The cells were collected and washed with cold
PBS two times and finally resuspended in buffer A.
This buffer contained 10 mM 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid (HEPES), 15 mM KCl,
2 mM MgCl2 and 1 mM EDTA and, at the time of
use, 1 mM PMSF and 1 mMDTTwere added. The cells
thus obtained were stored at −80°C for further analysis.
RNA extraction and qRT-PCR analysis
RNA extraction
Total RNA from PBMCs was extracted using the
trizol method according to the recommendations of
the manufacturer (Tri Reagent®, Sigma, St Louis,
MO, USA) and quantified in a NanoDrop 1000A
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Spectrophotometer. RNA integrity was verified on
agarose gel electrophoresis and stored at −80°C. Next,
since polymerase chain reaction (PCR) can detect
even a single molecule of DNA, RNA samples were
digested with DNAse I (AMPD-1 KT, Sigma) before
RT-PCR.
Biotrove open array™ real-time PCR
Each reaction was performed with 1 μl of a 1:5 (v/v)
dilution of the first cDNA strand, synthesized from
1 μg of total RNA using the commercial kit iScript
cDNA Synthesis Kit (Bio Rad) according to the
manufacturer’s instruction.
The reaction of real-time PCR was carried out using
the platform OpenArray™ NT Cycler (Applied Bio-
systems). This system of analysis of gene expression
used as a method for quantification TaqMan probes.
OpenArray™ subarrays were preloaded by Biotrove
with the selected primer pairs. The individual primer
pairs (synthesized by Sigma-Aldrich, St. Louis, MO,
USA) were preloaded into Bio Trove OpenArray™
plates. Each primer pair was spotted in duplicate. The
primers that amplify genes of interest were selected
from the database TaqMan Gene Expression Assays
(Applied Biosystems; https://products.appliedbiosys
tems.com/ab/en/US/adirect/ab?Cmd=catNavigate2&
catID=601267) in Assays search tab taking as search
criteria: selection and Homo sapiens Gene Expression
Assays for each of the genes of interest.
Samples were loaded into OpenArray plates with
the OpenArray NT Autoloader according to the
manufacturer's protocols. Each subarray was loaded
with 5.0 μl of master mix consisted of 1× LighCycler
FastStart DNA Master SYBR Green Kit (Roche
Applied Sciences, Indianapolis, IN, USA), 1× SYBR
Green I 80×, 0.5% glycerol, 0.2% Pluronic F-68,
1 mg/mL bovine serum albumin (New England
Biolaboratories, Beverly, MA, USA), 1 mM MgCl2,
400 nM FP, 400 nM RP, 8% Formamide, 0.25× Rox,
1× TfR amplicon, and cDNA samples. The PCR
OpenArray thermal cycling protocol consisted of 95°C
for 10 min, followed by cycles of 10 s at 95°C, 10 s at
53°C, and 10 s at 72°C. All samples were tested in
duplicate. The Biotrove OpenArrayTM NT Cycler
System Software (version 1.0.2) uses a proprietary
calling algorithm that estimates the quality of each
individual CT value by calculating a CT confidence
value for de amplification reaction.
In our assay, CT values with CT confidence values
below 700 were regarded as background signals. The
remaining positive amplification reactions were ana-
lyzed for amplicon specificity by studying the individual
melting curves.
The same program allowed the selection of the most
stable housekeeping gene in the samples processed for
the relativization of the expression of genes of interest.
Following this methodology, we analyzed the relative
gene expression of these genes: Nrf2, p47phox, and
p22phox (nicotinamide adenine dinucleotide phosphate
(NADPH) oxidase subunits), superoxide dismutase 1
and 2 (SOD1 and SOD2), glutathione peroxidase 1
(GPx1), and thioredoxin reductase (TrxR).
Western blot analysis
Protein extraction
PMBCs were thawed on ice and buffer A was
supplemented with 5 μg Aprotinin, 10 μg Leupeptin
and 0.8% Nonidet NP-40. Cells were incubated on ice
for 5 min, subjected to gentle agitation for 20 s in the
vortex and then centrifuged at 13,000 rpm for 5 min at
4°C. The supernatant containing cytoplasmic proteins
was distributed in aliquots that were stored at −80°C.
The pellet was treated with 100 μL of lysis buffer
(20 mM HEPES, 400 mM NaCl, 1 mM EDTA, 1 mM
EGTA, 1 mM PMSF, 1 mMDTT, 20 μg Aprotinin, and
40 μg Leupeptin). The sample was incubated on ice for
20min with periodic mixing with a vortex by stirring for
30 s every 5 min of incubation. Cells were then
centrifuged at 13,000 rpm for 5 min at 4°C. The
supernatant thus obtained, containing the nuclear pro-
teins, was distributed in aliquots, and stored at −80°C.
The extracted proteins were quantified using the method
of Bradford (1976).
Western blot
Electrophoretic separation was carried out with 50 μg of
protein for both cytoplasmic and nuclear fractions. After
separation in sodium dodecyl sulfate polyacrylamide gel
electrophoresis gels (11% polyacrylamide), proteins
were transferred to nitrocellulose membranes (BioTrace
NT Membrane; PALL Gelman Laboratory). The fol-
lowing proteins were detected using their corresponding
antibodies: Nrf2 (C-20, sc-722: mouse monoclonal;
Santa Cruz Biotechnology, Inc.), Kelch-like ECH
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associating protein 1 (Keap-1; H-190, sc-33569:
rabbit polyclonal; Santa Cruz Biotechnology, Inc.);
Actin (C-2, sc-8432: mouse monoclonal; Santa
Cruz Biotechnology, Inc.). After incubation with
these primary antibodies, samples were incubated with
respective secondary antibodies (goat anti-mouse or
anti-rabbit HRP-conjugate; Santa Cruz Biotechnology,
Inc.). The development process was carried out
with ECL-Plus Western Blotting Detection System
(Amersham™) and used for autoradiography
Hyperfilm MP high-performance autoradiography
film (Amersham™).
Quantification of protein bands
The proteins were identified in the autoradiography
by its position relative to molecular weight markers:
57 kDa for Nrf2, 69 kDa for Keap-1, and 40 kDa for
actin. The relative amount of each was quantified by
densitometry using the software WIN1D.
Statistical analysis
The Statistical Package for the Social Sciences (SPSS
17.0 for Windows Inc., Chicago, IL, USA) was used
for the statistical comparisons. The Kolmogorov–
Smirnov test did not show a significant departure from
normality in the distribution of variance values. In order
to evaluate data variation, Student’s t test and an
analysis of variance for repeated measures was
performed, followed by Bonferroni’s correction for
multiple comparisons. We studied the statistical
effects of the type of fat meal ingested, independent of
time (represented by p1), the effect of time (repre-
sented by p2), and the interaction of both factors,
indicative of the degree of the postprandial response
in each group of subjects with each fat meal
(represented by p3). Differences were considered to
be significant when p<0.05. All data presented in text
and tables are expressed as means±standard error (±SE).
Results
Metabolic parameters levels
The baseline characteristics of the 20 participants who
completed the three dietary intervention periods showed
that males had higher height, waist circumference, TG
and Apo B than females. We did not find any other
differences by gender (Supporting Table S2).
Moreover, we previously observed higher fasting
plasma CoQ concentration (p<0.001) after the intake
of the Med+CoQ diet compared with the Med and
SFA diets. At 2 and 4 h after consumption of the Med+
CoQ diet we observed a greater postprandial increase in
plasma CoQ levels compared with the Med and SFA
diets (p=0.018 and p=0.032, respectively; Supporting
Fig. S2; Yubero-Serrano et al. 2010).
Diet intake- and expression genes-related oxidative
stress in PBMCs
Nrf2
Nrf2 is the central transcription factor, essential for
the coordinated induction of those genes encoding
many stress-responsive or cytoprotective enzymes
and related protein, such as SOD, GPx, glutathione
S-transferase, and Thioredoxin (Dinkova-Kostova and
Talalay 2008; Chen and Kong 2004). At 4 h after
intake of the Med+CoQ diet, we observed a greater
postprandial decrease in Nrf2 mRNA levels compared
with the other diets (p=0.029; Fig. 1a). Furthermore,
Nrf2 mRNA levels were lower after consumption of
the Med diet compared with the SFA diet (p=0.039).
No significant differences were detected in Nrf2
mRNA levels in fasting and at 2 h after intake of
the three diets (Fig. 1a).
NADPH oxidase
NADPH oxidases are likely to be the predominant
source of ROS in the vasculature (Brandes and
Kreuzer 2005; Forstermann 2008; Grienling 2004).
Activation of the NADPH oxidase enzyme complex
requires the assembly of the cytosolic regulatory
subunits (p47phox, p67phox, p40phox, and Rac) with
the membrane-bound cytochrome b558 (subunits
gp91phox and p22phox; Brandes and Kreuzer 2005).
We observed a decrease in fasting p22phox mRNA
levels after intake of the Med and Med+CoQ diets
compared to the SFA diet (p=0.032; Fig. 1b). At 2 h
and 4 h after the SFA diet, we found higher
postprandial p22phox and p47phox mRNA levels
compared with the Med and Med+CoQ diets (p=
0.038 and p=0.003, respectively; Fig. 1b,c). No
significant differences were detected in p47phox
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mRNA levels in fasting after intake of any of the
three diets (Fig. 1c).
SODs
SOD is a key antioxidant enzyme, scavenging the
superoxide radical (O2
−). SOD form the first line of
defence against oxidative stress. We studied the
expression of the two isoforms of human SOD:
cytoplasmic SOD gene (SOD1 gene) and mitochondrial
SOD gene (SOD2 gene). Fasting SOD2 mRNA levels
were lower after participants consumed the Med and
Med+CoQ diets than when they consumed the SFA diet
(p=0.007; Fig. 2a). At 2 and 4 h after the SFA diet,
we found higher postprandial SOD2 mRNA levels
compared with the Med and Med+CoQ diets (p=
0.008 and p=0.003, respectively). At 4 h after intake
of the Med and Med+CoQ diets, we observed a
greater postprandial decrease in SOD1 mRNA levels
with respect to the SFA diet (p=0.011). However, no
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significant differences were detected in SOD1 mRNA
levels in fasting and at 2 h after intake of the three
diets (Fig. 2b).
Gpx1
GPx enzyme catalyzes the reduction of H2O2 and
scavenges organic hydroperoxides (de Haan et al.
1998). Fasting Gpx1 mRNA levels were greater after
participants consumed the SFA diet than when they
consumed the other two diet period (p=0.013;
Fig. 2c). At 2 and 4 h after the Med+CoQ diet, we
found lower postprandial Gpx1mRNA levels compared
with the SFA diet (p=0.013; Fig. 2c).
TrxR
TrxR is a ubiquitous oxidoreductase enzyme with
antioxidant and redox regulatory roles. It also contrib-
utes to redox homeostasis and is involved in prevention,
intervention, and repair of damage caused by H2O2-
based oxidative stress (Nordberg and Arner 2001).
At 4 h after intake of the SFA diet, we found a greater
postprandial increase in TrxR mRNA levels compared
to the other diets (p=0.023). No significant differences
were detected in TrxR mRNA levels in fasting and at
2 h after intake of the three diets (Fig. 2d).
Diet intake and cellular protein levels related
to oxidative stress
Cytoplasmic and nuclear Nrf2 in PBMCs
In fasting and at 4 h after intake of the Med+CoQ diet,
we observed higher cytoplasmic Nrf2 protein levels
compared to the other diets (p=0.033 and p=0.011,
respectively; Fig. 3a). In addition, at 4-h Med diet
induced a significant increase of cytoplasmic Nrf2
protein levels compared to the SFA diet (p=0.026).
However, both in fasting and at 4 h after intake of the
Med+CoQ diet, we found lower nuclear Nrf2 protein
levels compared to the SFA diet (p=0.001 and p=
0.019, respectively), with an intermediate effect for
the Med diet (Fig. 3b).
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Keap-1 in PBMCs
Nrf2 activity is repressed by the cytosolic protein Keap-1,
which has been proposed to act by sequestering and
tethering the transcription factor in the cytoplasm
(Nguyen et al. 2005). In fasting and at 4 h after intake
of the Med+CoQ diet, we observed higher Keap-1
protein levels compared to the other diets (p=0.035 and
p=0.003, respectively) (Fig. 3c). In addition, at 4 h
Med diet induced a significant increase of postpran-
dial Keap-1 protein levels compared to the SFA diet
(p=0.017).
Discussion
The present study demonstrates that the consump-
tion of a Med diet reduces the postprandial
expression of genes that encoded proteins related
to oxidative stress such as SOD (SOD1 and
SOD2), TrxR, and NADPH-oxidase (p22phox and
p47phox subunits) and increases the cytoplasmic Nrf2
protein levels in PBMCs. Moreover, the addition of
CoQ had an additive effect on the Med diet since the
participants that consumed this diet showed a greater
postprandial decrease in gene expression of Nrf2 and
GPx1 and a greater postprandial increase in cytoplasmic
Nrf2 and Keap-1 protein levels in PBMCs with respect
to the other diets.
In the same population of this study, we
previously demonstrated that the Med diet improves
the postprandial oxidative stress with a higher
increase in capillary flow and plasma nitric oxide
levels, a lower plasma lipid peroxidation products,
nitrotyrosine and protein carbonyl levels, lower
plasma antioxidant enzyme activities (GPx, catalase
(CAT) and SOD), (Yubero-Serrano et al. 2010) and
lower DNA damage in PBMCs (Gutierrez-Mariscal et
al. 2011). Addition of exogenous CoQ in synergy
with a Med diet had an additive effect reducing the
postprandial oxidative stress in elderly men and
women.
Moreover, few studies explored into the molecular
effects that diet has on antioxidant gene expression
and levels of proteins related with oxidative stress as
Nrf2 and Keap-1 during the postprandial state, or into
the effect of CoQ supplements in humans (Wang et al.
2010). While it is now widely accepted that oxidative
damage plays an important role in the aging process
(Lombard et al. 2005), the influence of age on the
gene expression of antioxidant enzymes has not been
widely studied; moreover, the few studies that have
been performed have yielded conflicting results (Rao
et al. 1990).
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A central role in the defense against oxidative stress
has been attributed to the transcription factor Nrf2. Nrf2
is localized in the cytoplasm where it interacts with the
Keap-1, and is rapidly degraded by the ubiquitin–
proteasome pathway (Zhang 2006). When the cell is
exposed to oxidative stress, induction of Nrf2 occurs
which dissociates Nrf2 from Keap-1. Stabilized Nrf2
then translocates to the nucleus and promotes the
expression of genes encoding many antioxidant
proteins and phase-II detoxifying enzymes such as
CAT, SOD, GPx, and heme oxygenase-1 through
binding specifically to the antioxidant-response element
(ARE) found in the gene promoters (Xu et al. 2008;
Kobayashi and Yamamoto 2005).
Our results show a greater increase in the cytoplasmic
Nrf2 protein levels after intake of the Med+CoQ diet
compared with the SFA diet, with an intermediate effect
for the Med diet. These finding could be explained by
the fact that the increase of Keap-1 protein levels
obtained after intake of the Med+CoQ diet promotes
its interaction with Nrf2 in the cytoplasm, which
prevents the translocation of Nrf2 to the nucleus and
does not allow the antioxidant genes expression. This
hypothesis is corroborated with a greater postprandial
decrease in the nuclear Nrf2 protein levels after intake of
theMed+CoQ diet compared with the SFA diet, with an
intermediate effect for theMed diet. Thus, after intake of
the SFA diet, lower levels of Keap-1 in the cytoplasm
and higher levels of nuclear Nrf2 protein may have
favored the binding of Nrf2 to the ARE found in the
antioxidant gene promoters and subsequent transcrip-
tional gene activation. In fact, a postprandial rise in
Nrf2, GPx1, SOD1, SOD2, and TrxR mRNA levels
were observed for the SFA diet in our study.
SOD, GPx, and CAT are regarded as the first line of
the antioxidant defense system enzymes against ROS.
They protect cells against ROS produced during normal
metabolism and after an oxidative insult. SOD metab-
olizes and protects the cells against O2
−-mediated lipid
peroxidation, while CAT and GPx acts on H2O2 and/
or ROOH by decomposing them, thereby neutralizing
their toxicity. Also, peroxides, including lipid hydro-
peroxides and hydrogen peroxide can directly be
reduced by TrxR (Zhong and Holmgren 2000;
Bjornstedt et al. 1995). By this mechanism, TrxR
could function as an alternative enzymatic pathway
for the detoxification of lipid hydroperoxides, other-
wise mainly managed by GPx. Any changes in one of
these systems may break the equilibrium and cause
cellular damage (Arsova-Sarafinovska et al. 2009).
Previous studies have shown that the expression of
SOD is upregulated by ROS (Mates et al. 1999).
Thus, the decrease in SOD1 and SOD2 mRNA levels
observed along the postprandial state of the Med and
Med+CoQ diets with respect to the SFA diet could be
explained on the basis of lower generation of
superoxide in these diets. In addition, GPx1 mRNA
levels showed the lowest postprandial levels in Med+
CoQ diet with respect to the other diets. Presumably,
CoQ supplementation contributed to a reduction in
the production of H2O2 and in this way suppressed the
GPx1 gene expression for which H2O2 serves as a
substrate (Stachowska et al. 2005) since CoQ deficiency
interferes with assembly or stability of the respiratory
chain enzymes leading to unbalanced oxidative
phosphorylation and enhanced ROS production
(Quinzii et al. 2008). This phenomenon, together
with the fact that there were observed an increase in
TrxR mRNA levels after intake of the SFA diet
compared with the Med and Med+CoQ diets could be
due to the fact that the damage caused by oxidative
stress is higher in the SFA diet than in the other diets.
NADPH oxidases are likely to be the predominant
source of ROS in the vasculature (Brandes and
Kreuzer 2005; Forstermann 2008; Grienling 2004).
Activation of the NADPH oxidase enzyme complex
requires the assembly of the cytosolic regulatory
subunits (p47phox, p67phox, p40phox, and Rac) with
the membrane-bound cytochrome b558 (gp91phox and
p22phox; Brandes and Kreuzer 2005). High-fat diet
had a significant increase in NADPH oxidase expres-
sion compared to low-fat diet in mice (Coate and
Huggins 2010). Thus, we have observed that during
the postprandial period, the intake of the SFA diet
induced an increase in fasting and postprandial
p22phox and postprandial p47phox mRNA levels,
which could be due to an increased ROS production
after the ingestion of this diet compared with the Med
and Med+CoQ diets.
The present study has the advantage of a randomized
crossover design in which all the participants have
experienced the three diet periods, each individual
acting as his/her own control and strengthening the fact
that the effects observed are due to the influence of the
type of diet. We acknowledge that our study has certain
limitations, since ensuring adherence to dietary instruc-
tions is difficult in a feeding trial. However, adherence
to the recommended dietary patterns was satisfactory, as
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can be judged by the measurements of compliance.
Another limitation of this study is that we did not study
if supplementation with CoQ of the saturated fatty acid-
rich diet may partly reduce the negative effects of this
dietary model on postprandial oxidative stress.
A thorough nutrition status may be basic to under-
stand the elderly total health. Therefore, our results
support that consumption of a Med diet rich in olive oil
(combined with vegetables, fruits, cereals, and a healthy
lifestyle) contributes to redox homeostasis and is
involved in prevention caused byH2O2-based oxidative
stress. This protection is enhanced by exogenous CoQ
supplementation, lowering of postprandial oxidative
stress, modifying the postprandial antioxidant protein
levels, and reducing the postprandial expression of
antioxidant genes in PBMCs in elderly men and
women. We can conclude that specific dietary
intervention might be a new, interesting, and promis-
ing challenge in the treatment (and mainly prevention)
of processes that lead to a rise in oxidative stress, such as
cardiovascular, neurodegenerative diseases, and aging.
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1
AGING is a biological process characterized by time-dependent, progressive physiological declines accom-
panied by the increased incidence of age-related diseases 
(1). A growing body of evidence points toward the oxidative 
damage caused by reactive oxygen species (ROS) as one of 
the primary determinant of aging (2). However, recent sci-
entific studies have advanced the notion of chronic inflam-
mation as other risk factor underlying aging and age-related 
diseases as neurodegenerative disorders, type 2 diabetes, 
atherosclerosis, and cardiovascular diseases (3–5). Address-
ing the central mechanisms underlying these pathologies 
will have implications for aging and should lead to new 
therapeutic approaches for treating these conditions (6).
One potential emerging mechanism involves the endo-
plasmic reticulum (ER), the organelle responsible for pro-
tein folding, maturation, quality control, and trafficking. 
When the ER becomes stressed due to the accumulation of 
newly synthesized unfolded proteins, the unfolded protein 
response is activated. A close examination of ER stress and 
unfolded protein response pathways has demonstrated 
many links to major inflammatory and stress signaling  
networks, including the activation of the JNK-AP1 and 
NF- B-IKK pathways (7,8), as well as production of ROS 
and nitric oxide (9,10).
Nutritional intervention may influence the intrinsic rate 
of aging as well as the incidence of these age-associated 
diseases. Increasing evidence suggests that the quality of 
diet may also be important in modulating inflammation 
(11,12). Thus, consumption of a meal high in carbohydrates 
and fat results in multiple metabolic changes including 
oxidative and inflammatory stress and increase in insulin 
resistance, transient endothelial dysfunction, and platelet 
activation with impaired homeostasis. However, extensive 
scientific evidence shows that the Mediterranean diet 
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(Med diet) prevents the onset and progression of coronary 
heart disease (13), metabolic disorders, and other aging-
related diseases (14,15) and has beneficial effects on se-
lected cancers that are potentially more diet related (16,17). 
Common components of this diet include monounsaturated 
fatty acids (MUFA), !-tocopherol, phenolic compounds, 
phytoesterols, and other antioxidants so the leading hypoth-
esis on the mechanism of this association is a decrease of 
oxidative stress due to the antioxidant capacity of this diet 
(16,18).
On the other hand, fasting is not the typical physiological 
state of the modern human being, which spends most the 
time in the postprandial state. For all these reasons, it is 
essential to know what changes are produced during the 
postprandial phase that is influenced by the quantity 
and quality of the fat ingested. With regard to the postpran-
dial state, we have recently demonstrated the antioxidant 
effect of Med diet rich in olive oil and that exogenous coen-
zyme Q10 (CoQ: 2,3-dimethoxy-5-methy-6-decaprenyl-1,
4-benzoquinone) supplementation in synergy with a Med 
diet (Med + CoQ diet) has an additive effect, improving the 
postprandial oxidative stress in elderly men and women, 
with a higher increase in capillary flow, a lower plasma bio-
marker of oxidative stress levels, and a greater postprandial 
decrease in plasma antioxidant enzymatic activities with 
respect to a Western diet rich in saturated fat (SFA diet (19)).
According to these premises, the aim of this study was to 
determine whether diets with different fat quality influence 
on the postprandial expression of proinflammatory genes 
and genes related with ER stress and that this hypothetical 
improvement could be boosted by supplementation with a 
natural antioxidant, like CoQ, to a Mediterranean diet in 
peripheral blood mononuclear cells (PBMCs) of aged persons.
Materials and Methods
Participants and Recruitment
Volunteers were recruited using various methods includ-
ing the use of general practitioner databases and poster and 
newspaper advertisements. A total of 63 persons were con-
tacted among those willing to enter the study. All partici-
pants underwent a comprehensive medical history, physical 
examination, and clinical chemistry analysis before enroll-
ment and gave their informed consent before joining the 
study. Inclusion and exclusion criteria were fulfilled by 20 
patients (age   65 years; 10 men and 10 women). Clinical 
inclusion criteria were age 65 years or older, body mass 
index 20–40 kg/m2, total cholesterol concentration less than 
or equal to 8.0 mmol/L, and nonsmokers. Clinical exclusion 
criteria were age less than 65 years, diabetes or other endo-
crine disorders, chronic inflammatory conditions, kidney or 
liver dysfunction, iron deficiency anemia (hemoglobin < 12 
g/dL men, < 11 g/dL women), prescribed hypolipidemic 
and anti-inflammatory medication, fatty acid supplements 
including fish oil, consumers of high doses of antioxidant 
vitamins (A, C, E, "-carotene), highly trained or endurance 
athletes or those who participate in more than three periods 
of intense exercise per week, weight change greater than or 
equal to 3 kg within the last 3 months, smokers, and alcohol 
or drug abuse (based on clinical judgment). The study pro-
tocol was approved by the Human Investigation Review 
Committee of the Reina Sofia University Hospital, accord-
ing to institutional and Good Clinical Practice guidelines.
Study Design
Participants were randomly assigned to receive, in a 
crossover design, three isocaloric diets for 4-week periods 
each. Three dietary periods were administered continuously 
(see Supplementary Figure 1). The three diets were as fol-
lows: (1) Mediterranean diet supplemented with coenzyme 
Q (Med + CoQ diet; 200 mg/day in capsules), containing 
15% of energy as protein, 47% of energy as carbohydrate, 
and 38% of total energy as fat (24% MUFA [provided by 
virgin olive oil], 10% SFA [saturated fatty acid], and 4% 
PUFA [polyunsaturated fatty acid]); (2) Mediterranean diet 
not supplemented with CoQ (Med diet), with the same com-
position of the first diet, but supplemented by placebo cap-
sules; and (3) Western diet rich in saturated fat (SFA diet), 
with 15% of energy as protein, 47% of energy as carbohy-
drate, and 38% of total energy as fat (12% MUFA, 22% 
SFA, and 4% PUFA).
The cholesterol intake was kept constant (<300 mg/day) 
during the three periods. Both the CoQ and the placebo cap-
sules were specially produced by the same company 
(Kaneka Corporation, Osaka, Japan) and were identical in 
weight and external aspect. Patients taking capsules were 
unaware whether they were in the Med + CoQ or Med 
dietary period (see Supplementary Table 1). The composi-
tion of the experimental diets was calculated by using 
the U.S. Department of Agriculture (20) food tables and 
Spanish food composition tables for local foodstuffs (21).
Before the start of the intervention period, volunteers 
completed a 3-day weighed food diary and an extensive 
Food Frequency Questionnaires, which allowed identifica-
tion of foods to be modified. At the start of the intervention 
period, each patient was provided with a handbook for the 
diet to which they had been randomized. Advice was given 
on foods to choose and those to avoid if eating outside 
home. They were also instructed to write down in the diary 
about any menu eaten out of the home and to call the moni-
toring study nurse reporting such event. At baseline, volun-
teers were provided with a supply of study foods to last for 
2 weeks. They collected additional study foods every fort-
night or when required. At these times, a 24-hour recall of 
the previous day’s food intake and a short food-use ques-
tionnaire based on the study foods were completed to moni-
tor and motivate volunteers to adhere to the dietary advice. 
A point system was used to assess the number of food 
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 MEDITERRANEAN DIET, COQ10, AND INFLAMMATORY RESPONSE 3
exchanges achieved in the 24-hour recall, and additional 
advice was given if either the 24-hour recall or food-use 
questionnaire showed inadequate intake of food exchange 
options. Volunteers were asked to complete 3-day weighed 
food diaries at baseline, Weeks 2, and 4. Weighed food 
intake over two weekdays and one weekend day was 
obtained using scales provided by the investigators. Fat 
foods were administered by dietitians in the intervention 
study. The dietary analysis software Dietsource version 2.0 
was used. (Novartis S.A., Barcelona, Spain).
At the end of the dietary intervention period, the partici-
pants were given a fatty breakfast with the same fat compo-
sition as consumed in each of the diets. Patients presented 
at the clinical centers at 8 hours following a 12-hour fast 
(Time 0), abstained from alcohol intake during the preced-
ing 7 days. After cannulation of a blood vessel, a fasting 
blood sample was taken before the test meal, which was 
then ingested within 20 minutes under supervision. The test 
meal reflected fatty acid composition of each subject after 
the chronic dietary intervention. Subsequent blood samples 
were drawn at 2 and 4 hours. Test meals provided an equal 
amount of fat (0.7 g/kg body weight), cholesterol (5 mg/kg 
of body weight), and vitamin A (60,000 IU/m2 body surface 
area). The test meal provided 65% of energy as fat, 10% as 
protein, and 25% as carbohydrates. The composition of 
the breakfasts was as follow: Med with CoQ (400 mg in 
capsules) breakfast (12% SFA, 43% MUFA, and 10% 
PUFA), Med with placebo capsules breakfast (12% SFA, 
43% MUFA, and 10% PUFA), and SFA-rich breakfast 
(38% SFA, 21% MUFA, and 6% PUFA).
Biochemical Determinations
Plasma samples.—Venous blood samples were obtained 
at the end of the each dietary intervention period on fasting 
state, after a 12-hour fast, before to breakfast ingest, and at 
2 and 4 hours after the ingestion of the breakfast. Samples 
from the fasting and postprandial states were collected in 
tubes containing 1 g EDTA/L and were stored in containers 
with ice and kept in the dark. Particular care was taken 
to avoid exposure to air, light, and ambient temperature. 
Plasma was separated from whole blood by low-speed 
centrifugation at 1,500g for 15 minutes at 4°C within 1 hour 
of extraction.
Isolation of PBMCs.—PBMCs were isolated from 20 mL 
of venous blood in tubes containing 1 mg/mL of EDTA. The 
blood samples were diluted 1:1 in phosphate-buffered 
saline, and cells were separated in Ficoll gradient by centrifu-
gation at 800g for 25 minutes at 20°C. The cells were col-
lected and washed with cold phosphate-buffered saline two 
times and finally resuspended in Buffer A. This buffer con-
tained 10 mM HEPES, 15 mM KCl, 2 mM MgCl2, and 1 mM 
EDTA, and at the time of use, 1 mM phenylmethylsulfonyl 
fluoride and 1 mM Dithiothreitol were added. The cells thus 
obtained were stored at −80°C for further analysis.
RNA Extraction and Quantitative Real Time-Polymerase 
Chain Reaction Analysis
RNA extraction.—Total RNA from PBMCs was extracted 
using the Trizol method according to the recommendations 
of the manufacturer (Tri Reagent; Sigma, St Louis, MO) 
and quantified in a NanoDrop 1000A Spectrophotometer. 
RNA integrity was verified on agarose gel electrophoresis 
and stored at −80°C. Next, because polymerase chain reac-
tion can detect even a single molecule of DNA, RNA sam-
ples were digested with DNAse I (AMPD-1 KT; Sigma) 
before RT-PCR.
Biotrove OpenArray real-time PCR.—Each reaction was 
performed with 1 #L of a 1:5 (v/v) dilution of the first com-
plementary DNA strand, synthesized from 1 #g of total 
RNA using the commercial kit iScript cDNA Synthesis Kit 
(Bio-Rad) according to the manufacturer’s instruction.
The reaction of real-time polymerase chain reaction was 
carried out using the platform OpenArray NT Cycler (Ap-
plied Biosystems employing Taqman probes). OpenArray 
subarrays were preloaded by Biotrove with the selected 
primer pairs. The individual primer pairs (synthesized by 
Sigma-Aldrich, St Louis, MO) were preloaded into BioTrove 
OpenArray plates. Each primer pair was spotted in duplicate. 
The primers that amplify genes of interest were selected 
from the database TaqMan Gene Expression Assays (Ap-
plied Biosystems), https://products.appliedbiosystems.com/a
b/en/US/adirect/ab? Cmd = catNavigate2 & catID = 601267 
in Assays search tab taking as search criteria: selection and 
homo sapiens Gene Expression Assays for each of the genes 
of interest.
Samples were loaded into OpenArray plates with the 
OpenArray NT Autoloader according to the manufacturer’s 
protocols. Each subarray was loaded with 5.0 #L of master 
mix consisted of 1× LighCycler FastStart DNA Master 
SYBR Green Kit (Roche Applied Sciences, Indianapolis, 
IN), 1× SYBR Green I 80×, 0.5% glycerol, 0.2% Pluronic 
F-68, 1 mg/mL bovine serum albumin (New England Biola-
boratories, Beverly, MA), 1 mM MgCl2, 400 nM FP, 400 
nM RP, 8% Formamide, 0.25× Rox, 1× TfR amplicon,  
and complementary DNA samples. The PCR OpenArray 
thermal cycling protocol consisted of 95°C for 10 minutes, 
followed by cycles of 10 seconds at 95°C, 10 seconds at 
53°C, and 10 seconds at 72°C. All samples were tested in 
duplicate. The Biotrove OpenArray NT Cycler System Soft-
ware (version 1.0.2) uses a proprietary calling algorithm that 
estimates the quality of each individual CT value by calcu-
lating a CT confidence value for the amplification reaction.
In our assay, CT values with CT confidence values below 
700 were regarded as background signals. The remaining 
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YUBERO-SERRANO ET AL.4
positive amplification reactions were analyzed for amplicon 
specificity by studying the individual melting curves.
The same program allowed the selection of the most 
stable housekeeping gene in the samples processed for 
the relativization of the expression of genes of interest. 
Following this methodology, we analyzed the relative gene 
expression of these genes: p65 (RelA), IkB-! (inhibitor 
of kB-subunit !), IKK-" (IkB kinase-subunit "), MMP-9 
(metalloproteinase-9), IL-1" (interleukin-1"), JNK-1 (c-Jun 
N-terminal kinase-1), sXBP-1 (x-box–binding protein-1), 
CRT (calreticulin), and BiP/Grp78 (glucose-regulated protein 
78 kDa).
Statistical Analysis
The Statistical Package for the Social Sciences (SPSS 
17.0 for Windows Inc., Chicago, IL) was used for the statis-
tical comparisons. The Kolmogorov–Smirnov test did not 
show a significant departure from normality in the distribu-
tion of variance values. In order to evaluate data variation, 
Student’s t test and an analysis of variance for repeated 
measures were performed, followed by Bonferroni’s cor-
rection for multiple comparisons. We studied the statistical 
effects of the type of fat meal ingested, independent of time 
(represented by p1), the effect of time (represented by p2), 
and the interaction of both factors, indicative of the degree 
of the postprandial response in each group of participants 
with each fat meal (represented by p3). Differences were 
considered to be significant when p < .05. All data presented 
in text and tables are expressed as means ± SE.
Results
Metabolic Parameters Levels
The baseline characteristics of the 20 participants who 
completed the three dietary intervention periods showed that 
males had higher height, waist circumference, triglycerides, 
and apolipoprotein B than females. We did not find any other 
differences by gender (see Supplementary Table 2).
Moreover, we previously observed higher fasting plasma 
CoQ concentration (p < .001) after the intake of the Med + 
CoQ diet compared with the Med and SFA diets. At 2 and 
4 hours after consumption of the Med + CoQ diet, we 
observed a greater postprandial increase in plasma CoQ 
levels compared with the Med and SFA diets (p = .018 and 
p = .032, respectively; see Supplementary Figure 2 (19)).
Diet Intake and Genes Related With Activation of Nuclear 
Factor Kappa B in PBMCs
The nuclear factor kappa B (NF- B) transcription factor 
functions as homo- or heterodimers of the Rel family of 
proteins, which includes p50, p65, c-Rel, p52, and RelB. 
The most common combination of subunits is a heterodi-
mer of the p50 and p65 proteins. Activation of NF- B 
dimers is the result of IKK-mediated phosphorylation- 
induced degradation of the IkB, which enables the NF- B 
dimers to enter the nucleus and activate specific target gene 
expression (22).
At 2 and 4 hours after intake of the Med + CoQ diet, we 
found lower postprandial p65 (RelA) messenger RNA 
(mRNA) levels compared with the other diets (p = .008 and 
p = .012, respectively; Figure 1A). Furthermore, p65 (RelA) 
mRNA levels were lower after consumption of the Med diet 
compared with the SFA diet (p = .033).
At 2 hours after intake of the Med + CoQ diet, we 
observed a greater postprandial decrease in IKK-" mRNA 
levels compared with the other diets (p = .010; Figure 1B). 
Furthermore, IKK-" mRNA levels were lower after 
consumption of the Med diet compared with the SFA diet 
(p = .034). At 4 hours after intake of the Med and 
Figure 1. Fasting and postprandial levels of p65 (RelA) mRNA (A), IKK-" 
mRNA (B), and IkB-! mRNA (C) in peripheral mononuclear cells according to 
the type of fat consumed. Data were analyzed using analysis of variance for 
repeated measures. All values represent the mean ± SEs. Bars with different 
superscript letters depict statistically significantly differences (p < .05). p1: diet 
effect, p2: time effect, and p3: Diet × Time interaction.
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 MEDITERRANEAN DIET, COQ10, AND INFLAMMATORY RESPONSE 5
Med + CoQ diets, we observed a greater postprandial 
decrease in IKK-" mRNA levels with respect to the SFA 
diet (p = .011).
At 2 hours after intake of the Med and Med + CoQ diets, 
we observed a greater postprandial increase in IkB-! 
mRNA levels compared with the SFA diet (p = .028). At 
4 hours after the Med diet, we found higher postprandial 
IkB-! mRNA levels compared with the SFA diet (p = .018; 
Figure 1C).
No significant differences were detected in p65 (RelA), 
IKK-", and IkB-! mRNA levels in fasting after intake of 
any of the three diets (Figure 1A, B, and C, respectively).
Diet Intake and Genes Related With the Inflammatory 
Response in PBMCs
MMP-9 is a metalloproteinase, which is involved in 
several stages of atherosclerosis through remodeling of the 
extracellular matrix (23). We observed a decrease in fasting 
MMP-9 mRNA levels after intake of the Med diet com-
pared with the SFA diet (p = .034; Figure 2A). At 2 and 
4 hours after the SFA diet, we found higher postprandial 
MMP-9 mRNA levels compared with the Med and Med + 
CoQ diets (p = .008 and p = .032, respectively; Figure 2A).
IL-1 is an inflammatory cytokine that consists of two dis-
tinct ligands (IL-1! and IL-1"), and both subunits appear to 
play an essential role in many inflammatory response (24).
Fasting IL-1" mRNA levels were lower after participants 
consumed the Med and Med + CoQ diets than when they 
consumed the SFA diet (p = .017; Figure 2B). At 2 hours 
after intake of the Med + CoQ diet, we observed a greater 
postprandial decrease in IL-1" mRNA levels compared 
with the other diets (p = .011; Figure 1B). Furthermore, 
IL-1" mRNA levels were lower after consumption of the 
Med diet compared with the SFA diet (p = .029). At 4 hours 
after intake of the Med and Med + CoQ diets, we observed 
a greater postprandial decrease in IL-1" mRNA levels with 
respect to the SFA diet (p = .015; Figure 2B).
JNK is involved in inflammatory signals, changes in lev-
els of ROS, and a variety of stress stimuli and consist of 
10 isoforms derived from three genes: JNK-1 (4 isoforms), 
JNK-2 (4 isoforms), and JNK-3 (2 isoforms (25)).
Fasting JNK-1 mRNA levels were lower after partici-
pants consumed the Med and Med + CoQ diets than when 
they consumed the SFA diet (p = .037; Figure 2C). At 2 and 
4 hours after the SFA diet, we found higher postprandial 
JNK-1 mRNA levels compared with the other diets (p = .009 
and p = .011, respectively; Figure 2C).
Diet Intake and Genes Related With ER Stress in PBMCs
The transcription factor sXBP-1 has been identified as a 
key regulator of the mammalian unfolded protein response 
or ER stress response, which is activated by environmental 
stressors such as protein overload that require increased 
ER capacity (26). CRT, BiP/Grp78, calnexin, and other ER 
Ca2+ binding chaperons and folding enzymes are impor-
tant component of protein folding and quality control (27).
At 2 and 4 hours after the Med and Med + CoQ diets, we 
found lower postprandial sXBP-1 mRNA levels compared 
with the SFA diet (p = .033 and p = .008; Figure 3A). No 
significant differences were detected in sXBP-1 mRNA lev-
els in fasting after intake of any of the three diets (Figure 3A). 
In addition, fasting CRT mRNA levels were lower after par-
ticipants consumed the Med and Med + CoQ diets than 
when they consumed the SFA diet (p = .031; Figure 3B).
At 2 hours after intake of the SFA diet, we found a greater 
postprandial increase in BiP/Grp78 mRNA levels compared 
with the other diets (p = .021). No significant differences 
were detected in BiP/Grp78 mRNA levels in fasting and at 
4 hours after intake of the three diets (Figure 3C).
Figure 2. Fasting and postprandial levels of MMP-9 mRNA (A), IL1-" 
mRNA (B), and JNK-1 mRNA (C) in peripheral mononuclear cells according 
to the type of fat consumed. Data were analyzed using analysis of variance for 
repeated measures. All values represent the mean ± SEs. Bars with different 
superscript letters depict statistically significantly differences (p < .05). p1: diet 
effect, p2: time effect, and p3: Diet × Time interaction.
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Discussion
The present study demonstrates that the consumption of 
a Med diet reduces the postprandial expression of genes 
related to both the activation of NF- B as the inflammatory 
response such as p65 (RelA) and IKK-" and MMP-9, IL1-" 
and JNK-1, respectively, and increases the expression of 
IkB-! mRNA levels in PBMCs. Additionally, the consump-
tion of a Med diet reduces the expression of genes related 
with ER stress (sXBP-1, CRT, and BiP/Grp78). Moreover, the 
addition of CoQ had an additive effect on the Med diet 
because the participants who consumed this diet showed a 
greater postprandial decrease in gene expression of p65 (RelA), 
IKK-", and IL1-" in PBMCs with respect to the other diets.
In the same population of this study, we previously demon-
strated that the Med diet improves the postprandial oxidative 
stress with a higher increase in capillary flow and plasma nitric 
oxide levels, a lower plasma lipid peroxidation products, nitro-
tyrosine and protein carbonyl levels, lower plasma antioxidant 
enzyme activities (GPx, CAT, and SOD (19)), and lower DNA 
damage in PBMCs (28). Addition of exogenous CoQ in syn-
ergy with a Med diet had an additive effect, reducing the post-
prandial oxidative stress in elderly men and women.
The process of aging has been attributed to cellular free 
radical damage as well as a decrease in exogenous antioxi-
dants. With the current understanding from human and 
animal studies, evidence supports that vitamins A and E 
supplementation may only provide life-span benefits when 
initiated early in life, and they may accumulate within our 
body, increasing their risk of toxicity (29–32). In addition, 
vitamins E and C have in combination shown long-term 
antiatherogenic effects, but their combined effect on 
clinical end points has been inconsistent (33).
Thus, interest in CoQ comes from the fact that it has a 
pivotal role as a redox link between flavoproteins and cyto-
chromes in the mitochondrial respiratory chain (34) where 
additionally it plays very important antioxidant properties 
(35). CoQ is the only known bodily-synthesized lipophilic 
antioxidant, and as an endogenous compound, its toxicity 
risk may be lesser (36). Not only can reduced CoQ prevent 
lipid peroxidation chain reaction by itself it can also act 
by reducing (regenerating) other antioxidants such as 
!-tocopherol and ascorbate (37,38,39). Previous studies 
shown that lifelong supplementation of polyunsaturated 
fatty acid (PUFA) together with dietary CoQ increased life 
span and may also protect against the deleterious effects of 
PUFA diet when taken together in rats (29,35). Besides, 
CoQ can modulate proteins, decrease oxidative stress and 
cardiovascular risk, as well as control inflammation during 
aging in rats (40). In healthy humans, plasma oxidative 
damage may be partially prevented by CoQ supplementa-
tion (41), which has been replicated in other populations, 
like psoriasis (42) or coronary heart disease patients (43). 
However, whether CoQ added to a Mediterranean has an 
antioxidant additive effect has not been tested at present.
Accumulating evidence indicates that unresolved, low-
grade chronic systemic inflammation plays a significant role 
in modulating the aging process and age-related diseases, 
such as metabolic syndrome, atherosclerosis, cancer, and 
osteoporosis (3–5). In fact, the NF- B transcription factor 
can be viewed as the master regulator of the inflammatory 
process and can be activated by oxidative stimuli. In most 
cells, NF- B (p50/p65) is present in an inactive form in the 
cytoplasm, bound to an inhibitor IkB. Oxidative and other 
stimuli such as the cytokines (IL-1", IL-8, and others) result 
in the phosphorylation of IkB proteins by IKK, ubiquitina-
tion, followed by degradation via the 26 S proteasome. This 
allows active NF- B to translocate to the nucleus, where 
it binds to its consensus sequences within the promoter 
regions of genes, thus activating transcription (44).
Aljada and colleagues (45) have demonstrated that con-
sumption of a hypercaloric breakfast increased the nuclear 
Figure 3. Fasting and postprandial levels of sXBP-1 mRNA (A), CRT 
mRNA (B), and BiP/Grp78 mRNA (C) in peripheral mononuclear cells accord-
ing to the type of fat consumed. Data were analyzed using analysis of variance 
for repeated measures. All values represent the mean ± SEs. Bars with different 
superscript letters depict statistically significantly differences (p < .05). p1: diet 
effect, p2: time effect, and p3: Diet × Time interaction.
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NF- B activity, accompanied by a reduction in the cyto-
plasmic IkB-! expression in healthy participants. Further-
more, our group has already demonstrated that the Med diet 
decreases NF- B activation in PBMCs when compared 
with butter- and walnut-enriched diets or a typical Western 
diet in healthy young people (46,47).
Consistently, our results shown a greater postprandial 
decrease in p65 (RelA) and IKK-" mRNA levels after 
intake of the Med + CoQ diet compared with the SFA diet, 
with an intermediate effect for the Med diet and greater 
postprandial increase in IkB-! mRNA levels after intake of 
the Med and Med + CoQ diets compared with the SFA diet.
The transcription factor NF- B has been shown to regulate 
IL-1", tumor necrosis factor-alpha, interleukin-6 (IL-6), and 
COX-2 expression (48,49). Thus, we observed, consistently, 
a greater increase in IL-1" mRNA levels after intake of the 
SFA diet compared with the Med and Med + CoQ diets.
Another interesting factor is MMP-9, which is involved 
in several stages of atherosclerosis through remodeling of 
the extracellular matrix. The expression of MMP-9 in ath-
erosclerotic plaques coincides with the production of free 
radicals (50). Moreover, MMP-9 might be a potential 
mediator of the NADPH oxidase–dependent ROS produc-
tion in the atherosclerotic process, and previous studies sug-
gested that NADPH oxidase activity increase significantly 
after consumption of a hypercaloric breakfast (45). In our 
study, we observed a reduction in MMP-9 mRNA levels 
after the Med and Med + CoQ diets compared with the SFA 
diet, which indicate that this diet may influence not only the 
rate of atherosclerosis development but also promote the 
stability of the plaque (23). The mechanism responsible for 
rises in the levels of MMP-9 with SFA diet could be the 
increase in ROS production, inducing the activation of the 
inflammatory response when this type of fat is consumed.
Activation of stress-kinase signaling has recently been 
recognized as an important pathophysiological mechanism 
in the development of diet-induced obesity, type 2 diabetes 
mellitus, and other aging-related pathologies. Hotamisligil 
and colleagues (51) revealed that mice deficient for the 
stress mediator JNK-1 are protected from the development 
of high-fat diet-induced obesity and glucose intolerance, as 
well as insulin resistance. The family of JNK kinases can 
not only be activated by cytokines but also by ER stress and 
hyperlipidemia (52). In our study, Med and Med + CoQ 
diets were associated with a lower expression of the JNK-1 
and genes related with ER stress as sXBP-1, CRT, and 
BiP/Grp78, which act to increase ROS levels that may elicit 
inflammatory responses, thereby providing yet another 
potential link between ER stress and inflammation (6).
The present study has the advantage of a randomized cross-
over design in which all the participants have experienced the 
three diet periods, each individual acting as his or her own 
control and strengthening the fact that the effects observed are 
due to the influence of the type of diet. We acknowledge that 
our study has certain limitations because ensuring adherence 
to dietary instructions is difficult in a feeding trial. However, 
adherence to the recommended dietary patterns was satisfac-
tory, as can be judged by the measurements of compliance.
In conclusion, our results show that the anti-inflammatory 
effect of Med diet rich in olive oil and that exogenous CoQ 
supplementation, in synergy with a Med diet, has an additive 
effect modulating the inflammatory response and ER stress in 
elderly men and women and support that the consumption of a 
Med diet supplemented with CoQ is beneficial for healthy ag-
ing of individuals. We can conclude that specific dietary inter-
vention might be a new, interesting, and promising challenge 
in the treatment (and mainly prevention) of processes that lead 
to a rise in chronic inflammation and oxidative stress, such as 
cardiovascular, neurodegenerative diseases, and aging.
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 2 
Abstract  26 
Previous evidences support that increased oxidative stress (OxS) may play an important role 27 
in metabolic syndrome (MetS) and both are closely linked to vascular dysfunction. This 28 
study determined whether there is a direct relationship between endothelial function and 29 
relative telomere length (RTL) in MetS subjects. In this cross-sectional study from the 30 
LIPGENE cohort, a total of 88 subjects (36 men and 52 women) were divided into four 31 
groups by quartiles of telomere length. We measured ischemic reactive hyperemia (IRH), 32 
total nitrite (NO) and protein carbonyl (PC) plasma levels, superoxide dismutase (SOD) and 33 
glutathione peroxidase (GPx) plasma activities. IRH and NO plasma levels were higher in 34 
subjects with longer RTL (quartile 3 and 4), while PC plasma levels and GPx and SOD 35 
plasma activities were lower in quartile 4 subjects (longest RTL). Additionally, MetS 36 
subjects with longer RTL had greater homeostatic model assessment-β (HOMAβ) level and 37 
lower triglycerides (TG) plasma levels. Our results suggest that endothelial dysfunction, 38 
associated by high levels of OxS, could be entailed in an increment of telomere attrition. 39 
Thus, further support of the molecular and cellular mechanisms involved in vascular 40 
dysfunction may contribute to the development of strategies to decelerate vascular aging or 41 
prevent cardiovascular disease. 42 
 43 
 44 
Keywords: endothelial dysfunction; LIPGENE study; metabolic syndrome; oxidative stress; 45 
telomeres 46 
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 3 
Introduction 51 
According to the criteria defined by the Third Report of the National Cholesterol Education 52 
Program Adult Treatment Panel III (National Cholesterol Education Program (NCEP) Expert 53 
Panel on Detection E 2002), metabolic syndrome (MetS) refers to the clustering of three or 54 
more characteristics such as hyperglycemia, hypertriglyceridemia, low level of high-density 55 
lipoprotein cholesterol (HDL-C), hypertension and abdominal obesity (Duvnjak and Duvnjak 56 
2009). One of the mechanisms underlying this pathology is oxidative stress (OxS) (Pena-57 
Orihuela, Camargo et al. 2013). In fact, it has been recently published that the degree of OxS 58 
is influenced by the number of components of the metabolic syndrome (Yubero-Serrano, 59 
Delgado-Lista et al. 2013).  60 
OxS is often defined as the imbalance between reactive oxygen species (ROS) and the 61 
antioxidant capacity of an organism (Jones 2006). In this regard, antioxidant enzymes such as 62 
superoxide dismutase (SOD) and glutathione peroxidase (GPx) play a substantial role in the 63 
first line of defense for the detoxification of products resulting from OxS (Ray and Husain 64 
2002; Johnson and Giulivi 2005). Also, protein carbonyl (PC) is considered as a biomarker of 65 
severe OxS, characterized by an irreversible damage to the protein structure and function 66 
(Hopps and Caimi 2013).  67 
It is established that an increase in OxS levels, coupled with an impairment in nitric oxide 68 
(NO) availability, may cause alteration of endothelial cells causing endothelial dysfunction 69 
(Ferroni, Basili et al. 2006). These findings would be reflected in decreased ischemic reactive 70 
hyperemia (IRH), which is a method for measuring changes in acute endothelial reactivity 71 
(Fernandez, Da Silva-Grigoletto et al. 2010).  72 
Telomeres are DNA-protein complexes that cap and preserve the integrity of the 73 
chromosomal ends. They consist of several thousands of repetitive sequences of TTAGGG 74 
that are naturally shortened with each cell division due to the end replication problem 75 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
 4 
(Nakashima, Ozono et al. 2004; Saliques, Zeller et al. 2010). Progressive attrition of the 76 
telomere leads to a critical length that triggers the cell arrest phenomenon known as 77 
senescence (Khan, Chuturgoon et al. 2012), and due to the universal fact that telomere 78 
shorten with age, its study is crucial for understanding mechanisms of age-related diseases 79 
(Armanios 2013). Notably, it has been reported that telomere attrition and oxidative DNA 80 
damage in endothelial progenitor cells is higher in coronary artery disease patients with MetS 81 
than in those without MetS (Satoh, Ishikawa et al. 2008). In addition, endothelial damage and 82 
atherosclerosis have been shown to be associated with telomere shortening in white blood 83 
cells more tightly than chronological aging (Nakashima, Ozono et al. 2004). Nonetheless, 84 
there is still a lack of data in this field. It has not been described yet an explicit correlation 85 
between endothelial function (measured in terms of IRH) and telomere length in MetS 86 
subjects. 87 
Taking this into account, the purpose of this study was to determine whether there is a direct 88 
relationship between endothelial function, through high OxS, and relative telomere length 89 
(RTL) in a cross-sectional study of MetS subjects of four groups divided by quartiles of 90 
telomere length.  91 
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Materials and Methods 102 
Subjects and Design 103 
This study was conducted within the framework of the LIPGENE study (‘Diet, genomics and 104 
the metabolic syndrome: an integrated nutrition, agro-food, social and economic analysis’), a 105 
Framework VI Integrated Project funded by the European Union (Tierney, McMonagle et al. 106 
2011) 107 
Subject eligibility was determined using a modified version of the NCEP criteria for MetS,
 
108 
according to published criteria (2001).  109 
Subjects were required to meet at least two of the following five criteria: waist circumference 110 
>102 cm (men) or >88 cm (women); fasting glucose 5.5–7.0 mmol/l; triglycerides ≥1.5 111 
mmol/l; high-density lipoprotein cholesterol (HDL-C) <1.0 mmol/l (men) or <1.3 mmol/l 112 
(women); blood pressure (BP) ≥130/85 mmHg or treatment of previously diagnosed 113 
hypertension. We used a subgroup of pre-intervention data for 88 subjects (36 men and 52 114 
women), which conformed to the LIPGENE inclusion and exclusion criteria (“Online 115 
Resource 1”) (Perez-Martinez, Moreno-Conde et al. 2010). 116 
All participants provided written informed consent and underwent a comprehensive medical 117 
history, physical examination and clinical chemistry analysis before enrollment. Participants 118 
displayed no signs of cardiac dysfunction or hepatic, renal and thyroid diseases and were 119 
requested to maintain their regular physical activity and lifestyle. Participants were also 120 
asked to record in a diary any event that could affect the outcome of the study, such as stress, 121 
changes in smoking habits and alcohol consumption or intake of foods not included in the 122 
experimental design. None of the participants showed evidence of high alcohol consumption 123 
or a family history of early-onset cardiovascular disease, nor were any active smokers. All 124 
patients were free from cardiovascular complications at the time of the enrollment. The study 125 
was carried out in the Lipid and Atherosclerosis Unit at the Reina Sofia University Hospital, 126 
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 6 
from February 2005 to April 2006. The experimental protocol was approved by the local 127 
ethics committee according to the Helsinki Declaration. The study was registered with the 128 
US National Library of Medicine Clinical Trials registry (NCT00429195). 129 
 130 
Anthropometric measurements 131 
After recording clinical histories and conducting physical examinations, we obtained the 132 
following anthropometric measurements for each individual: weight, height, body mass index 133 
and waist circumference. Weight was measured while the subject was wearing light indoor 134 
clothing, without shoes and after voiding. Height was obtained with a stadiometer graduated 135 
in millimeters. The subject was barefoot with the back and head in contact with the 136 
stadiometer in the Frankfurt horizontal plane. Body mass index was calculated by dividing 137 
weight (kg) by height squared (m2). Waist circumference (cm) was measured to the nearest 138 
0.5cm with a tape measure at the umbilical scar level. A non-stretchable tape measure was 139 
used to measure waist circumference. The measurement was taken directly on the skin with 140 
the subject in a standing position with the abdomen relaxed, the arms at the sides and the feet 141 
together. We used the homeostatic model assessment index for insulin resistance (HOMAIR: 142 
fasting insulin (mUl
-1
)/fasting glucose (mmol l
-1
)/22.5) and HOMAb-cell function as the 143 
index of insulin secretory function derived from fasting plasma glucose and insulin 144 
concentrations, calculated as 20 x fasting insulin (mUl
-1
)/fasting glucose (mmol l
-1
)-3.5 145 
(Matthews, Hosker et al. 1985). Insulin sensitivity was estimated by a quantitative insulin 146 
sensitivity check index (QUICKI) (1/[log insulin (mU l
-1
) + log baseline glucose (mg dl
-1
)]) 147 
(Conwell, Trost et al. 2004). BP was measured using an automatic BP device. In accordance 148 
with the European Society of Hypertension Guidelines (Guidelines and Committee 2003), BP 149 
measurement was obtained with an appropriately sized cuff positioned at the heart level and 150 
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 7 
after the patient had been relaxed for at least 5min. The same arm was used for each 151 
measurement, and the average of two measurements was used for data processing. 152 
 153 
Biochemical determinations 154 
Plasma samples  155 
Blood was collected in tubes containing ethylene diaminetetraacetic acid (EDTA) to yield a 156 
final concentration of 0.1% EDTA. Plasma was separated from red cells by centrifugation at 157 
1500 x g for 15 min at 4 °C within 1 h of extraction.
 
Plasma was immediately aliquoted and 158 
stored at -80 ºC until analysis. 159 
 160 
Biochemical analysis 161 
The lipid variables were analyzed with a modular autoanalyzer (DDPPII Hitachi; Roche, 162 
Basel, Switzerland) with the use of Boehringer-Mannheim reagents. Triglycerides (TG) in 163 
plasma was assayed by means of enzymatic procedures (Bucolo and David 1973). HDL-C 164 
was measured by analyzing the supernatant obtained following precipitation of a plasma 165 
aliquot in dextran sulfate-Mg
2+
, as described by Warnick et al. (Warnick, Benderson et al. 166 
1982). Plasma glucose concentrations were measured with an Architect-CG16000 analyzer 167 
(Abbott Diagnostics, Tokyo, Japan) by the hexokinase method. Plasma insulin concentrations 168 
were measured by chemoluminescence with an Architect-I2000 analyzer (Abbott 169 
Diagnostics, Tokyo, Japan). High-sensitivity C-reactive protein concentrations were 170 
measured according to Rifai et al. (Rifai, Tracy et al. 1999). 171 
 172 
Relative telomere length measurement 173 
DNA isolation 174 
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 8 
DNA was extracted from buffy coats using the Gentra Puregene Blood kit (Gentra Systems 175 
Inc., Minneapolis, MN, USA), and low yielding samples (<10 ng) were subjected to whole 176 
genome amplification using the REPLI-g kit (Qiagen Ltd. West Sussex, UK). 177 
 178 
Quantitative PCR analysis of telomere length 179 
RTL was determined using the Cawthon method where the measurements are performed by 180 
qPCR (Cawthon 2002). We estimated the relative ratio of telomere repeat copy number (T) 181 
normalized against a single copy gene copy number (Homo sapiens ribosomal protein L13a 182 
gene RPL13a; S) for all the samples. Results for each PCR were relativized to a standard 183 
curve built using a reference DNA sample. The standard curves for telomere and genomic 184 
PCRs consisted of eight standards of reference DNA (1-25 ng). The correlation between 185 
relative T/S ratios measured by qPCR and relative telomere DNA restriction fragment length 186 
by Southern blotting has been confirmed previously to be highly consistent (Cawthon 2002; 187 
Epel, Blackburn et al. 2004). 188 
All PCRs were performed in duplicate with the use of iQ5-BIORAD thermal cycler and 189 
SensiFAST
TM
 SYBR Lo-ROX kit (Bioline). The thermal cycler profile for both amplicons 190 
began with a 95ºC incubation for 3 min to activate the polymerase, followed by 40 cycles of 191 
95ºC for 5 s, 54ºC 15 s. The reaction mix composition was identical except for the 192 
oligonucleotide primers: 20 ng template DNA; 1X SensiFAST
TM
 SYBR Lo-ROX; 200 nM 193 
reverse primer; 200 nM forward primer. The primer sequences were (written 5’à 3’):  194 
RPL13aF, CCTGGAGGAGAAGAGGAAAGAGA;  195 
RPL13aR, TTGAGGACCTCTGTGTATTTGTCAA  196 
teloF, CGGTTTGTTTGGGTTTGGGTTTGGGTTTGGGTTTGGGTT;  197 
teloR, GGCTTGCCTTACCCTTACCCTTACCC TTACCCTTACCCT (O'Callaghan and 198 
Fenech 2011).  199 
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 9 
Study of endothelial function using laser Doppler 200 
The Laser-Doppler linear Periflux 5000 (Perimed S.A., Stockholm, Sweden) was used to 201 
measure IRH. We found an inter-study variability of 8.85% and an intra-study variability of 202 
8.7%. 203 
Briefly, capillary flow of the second finger of the dominant arm of the patient was assessed 204 
for one minute before (t0) and after applying four minutes (td) of ischemia to the arm using a 205 
sphygmomanometer. The ischemic reactive hyperemia was obtained via IRH = (AUCtd - 206 
AUCt0) × 100 AUCt0.  207 
 208 
Determination of oxidative stress biomarkers 209 
Nitric oxide (NO) is a free gas produced endogenously by a variety of mammalian cells. This 210 
molecule induces vasodilatation and inhibits platelet aggregation and adhesion to the 211 
vascular endothelium. Total nitrite (nitrite and nitrate) was used as an indicator of NO 212 
production and was assayed using the Griess method (Ricart-Jane, Llobera et al. 2002), with 213 
an intra-assay coefficient of variation of 6.1%, and an inter-assay coefficient of variation of 214 
7.7%. The reaction was monitored at 540 nm (UV-1603 spectrophotometer, Shimadzu). 215 
Protein carbonyl (PC) content was carried out in plasma samples using the method of Levine 216 
(Levine, Garland et al. 1990). Intra-assay coefficient of variation of 4.7%, and inter-assay 217 
coefficient of variation of 8.0%. The carbonyls were evaluated in a spectrophotometer (UV-218 
1603 Shimadzu, Kyoto, Japan) at 360 nm. 219 
 220 
Antioxidant enzyme activities 221 
Total superoxide dismutase (SOD; E.C: 1.15.1.1) activity was determined by colorimetric 222 
assay in plasma at wavelength of 525 nm according to the method described by McCord and 223 
Fridovich et al.(Nebot, Moutet et al. 1993), with an intra-assay coefficient of variation of 224 
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7.3%, and an inter-assay coefficient of variation of 8.7%.  Glutathione peroxidase (GPx; 225 
E.C.: 1.11.1.9) activity was evaluated in plasma by the Flohé and Gunzler method (Flohe and 226 
Gunzler 1984; Zhu, Zhang et al. 2008), with an intra-assay coefficient of variation of 6.5% 227 
and an inter-assay coefficient of variation of 7.2%.  The GPx assay is based on the oxidation 228 
of NADPH to NAD+, catalyzed by a limiting concentration of glutathione reductase, with 229 
maximum absorbance at 340 nm. The absorbance was evaluated in a Shimadzu UV-1603 230 
spectrophotometer (Kyoto, Japan).  231 
 232 
Statistical analysis 233 
The Statistical Package for the Social Sciences (SPSS 17.0 for Windows Inc., Chicago, IL, 234 
USA) was used for the statistical comparisons. RTL was analyzed as quartiles after removal 235 
of experimental outliers. Telomere length was categorized into quartiles (shortest to longest) 236 
and analyzed as a categorical variable. This resulted in the following distribution of RTL, 237 
quartile 1: RTL ≤ 1.10, quartile 2: 1.10 < RTL ≤ 1.26, quartile 3: 1.26 < RTL ≤ 1.56, quartile 238 
4: RTL > 1.56. 239 
 Univariate analysis of variance adjusted for age was performed to compare variables across 240 
quartiles of RTL with Bonferroni post hoc test used for multiple comparisons. Differences 241 
were considered to be significant when p < 0.05. All data presented in text and tables are 242 
expressed as the means ± standard error (SE). 243 
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Results 249 
Biochemical and anthropometric characteristics and metabolic assessment 250 
The anthropometric, biochemical, BP and metabolic parameters of the MetS subjects are 251 
shown in Table 1. Plasma TG was higher in the subjects with shortest RTL (quartile 1) 252 
compared to those in quartile 4 with largest RTL (p = 0.031). 253 
Baseline HOMAβ was greater in the subjects grouped in the quartile 4 with largest RTL 254 
compared with the subjects in the quartiles 1, 2 and 3 (p = 0.003). We did not find significant 255 
differences with respect to the remaining parameters between the four groups of MetS 256 
subjects acording to the RTL (Table 1). 257 
 258 
Study of endothelial function 259 
NO plasma levels were higher in the quartile 3 (p = 0.012) and 4 (p = 0.016) than the quartile 260 
1 (shortest RTL) (Figure 1a). In addition, IRH shows the same trend as the NO levels with 261 
greater percentage of change from baseline in the quartile 3 (longest RTL) (p = 0.015) and 4 262 
(p = 0.011) than quartile 1 (Figure 1b). 263 
 264 
Antioxidant enzymes activities and biomarker of oxidative stress 265 
We found that GPx plasma activity of subjects grouped in the quartile 4 with longer RTL was 266 
lower compared to quartile 1 with shorter RTL (p = 0.003), with intermediate activity levels 267 
for quartile 2 and 3 (Figure 2a). Although differences of SOD plasma activity between 268 
quartiles were not statistically significant, there was a marked trend that shows an increase in 269 
the activity of the enzyme in the quartile 1 with respect to the other RTL groups. 270 
PC plasma levels were higher in the subjects grouped in the quartile 1 with the shortest RTL 271 
compared with the subjects in quartile 4 (p =0.036; Figure 3). 272 
 273 
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Discussion 274 
MetS comprises a cluster of cardiovascular risk factors (low HDL-C, elevated BP, fasting 275 
glucose and TG, and abdominal obesity) (Reaven 2002) leading to accelerated 276 
atherosclerosis and an increased risk of type 2 diabetes. Additionally, MetS is associated with 277 
major cardiovascular events and a high mortality rate (McNeill, Rosamond et al. 2005; Van 278 
Guilder, Hoetzer et al. 2006). 279 
Although insulin resistance is considered to be at the core of the MetS in terms of molecular 280 
mechanisms, it is exponentially increasing the number of studies that point out the 281 
importance of OxS as a deep influence for MetS progression. In fact, in the same population 282 
of this study, we have previously demonstrated that MetS subjects with more MetS 283 
components (4 or 5 components) may have a higher OxS level (determined by SOD and GPx 284 
plasma activities, IRH and total nitrite plasma levels, among others parameters) (Yubero-285 
Serrano, Delgado-Lista et al. 2013). So, the study of the redox state in early MetS patients 286 
may provide a starting point for understanding the pathways that contribute to both the 287 
development of MetS and its subsequent complications.  288 
Taking this into account, the present cross-sectional study displays a gradual and inverse 289 
relationship between high OxS levels and endothelial dysfunction with regard to RTL in 290 
MetS patients showing that the shorter telomere length, the greater the degree of OxS, which 291 
leads to increased plasma activity of antioxidant enzymes (GPx, SOD), biomarker of OxS 292 
levels (PC) and decreased IRH and total NO levels. 293 
It has been documented that increased production of ROS results in damage to the 294 
endothelium, and along with others mechanisms involved in vascular aging process such as 295 
activation of inflammatory mediators, impairment of the NO pathway, telomeres length and 296 
telomerase activity, all together contribute to the dysregulation of vascular homeostasis 297 
(Marin, Yubero-Serrano et al. 2013).  298 
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NO is an endogenous vasodilator that promotes the increase of blood flow, decreases 299 
vascular resistance, inhibits platelet aggregation and also acts protecting endothelial cells 300 
from senescence and apoptosis (Ferroni, Basili et al. 2006; Toda 2012). A strong relationship 301 
has been found between telomere attrition and cell senescence in HUVECs, suggesting that 302 
DNA damage manifested as telomere shortening is likely to play a central role in the 303 
development of endothelial dysfunction in the pathogenesis of vascular disease (Hastings, 304 
Qureshi et al. 2004). Thus, MetS study subjects with the shortest RTL have the lowest level 305 
of plasmatic NO , and in accordance with this, they showed the lowest IRH as well . 306 
Interestingly, those MetS subjects with the shortest RTL are the ones whose antioxidant 307 
enzyme activities are higher, where plasma GPx activity is increased and plasma SOD 308 
activity presents the same trend. A plausible explanation to these observations is the fact that 309 
in response to OxS and to prevent oxidative damage, cells attempt to strengthen their 310 
antioxidant arsenal as the first line of defense. For this purpose, antioxidant enzymes such as 311 
SOD, GPx and catalase increase their activity to balance the excessive generated OxS 312 
(Yubero-Serrano, Delgado-Lista et al. 2013). Furthermore, we also found an increase in PC 313 
plasma levels in the subjects with the shortest RTL (Fig. 3). PC are an indicator of severe 314 
OxS, characterized by an irreversible damage to the protein structure and function and 315 
frequently associated with obesity, insulin resistance, diabetes mellitus and MetS (Hopps and 316 
Caimi 2013). Our present observation is consistent with a study in coronary artery disease 317 
patients with MetS where telomere shortening and oxidative stress damage in endothelial 318 
progenitor cells was higher than in those without MetS. They suggest that telomere attrition 319 
in response to OxS may induce enhanced endothelial damage and contribute to increase the 320 
risk of subsequent cardiovascular events (Satoh, Ishikawa et al. 2008). 321 
In this study, we measured telomere length in circulating leucocytes due to the fact that 322 
this method is less invasive than obtaining human vascular tissue from participants. 323 
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 14 
Although we did not study telomeres length in vascular cells, it has been demonstrated 324 
that circulating blood leucocyte DNA content is predictive of vascular telomere content 325 
and also is an accurate surrogate for vascular aging in population studies (Nakashima, 326 
Ozono et al. 2004; Wilson, Herbert et al. 2008). 327 
Furthermore, systemic OxS is increased in subjects with MetS and is strongly associated 328 
with visceral fat accumulation (Fujita, Nishizawa et al. 2006; Yubero-Serrano, Delgado-329 
Lista et al. 2013). In our study, we found that TG levels were higher and HOMAβ was 330 
lower in those people with shorter telomeres and increased OxS levels. The same 331 
findings have been shown in type diabetes mellitus patients where telomere length 332 
attrition was inversely correlated to TG levels and considerably explained by insulin 333 
resistance, which in turn, promoted an increase in ROS levels (Harte, da Silva et al. 334 
2012). 335 
We are aware that this cross-sectional study has some limitations since these findings do 336 
not prove a cause-and-effect relationship and the use of a small sample population. In 337 
this regard, larger and prospective studies are needed to elucidate which of the 338 
parameters studied herein has the strongest effect above the others. 339 
In summary, our results show that there is a clear link among endothelial function, OxS 340 
and RTL in MetS subjects. High levels of OxS may induce endothelial dysfunction and 341 
may increase telomere attrition. Thus, further support of the molecular and cellular 342 
mechanisms involved in vascular dysfunction may contribute to the development of 343 
strategies to decelerate vascular aging or prevent cardiovascular disease. 344 
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Figure captions 472 
Fig. 1 Total nitrite levels in plasma (A) and ischemic reactive hyperemia (B) across 473 
quartiles of RTL. Data were analyzed using univariate analysis of variance adjusted for 474 
age. All values represent the means ± s.e. Differences were considered to be significant 475 
when *p < 0.05 476 
 477 
Fig. 2 Glutathione peroxidase (GPx) plasma activity (A) and superoxide dismutase 478 
(SOD) plasma activity (B) across quartiles of RTL. Data were analyzed using univariate 479 
analysis of variance adjusted for age. All values represent the means ± s.e. Differences 480 
were considered to be significant when *p < 0.05 481 
 482 
Fig. 3 Protein carbonyl plasma levels across quartiles of RTL. Data were analyzed using 483 
univariate analysis of variance adjusted for age. All values represent the means ± s.e. 484 
Differences were considered to be significant when *p < 0.05 485 
 486 
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Abstract  
Previous evidences support that increased oxidative stress (OxS) may play an important role 
in metabolic syndrome (MetS) and both are closely linked to vascular dysfunction. This 
study determined whether there is a direct relationship between endothelial function and 
relative telomere length (RTL) in MetS subjects. In this cross-sectional study from the 
LIPGENE cohort, a total of 88 subjects (36 men and 52 women) were divided into four 
groups by quartiles of telomere length. We measured ischemic reactive hyperemia (IRH), 
total nitrite (NO) and protein carbonyl (PC) plasma levels, superoxide dismutase (SOD) and 
glutathione peroxidase (GPx) plasma activities. IRH and NO plasma levels were higher in 
subjects with longer RTL (quartile 3 and 4), while PC plasma levels and GPx and SOD 
plasma activities were lower in quartile 4 subjects (longest RTL). Additionally, MetS 
subjects with longer RTL had greater homeostatic model assessment-β (HOMAβ) level and 
lower triglycerides (TG) plasma levels. Our results suggest that endothelial dysfunction, 
associated by high levels of OxS, could be entailed in an increment of telomere attrition. 
Thus, further support of the molecular and cellular mechanisms involved in vascular 
dysfunction may contribute to the development of strategies to decelerate vascular aging or 
prevent cardiovascular disease. 
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Table 1. Baseline characteristics of the study population according to quartiles of RTL
 1,2,3
. 
 
 
 
1 
Data are means ± SE. HOMAIR, homeostatic model assessment index for insulin resistance; HOMAβ, 
homeostatic model assessment index of insulin secretory function; BMI, body mass index; TG, 
triglycerides; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol; 
SBP, systolic blood pressure; DBP, diastolic blood pressure; hsCRP, high sensitivity C-reactive protein. 
2 
Means in a column with different superscript letters are significantly different, p < 0.05 (Univariate analysis 
of variance adjusted for age).  
3 
Quartile 1: RTL ≤ 1.10, quartile 2: 1.10 < RTL ≤ 1.26, quartile 3: 1.26 < RTL ≤ 1.56, quartile 4: RTL > 
1.56. 
 
Quartile 1 
(n = 22) 
Quartile 2 
(n = 24) 
Quartile 3 
(n = 20) 
Quartile 4 
(n = 22) 
p 
 
Age (years) 
Sex (female/male) 
HOMAIR  
HOMAβ 
 
59.73 ± 1.87 
14/8 
3.37 ± 0.07 
89.94 ± 9.31a 
 
59.71 ± 1.55 
14/10 
3.97 ± 0.10 
91.77 ± 8.93 a 
 
58.60 ± 1.60 
12/8 
3.42 ± 0.11 
94.21 ± 9.69 a 
 
56.59 ± 1.94 
12/10 
4.32 ± 0.12 
139.14 ± 9.49 b 
  
       0.540 
 
       0.700 
       0.003 
Weight (kg) 87.78 ± 2.74 86.50 ± 2.63 89.66 ± 2.85 96.06 ± 2.79 0.940 
Height (m) 1.57 ± 0.03 1.62 ± 0.02 1.54 ± 0.05 1.56 ± 0.04 0.129 
BMI 
Waist 
circumference (cm) 
34.28 ± 0.88 
106.34 ± 2.18 
 
33.68 ± 0.84 
103.54 ± 2.09 
 
34.28 ± 0.92 
108.40 ± 2.27 
 
35.28 ± 0.90 
109.71 ± 2.22 
 
0.800 
0.937 
Insulin (mU/L) 12.22 ± 2.10 14.71 ± 2.05 12.69 ± 2.19 15.04 ± 2.14 0.657 
Glucose (nmol/L) 6.29 ± 0.22 6.20 ± 0.22 5.93 ± 0.23 5.03 ± 0.23 0.143 
TG (nmol/L) 1.89 ± 0.14 a 1.51 ± 0.13 a, b 1.55 ± 0.15 a, b 1.27 ± 0.14 b 0.031 
LDL-C (nmol/L) 17.38 ± 8.63 34.02 ± 8.27 21.30 ± 8.78 26.16 ± 8.97 0.647 
HDL-C (nmol/L) 1.11 ± 0.05 1.22 ± 0.05 1.08 ± 0.06 1.09 ± 0.06 0.325 
hsCRP (mg/L) 6.63 ± 1.17 5.24 ± 1.12 7.09 ± 1.19 6.52 ± 1.16 0.573 
SBP (mm Hg) 142 ± 3 144 ± 3 138 ± 3 142 ± 3 0.306 
DBP (mm Hg) 87 ± 3 87 ± 2 88 ± 3 89 ± 3 0.900 
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Supplementary Table 1. Inclusion and exclusion criteria of the LIPGENE study
Inclusion Criteria 
Age: 35-70 years. 
Gender: males and females (not pregnant or lactating). 
Body mass index (BMI) 20-40 kg/m2
Total cholesterol concentration equal to or <8.0 mmol/L. 
Medications/nutritional supplements allowed, on conditions that the subjects adhere to the same regimen 
during the study: anti-hypertensive medication (including beta-blockers), oral contraceptives, hormone 
replacement therapy, multi-vitamin supplements, other non-fatty acid based nutritional supplements. 
Smokers and non-smokers. 
Regular consumers of alcohol, which is not excessive as defined by elevated liver enzymes (AST and 
ALT). 
Ethnicity: intention to include white Europeans. 
Exclusion criteria 
Age: <35 or >70 years. 
Diabetes or other endocrine disorders. 
Chronic inflammatory conditions. 
Kidney or liver dysfunction. 
Iron deficiency anaemia (haemoglobin <12 g/dL men, <11g/dL women). 
Prescribed hypolipidaemic medication. 
Prescribed anti-inflammatory medication. 
Fatty supplements including fish oils, evening primrose oil, etc. 
Consumers of high doses of antioxidant vitamins (A, C, E,  -carotene). 
Red rice yeast (Monascus purpureus) supplement usage. 
High consumers of oily fish (>2 serving of oily fish per week). 
Highly trained or endurance athletes or those who participate in more than three periods of intense 
exercise per week. 
Volunteers planning to start a special diet or lose weight (e.g. the Slimfast Plan, Atkins Diet, etc.). 
Weight change equal or >3 kg within the last 3 months. 
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Alcohol or drug abuse (based on clinical judgment). 
Pregnant/lactating females/women planning a pregnancy in the next 12 months.  


